Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
hepaticobiliary system development (GO:0061008),6/21,4.3681286612199635e-4,1,0,0,5.7142857142857135,44.20574673462788,NIPBL;RARA;ARID5B;PCSK9;LSR;PROX1
ear development (GO:0043583),3/6,0.0022241766503380937,1,0,0,10,61.08368476639271,NIPBL;SHROOM2;ECE1
positive regulation of T-helper 2 cell differentiation (GO:0045630),3/6,0.0022241766503380937,1,0,0,10,61.08368476639271,RARA;IL18;NLRP3
liver development (GO:0001889),6/31,0.0038666123029882523,1,0,0,3.8709677419354835,21.50468333887265,RARA;PCSK9;ARID5B;LSR;PROX1;PCK2
regulation of clathrin-dependent endocytosis (GO:2000369),4/15,0.005444864346461733,1,0,0,5.333333333333333,27.803106327047363,DAB2;BMP2K;SNAP91;SCYL2
regulation of RNA export from nucleus (GO:0046831),4/15,0.005444864346461733,1,0,0,5.333333333333333,27.803106327047363,RBM27;ZC3H3;TPR;IWS1
regulation of dopamine uptake involved in synaptic transmission (GO:0051584),3/8,0.005774732022768516,1,0,0,7.5,38.65697569976054,DRD3;DRD4;SNCA
ketone biosynthetic process (GO:0042181),3/8,0.005774732022768516,1,0,0,7.5,38.65697569976054,CYP11B2;LHB;CACNA1H
regulation of T-helper 2 cell differentiation (GO:0045628),3/8,0.005774732022768516,1,0,0,7.5,38.65697569976054,RARA;IL18;NLRP3
regulation of systemic arterial blood pressure by hormone (GO:0001990),4/16,0.006976160030101439,1,0,0,5,24.82628326271881,AVPR1B;CYP11B2;ECE1;CORIN
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,DMXL1;ATP6V0A2;TCIRG1
protein autoprocessing (GO:0016540),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,F12;HTRA2;PCSK9
proton-transporting V-type ATPase complex assembly (GO:0070070),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,DMXL1;ATP6V0A2;TCIRG1
regulation of receptor recycling (GO:0001919),4/17,0.008766901403579476,1,0,0,4.705882352941176,22.2906910717708,INPP5F;PCSK9;ECE1;SNCA
positive regulation of receptor recycling (GO:0001921),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,INPP5F;ECE1;SNCA
glucocorticoid biosynthetic process (GO:0006704),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,HSD11B1;CYP11B2;CACNA1H
positive regulation of type 2 immune response (GO:0002830),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,RARA;IL18;NLRP3
positive regulation of type I interferon production (GO:0032481),8/62,0.01172166235636015,1,0,0,2.5806451612903225,11.474365588675184,CREBBP;TBK1;PRKDC;FLOT1;POLR2E;POLR3F;POLR3K;POLR2K
gland development (GO:0048732),9/75,0.012264979583150324,1,0,0,2.4,10.56241743819921,TG;IGSF3;RARA;PCSK9;ARID5B;LSR;PROX1;PTF1A;DKK3
sulfur compound transport (GO:0072348),4/19,0.01318872540853091,1,0,0,4.2105263157894735,18.224812421427043,SLC5A6;SLC25A26;SLC26A8;SLC26A7
response to axon injury (GO:0048678),3/11,0.015204352818016067,1,0,0,5.454545454545454,22.833673759197463,DHFR;MORN4;MTR
positive regulation of heterotypic cell-cell adhesion (GO:0034116),3/11,0.015204352818016067,1,0,0,5.454545454545454,22.833673759197463,FGG;FLOT1;BMP7
positive regulation of T-helper cell differentiation (GO:0045624),3/11,0.015204352818016067,1,0,0,5.454545454545454,22.833673759197463,RARA;IL18;NLRP3
positive regulation of cellular metabolic process (GO:0031325),10/92,0.0165088392043829,1,0,0,2.1739130434782608,8.921433330782813,INPP5F;ANGPT1;RAB1B;CCL5;NR1H2;PCSK9;ECE1;AGPAT1;SCYL2;SNCA
regulation of actomyosin structure organization (GO:0110020),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,AKAP13;ASAP3;SLC9A1
microtubule bundle formation (GO:0001578),5/32,0.020257193169988103,1,0,0,3.125,12.185141656980141,RSPH4A;TPPP3;MTCL1;KIF20A;CDK5RAP2
regulation of endocytosis (GO:0030100),8/69,0.02140241958132488,1,0,0,2.318840579710145,8.914205910255662,RAB5B;DAB2;SNX17;FLOT1;BMP2K;ABL2;SYT7;SNCA
response to organic cyclic compound (GO:0014070),8/69,0.02140241958132488,1,0,0,2.318840579710145,8.914205910255662,DHFR;PAQR9;CHRNB3;KYNU;CCL5;IL18;DRD3;DRD4
water transport (GO:0006833),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,AQP10;AQP8;AQP4
alpha-linolenic acid metabolic process (GO:0036109),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,FADS2;ACSL1;FADS1
catecholamine biosynthetic process (GO:0042423),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,PNMT;INSM1;SNCA
pre-miRNA processing (GO:0031054),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,AGO3;AGO1;DROSHA
response to insulin (GO:0032868),8/71,0.024980280826104758,1,0,0,2.2535211267605635,8.314745988304397,GHRHR;CITED1;TBC1D4;PRKDC;PCSK9;INHBB;FOXO1;PCK2
melanosome organization (GO:0032438),4/23,0.025734894590821872,1,0,0,3.4782608695652173,12.730112841155169,BLOC1S6;TRAPPC6A;BLOC1S1;SHROOM2
regulation of interferon-beta production (GO:0032648),5/34,0.02579993741840051,1,0,0,2.941176470588235,10.757009449120288,TBK1;RNF216;FLOT1;POLR3F;NLRC3
regulation of lipid metabolic process (GO:0019216),10/100,0.02784947913949708,1,0,0,2,7.1618820302714505,NCOR2;CREBBP;HDAC3;ACSL1;TBL1XR1;PSAP;CYP4A11;EDF1;HMGCS2;FADS1
positive regulation of cytokine production (GO:0001819),18/220,0.027898246955660958,1,0,0,1.6363636363636362,5.856858695878907,CREBBP;PRKDC;IL18;AGPAT1;ISL1;CCDC88B;TBK1;IL7;RARA;FLOT1;POLR2E;POLR3F;NLRP3;LBP;TLR5;IL6ST;POLR3K;POLR2K
cellular modified amino acid biosynthetic process (GO:0042398),4/24,0.02969412469495944,1,0,0,3.333333333333333,11.722686914871057,GCLC;PLSCR1;PTDSS1;OPLAH
neuromuscular synaptic transmission (GO:0007274),4/24,0.02969412469495944,1,0,0,3.333333333333333,11.722686914871057,SLC5A7;CHRNB3;DTNA;RIMBP2
regulation of cardiac muscle cell action potential (GO:0098901),4/24,0.02969412469495944,1,0,0,3.333333333333333,11.722686914871057,SLMAP;CTNNA3;FGF13;DSC2
fluid transport (GO:0042044),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,AQP10;AQP8;AQP4
modified amino acid transport (GO:0072337),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,SLC5A6;SLC7A9;FOLR2
pancreas development (GO:0031016),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,PROX1;PTF1A;ISL1
cardiac muscle tissue development (GO:0048738),5/36,0.032227243715029656,1,0,0,2.7777777777777777,9.541508627909957,AKAP13;SGCD;PROX1;BMP7;SGCG
negative regulation of mRNA catabolic process (GO:1902373),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PKP1;PKP3
mineralocorticoid biosynthetic process (GO:0006705),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CYP11B2;CACNA1H
regulation of superoxide metabolic process (GO:0090322),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,DHFR;BMP7
regulation of dopamine metabolic process (GO:0042053),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,HTR1A;DRD4
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CTNNA3;DSC2
renal system process involved in regulation of blood volume (GO:0001977),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CYP11B2;CYP4A11
regulation of ribonucleoprotein complex localization (GO:2000197),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,ZC3H3;IWS1
intermediate filament bundle assembly (GO:0045110),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,KRT14;PKP1
regulation of cellular response to oxidative stress (GO:1900407),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,DHFR;BMP7
cerebral cortex cell migration (GO:0021795),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,HTR6;FGF13
telencephalon cell migration (GO:0022029),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,HTR6;FGF13
positive regulation of clathrin-dependent endocytosis (GO:2000370),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,DAB2;SCYL2
cellular nitrogen compound catabolic process (GO:0044270),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,TST;CYP3A5
negative regulation of delayed rectifier potassium channel activity (GO:1902260),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,KCNE3;KCNRG
regulation of mRNA export from nucleus (GO:0010793),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,ZC3H3;IWS1
regulation of sarcomere organization (GO:0060297),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,AKAP13;PROX1
negative regulation of Ras protein signal transduction (GO:0046580),5/37,0.03578300819815846,1,0,0,2.7027027027027026,9.000762512391741,RASA4B;MYOC;RASA1;SPRY2;STAMBP
regulation of mRNA metabolic process (GO:1903311),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,RBM27;CDK11A;IWS1
catecholamine metabolic process (GO:0006584),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,PNMT;DRD3;DRD4
vesicle coating (GO:0006901),7/63,0.037195930953808354,1,0,0,2.222222222222222,7.314568681439843,GRIA1;TRAPPC6A;SEC24A;SAR1B;PDCD6;RAB1B;PPP6R3
COPII vesicle coating (GO:0048208),7/63,0.037195930953808354,1,0,0,2.222222222222222,7.314568681439843,GRIA1;TRAPPC6A;SEC24A;SAR1B;PDCD6;RAB1B;PPP6R3
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",7/63,0.037195930953808354,1,0,0,2.222222222222222,7.314568681439843,GRIA1;TRAPPC6A;SEC24A;SAR1B;PDCD6;RAB1B;PPP6R3
monovalent inorganic cation homeostasis (GO:0055067),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,SLC12A5;CYP11B2;CYP4A11;SLC9A1
positive regulation of innate immune response (GO:0045089),5/38,0.03957106613030883,1,0,0,2.631578947368421,8.499097581720862,PLSCR1;CCL5;POLR3F;LBP;TLR5
response to organonitrogen compound (GO:0010243),6/51,0.040857843918708184,1,0,0,2.352941176470588,7.523897549447783,DHFR;VCP;AVPR1B;KYNU;DRD3;DRD4
coenzyme metabolic process (GO:0006732),6/51,0.040857843918708184,1,0,0,2.352941176470588,7.523897549447783,SLC5A6;VNN2;THEM4;GLYAT;PPCDC;COASY
lipopolysaccharide-mediated signaling pathway (GO:0031663),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,CCL5;IL18;LBP
C21-steroid hormone biosynthetic process (GO:0006700),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,CYP11B2;LHB;CACNA1H
DNA alkylation (GO:0006305),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,DNMT1;EHMT2;GATAD2A
DNA methylation or demethylation (GO:0044728),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,DNMT1;EHMT2;GATAD2A
negative regulation of transcription regulatory region DNA binding (GO:2000678),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,MSX2;HEY1;ANKRD33
linoleic acid metabolic process (GO:0043651),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,FADS2;ACSL1;FADS1
negative regulation of microtubule polymerization or depolymerization (GO:0031111),4/27,0.04362093265098386,1,0,0,2.962962962962963,9.280646332348267,STMN2;FGF13;SNCA;CLASP2
negative regulation of small GTPase mediated signal transduction (GO:0051058),4/27,0.04362093265098386,1,0,0,2.962962962962963,9.280646332348267,RASA4B;RASA1;SPRY2;STAMBP
negative regulation of cell-matrix adhesion (GO:0001953),4/27,0.04362093265098386,1,0,0,2.962962962962963,9.280646332348267,MYOC;RASA1;SEMA3E;CLASP2
phosphatidylserine metabolic process (GO:0006658),4/27,0.04362093265098386,1,0,0,2.962962962962963,9.280646332348267,PTDSS1;PLA2G12A;PLSCR1;PLA2G4E
inner ear receptor stereocilium organization (GO:0060122),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,CLIC5;STRC
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,CTNNA3;DSC2
axon regeneration (GO:0031103),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,DHFR;MTR
coenzyme A biosynthetic process (GO:0015937),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PPCDC;COASY
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,ACAA2;THEM4
ribonucleoside bisphosphate biosynthetic process (GO:0034030),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PPCDC;COASY
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,AGO3;AGO1
protein import into mitochondrial inner membrane (GO:0045039),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,TIMM29;TIMM10
positive regulation of protein deubiquitination (GO:1903003),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,VCP;SART3
regulation of histone H3-K9 acetylation (GO:2000615),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,ZNF451;PIH1D1
protein deglutamylation (GO:0035608),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,AGBL4;AGBL1
ion homeostasis (GO:0050801),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,SLC12A5;WNK4
purine nucleoside bisphosphate biosynthetic process (GO:0034033),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PPCDC;COASY
response to peptide hormone (GO:0043434),5/40,0.04785273553053826,1,0,0,2.5,7.599067484612446,GHRHR;EIF2B2;CITED1;CYP11B2;GNAI1
regulation of calcium ion-dependent exocytosis (GO:0017158),6/53,0.04794761992015593,1,0,0,2.2641509433962264,6.87768931830856,RIMS4;SYT2;SYTL1;SYT13;CACNA1H;SYT7
regulation of cellular component organization (GO:0051128),12/140,0.04815770081203593,1,0,0,1.7142857142857142,5.199898662402965,RAB5B;CDK11A;ZMYM2;BBS10;NCLN;SNX17;FAM107A;BMP2K;ABL2;NOX5;INSM1;SGK1
regulation of mRNA processing (GO:0050684),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,RBM27;CDK11A;IWS1;JMJD6
regulation of receptor internalization (GO:0002090),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,ANGPT1;FLOT1;PCSK9;SCYL2
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,SEC24A;SAR1B;HFE;HLA-C
regulation of telomere maintenance via telomere lengthening (GO:1904356),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,TNKS2;SLX1A;SMG6
negative regulation of telomere maintenance (GO:0032205),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,TNKS2;SLX1A;SMG6
cardiac atrium morphogenesis (GO:0003209),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,PROX1;ISL1;MYH6
epithelial cell differentiation (GO:0030855),9/96,0.05070537903135276,1,0,0,1.875,5.590731147599537,DAB2;CITED1;TST;DHRS9;PIH1D1;RARA;EDF1;PROX1;PCK2
cellular response to nutrient levels (GO:0031669),6/54,0.05175964311269336,1,0,0,2.222222222222222,6.580321164119916,PLEKHF1;EHMT2;PCSK9;INHBB;FADS1;FOXO1
C-terminal protein amino acid modification (GO:0018410),8/82,0.05220786888704381,1,0,0,1.951219512195122,5.7610186351061445,AGBL4;PSCA;VNN2;AGBL1;XPNPEP2;FOLR2;PRSS21;ATG4D
positive regulation of receptor-mediated endocytosis (GO:0048260),5/41,0.05234904272896249,1,0,0,2.4390243902439024,7.194686897103624,DAB2;ANGPT1;HFE;PCSK9;SCYL2
COPII-coated vesicle budding (GO:0090114),7/68,0.05279047635145934,1,0,0,2.0588235294117645,6.0558739225566685,GRIA1;TRAPPC6A;SEC24A;SAR1B;PDCD6;RAB1B;PPP6R3
cellular response to nitric oxide (GO:0071732),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,MTR;FOXO1
"regulation of synaptic transmission, dopaminergic (GO:0032225)",2/8,0.05721089072209802,1,0,0,5,14.305055007400815,FLOT1;DRD3
response to epinephrine (GO:0071871),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SLC9A1;SNCA
"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",2/8,0.05721089072209802,1,0,0,5,14.305055007400815,PRMT7;PRMT3
regulation of histone H4 acetylation (GO:0090239),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,PIH1D1;IWS1
organophosphate catabolic process (GO:0046434),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,LIPG;ENPP2
cellular response to reactive nitrogen species (GO:1902170),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,MTR;FOXO1
arachidonic acid secretion (GO:0050482),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,DRD3;DRD4
bundle of His cell to Purkinje myocyte communication (GO:0086069),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,CTNNA3;DSC2
negative regulation of voltage-gated potassium channel activity (GO:1903817),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,KCNE3;KCNRG
peptidyl-lysine hydroxylation (GO:0017185),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,P3H4;JMJD6
protein localization to microtubule cytoskeleton (GO:0072698),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,KIF20B;FAM83D
negative regulation of hippo signaling (GO:0035331),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,DLG5;MARK3
cellular response to epinephrine stimulus (GO:0071872),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SLC9A1;SNCA
arachidonate transport (GO:1903963),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,DRD3;DRD4
exocrine system development (GO:0035272),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,IGSF3;PTF1A
establishment of protein localization to chromatin (GO:0071169),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,NIPBL;PIH1D1
short-chain fatty acid catabolic process (GO:0019626),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,ACADS;PCK2
acid secretion (GO:0046717),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SLC51A;DRD3
peptidyl-lysine acetylation (GO:0018394),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,CREBBP;BLOC1S1
aldehyde biosynthetic process (GO:0046184),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,CYP11B2;CACNA1H
response to ammonium ion (GO:0060359),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,DRD3;DRD4
pantothenate metabolic process (GO:0015939),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SLC5A6;VNN2
negative regulation of microtubule depolymerization (GO:0007026),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,STMN2;FGF13;CLASP2
DNA methylation (GO:0006306),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,DNMT1;EHMT2;GATAD2A
cellular defense response (GO:0006968),6/56,0.059923284693461636,1,0,0,2.142857142857143,6.031478835629902,CX3CR1;CLEC5A;TCIRG1;LBP;KIR2DL4;KLRG1
organonitrogen compound catabolic process (GO:1901565),6/56,0.059923284693461636,1,0,0,2.142857142857143,6.031478835629902,SGPL1;TST;CPQ;ENPP2;GGACT;CYP3A5
negative regulation of secretion by cell (GO:1903531),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,PNKD;DRD3;DRD4;SNCA
regulation of sodium ion transmembrane transport (GO:1902305),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,FXYD6-FXYD2;BPIFA1;SLMAP;SCN1B
regulation of type I interferon production (GO:0032479),8/85,0.0620374999040044,1,0,0,1.8823529411764706,5.232971745159451,CREBBP;TBK1;RNF216;PRKDC;POLR2E;POLR3F;POLR3K;POLR2K
histone methylation (GO:0016571),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,PRMT7;EHMT2;PRMT3
production of small RNA involved in gene silencing by RNA (GO:0070918),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,AGO3;AGO1;DROSHA
regulation of heterotypic cell-cell adhesion (GO:0034114),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,FGG;FLOT1;BMP7
positive regulation of toll-like receptor signaling pathway (GO:0034123),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,FLOT1;LBP;TLR5
regulation of neuron migration (GO:2001222),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,NIPBL;ULK4;KIF20B
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,RARA;NLRC3;LBP;SLAMF1
renal water homeostasis (GO:0003091),4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,CYP11B2;PRKAR2A;CYP4A11;AQP4
positive regulation of interleukin-1 beta production (GO:0032731),4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,GSDMD;NLRP7;NLRP3;ISL1
inorganic anion transport (GO:0015698),5/44,0.06726261217595207,1,0,0,2.2727272727272725,6.134433491895637,CLIC5;SLC26A8;ANO9;SLC26A7;SLC17A3
positive regulation of cellular component biogenesis (GO:0044089),8/87,0.0691914842374525,1,0,0,1.839080459770115,4.911958591417849,VCP;TAL1;PIH1D1;DLG5;TPR;FLOT1;SLX1A;BMP7
small RNA loading onto RISC (GO:0070922),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,AGO3;AGO1
negative regulation of cytokine production involved in inflammatory response (GO:1900016),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NLRP7;NLRC3
megakaryocyte differentiation (GO:0030219),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,TAL1;ZNF385A
actin crosslink formation (GO:0051764),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,BAIAP2L2;PLS1
sterol catabolic process (GO:0016127),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SNX17;CYP46A1
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,PIH1D1;HTRA2
peptidyl-arginine omega-N-methylation (GO:0035247),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,PRMT7;PRMT3
L-ascorbic acid metabolic process (GO:0019852),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,GSTO2;GSTO1
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NLRC3;STAMBP
sympathetic ganglion development (GO:0061549),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,INSM1;SEMA3F
peptidyl-arginine methylation (GO:0018216),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,PRMT7;PRMT3
cholesterol catabolic process (GO:0006707),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SNX17;CYP46A1
negative regulation of microtubule polymerization (GO:0031115),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,STMN2;SNCA
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,HFE;HLA-C
brain development (GO:0007420),10/119,0.07467856020884321,1,0,0,1.680672268907563,4.360608806670558,EGR2;NIPBL;CENPF;ZIC1;SHROOM2;RARA;VCX;PROX1;EML1;CDK5RAP2
vacuolar acidification (GO:0007035),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,DMXL1;ATP6V0A2;TCIRG1
dopamine metabolic process (GO:0042417),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,DRD3;DRD4;SNCA
negative regulation of protein depolymerization (GO:1901880),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,STMN2;FGF13;CLASP2
eye morphogenesis (GO:0048592),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,NIPBL;MFAP2;SHROOM2
RNA secondary structure unwinding (GO:0010501),5/46,0.07838227433911542,1,0,0,2.1739130434782608,5.535124934351927,DDX3Y;DDX18;AGO3;AGO1;DDX21
positive regulation of cell-cell adhesion (GO:0022409),4/33,0.08064706826013496,1,0,0,2.4242424242424243,6.103449276278521,CCL5;FGG;FLOT1;BMP7
protein acetylation (GO:0006473),4/33,0.08064706826013496,1,0,0,2.4242424242424243,6.103449276278521,CREBBP;BLOC1S1;NAA35;FOXO1
positive regulation of cellular component organization (GO:0051130),9/106,0.08354955967552062,1,0,0,1.6981132075471697,4.215252386285451,VCP;DAB2;TMED9;TAL1;PIH1D1;DLG5;FLOT1;BMP7;SNCA
"positive regulation of gene expression, epigenetic (GO:0045815)",5/47,0.08428928588938157,1,0,0,2.127659574468085,5.26276705761003,WBP2;POLR2E;DDX21;ARID1A;POLR2K
ventricular cardiac muscle tissue development (GO:0003229),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,PROX1;ISL1;MYH6
positive regulation of receptor internalization (GO:0002092),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,ANGPT1;PCSK9;SCYL2
adrenal gland development (GO:0030325),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,INSM1;DKK3
ganglion development (GO:0061548),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,INSM1;SEMA3F
adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,DRD3;DRD4
neuron projection regeneration (GO:0031102),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,DHFR;MTR
oxalate transport (GO:0019532),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SLC26A8;SLC26A7
glycine metabolic process (GO:0006544),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,GLYAT;GCAT
negative regulation of gene silencing by miRNA (GO:0060965),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NCOR2;DND1
negative regulation of interleukin-1 beta secretion (GO:0050713),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NLRP7;NLRP3
coenzyme A metabolic process (GO:0015936),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PPCDC;COASY
glucocorticoid metabolic process (GO:0008211),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,HSD11B1;CYP11B2
response to histamine (GO:0034776),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,DRD3;DRD4
ketone body metabolic process (GO:1902224),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,OXCT1;HMGCS2
regulation of primary metabolic process (GO:0080090),11/139,0.08883451839382546,1,0,0,1.58273381294964,3.8317668809376055,NCOR2;CREBBP;HDAC3;ACSL1;TBL1XR1;PSAP;CYP4A11;EDF1;HMGCS2;OAZ1;FADS1
ion transport (GO:0006811),20/289,0.0892911579048934,1,0,0,1.384083044982699,3.343740915743597,CHRNB3;SLC12A5;TRPA1;AQP8;WNK4;CLCNKA;ANO9;AQP4;TCIRG1;MCOLN1;SLC9A1;TPCN1;SLC25A26;SLC25A18;ATP6V0A2;SLC26A8;SLC26A7;SGK1;SLC17A3;CNGB1
water-soluble vitamin metabolic process (GO:0006767),7/77,0.08989981224700702,1,0,0,1.8181818181818181,4.380108047221139,SLC5A6;DHFR;GSTO2;VNN2;GSTO1;MTR;FOLR2
monocarboxylic acid metabolic process (GO:0032787),9/108,0.09136126354936079,1,0,0,1.6666666666666665,3.9882228378768496,SLC5A6;SGPL1;VNN2;UGT1A1;KYNU;CYP4A11;THEM4;GLYAT;PCK2
response to lipid (GO:0033993),11/140,0.09230308564529764,1,0,0,1.5714285714285714,3.7442078259491387,PRDX3;RPS6KA3;PAQR9;TMEM161A;CITED1;NR1H2;RARA;LBP;PCK2;TNFRSF10D;SNCA
kidney development (GO:0001822),6/63,0.09416438282354153,1,0,0,1.9047619047619047,4.500406229636559,NIPBL;CENPF;CITED1;PCSK9;PROX1;BMP7
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),6/63,0.09416438282354153,1,0,0,1.9047619047619047,4.500406229636559,GRM4;PSAP;HTR1A;DRD3;GNAI1;DRD4
positive regulation of erythrocyte differentiation (GO:0045648),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,FAM210B;TAL1;ZNF16
regulation of microtubule depolymerization (GO:0031114),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,STMN2;FGF13;CLASP2
digestive system development (GO:0055123),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,NIPBL;CLMP;PTF1A
regulation of heart rate by cardiac conduction (GO:0086091),4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,KCNE3;CTNNA3;SCN1B;DSC2
regulation of sodium ion transport (GO:0002028),4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,BPIFA1;SLMAP;WNK4;SCN1B
negative regulation of tumor necrosis factor production (GO:0032720),4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,RARA;NLRC3;LBP;SLAMF1
double-strand break repair (GO:0006302),11/141,0.09585244935606095,1,0,0,1.5602836879432624,3.6587798316871667,VCP;NIPBL;HERC2;RECQL5;EYA1;PRKDC;RAD21L1;APLF;SMC5;SLX1A;POLL
RNA metabolic process (GO:0016070),14/191,0.09837144633280481,1,0,0,1.4659685863874343,3.3995880368694835,DDX3Y;DDX18;DIS3L;DDX21;RNASE1;LRPPRC;STK31;LSM7;AGO3;AGO1;XRN2;POLR2E;DROSHA;POLR2K
positive regulation of macromolecule metabolic process (GO:0010604),19/276,0.09943734490452574,1,0,0,1.3768115942028984,3.1779944289607007,DNMT1;RHOXF1;CITED1;ANGPT1;HFE;PCSK9;ECE1;ACTG2;MAPK11;PLSCR1;C1QTNF1;INPP5F;LAMP3;PKP1;ITGB8;SPRY2;PKP3;SCYL2;SNCA
cellular response to insulin stimulus (GO:0032869),9/110,0.09958757105985591,1,0,0,1.6363636363636362,3.7746293084737976,BAIAP2L2;TBC1D4;PRKDC;ATP6V0A2;PCSK9;INHBB;TCIRG1;FOXO1;PCK2
sulfate transmembrane transport (GO:1902358),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,SLC26A8;SLC26A7
regulation of hippo signaling (GO:0035330),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DLG5;MARK3
interleukin-27-mediated signaling pathway (GO:0070106),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,IL6ST;IL27RA
positive regulation of cell cycle phase transition (GO:1901989),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,FAM83D;ZNF16
xenobiotic glucuronidation (GO:0052697),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,UGT1A1;UGT2B28
cell-substrate junction assembly (GO:0007044),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,COL17A1;KRT14
low-density lipoprotein particle remodeling (GO:0034374),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,LPA;MPO
regulation of ventricular cardiac muscle cell action potential (GO:0098911),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CTNNA3;DSC2
myeloid cell activation involved in immune response (GO:0002275),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,LBP;SLAMF1
negative regulation of peptide secretion (GO:0002792),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DRD3;DRD4
negative regulation of histone acetylation (GO:0035067),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ZNF451;SNCA
negative regulation of receptor binding (GO:1900121),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,HFE;PCSK9
progesterone metabolic process (GO:0042448),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DHRS9;LHB
response to nitric oxide (GO:0071731),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,MTR;FOXO1
heart process (GO:0003015),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,SGCD;SGCG
regulation of synaptic vesicle cycle (GO:0098693),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,RIMS4;SNCA
cellular response to increased oxygen levels (GO:0036295),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ATP6V0A2;FOXO1
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DRD4;SLC9A1
icosanoid secretion (GO:0032309),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DRD3;DRD4
"negative regulation of translation, ncRNA-mediated (GO:0040033)",2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,AGO3;AGO1
hemidesmosome assembly (GO:0031581),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,COL17A1;KRT14
glutathione biosynthetic process (GO:0006750),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,GCLC;OPLAH
miRNA mediated inhibition of translation (GO:0035278),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,AGO3;AGO1
interleukin-35-mediated signaling pathway (GO:0070757),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,IL6ST;IL27RA
alcohol catabolic process (GO:0046164),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,SNX17;CYP46A1
regulation of receptor-mediated endocytosis (GO:0048259),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,HFE;FLOT1;BMP2K;SNAP91
transferrin transport (GO:0033572),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,HFE;ATP6V0A2;TCIRG1;MCOLN1
positive regulation of signaling (GO:0023056),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,RIMS4;INPP5F;ECE1;SNCA
zymogen activation (GO:0031638),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,F12;FGG;F11;FURIN
ferric iron transport (GO:0015682),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,HFE;ATP6V0A2;TCIRG1;MCOLN1
negative regulation of blood coagulation (GO:0030195),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,C1QTNF1;F12;FGG;F11
microtubule polymerization or depolymerization (GO:0031109),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,TPPP3;STMN2;FGF13
metanephros development (GO:0001656),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,NIPBL;CITED1;BMP7
epithelial to mesenchymal transition (GO:0001837),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,HEY1;DLG5;FAM83D;BMP7
regulation of regulated secretory pathway (GO:1903305),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,SYT2;SYTL1;SYT13;SYT7
regulation of sodium ion transmembrane transporter activity (GO:2000649),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,FXYD6-FXYD2;SLMAP;PCSK9;SCN1B
negative regulation of G0 to G1 transition (GO:0070317),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,RRM2;EHMT2;MGA;PHC3
regulation of macromolecule metabolic process (GO:0060255),10/129,0.1121294602199553,1,0,0,1.5503875968992247,3.3924049308497413,DDX3Y;MAPK11;CDK11A;SART3;NLRP7;RASA1;FLOT1;NLRP3;PROX1;INSM1
regulation of cell-matrix adhesion (GO:0001952),5/52,0.11715876376056604,1,0,0,1.9230769230769231,4.123510209226117,MYOC;RASA1;SEMA3E;EPHA1;SLC9A1
histone modification (GO:0016570),8/98,0.11716919712760449,1,0,0,1.6326530612244896,3.500630627798508,CREBBP;PRMT7;EYA1;TBL1XR1;EYA2;EHMT2;MSL3;CPA4
retinol metabolic process (GO:0042572),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,DHRS9;LRAT
carbohydrate derivative transport (GO:1901264),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,LBP;MFSD2A
cell differentiation in hindbrain (GO:0021533),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,KNDC1;PROX1
positive regulation of skeletal muscle tissue development (GO:0048643),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,GPC1;FLOT1
cellular response to arsenic-containing substance (GO:0071243),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,GSTO2;GSTO1
histone arginine methylation (GO:0034969),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,PRMT7;PRMT3
nonribosomal peptide biosynthetic process (GO:0019184),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,GCLC;OPLAH
plasminogen activation (GO:0031639),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,FGG;F11
spliceosomal tri-snRNP complex assembly (GO:0000244),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,SART3;PRPF8
negative regulation of interleukin-1 secretion (GO:0050711),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,NLRP7;NLRP3
establishment of protein localization to mitochondrial membrane (GO:0090151),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TIMM29;TIMM10
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,GPC1;SPRY2
positive regulation of neuron migration (GO:2001224),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,NIPBL;KIF20B
regulation of catabolic process (GO:0009894),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,FURIN;FAM83D
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,IL18;ISL1
cellular response to oxidative stress (GO:0034599),9/115,0.12194201055481342,1,0,0,1.565217391304348,3.2935455713301205,PRDX3;TMEM161A;PYROXD1;HTRA2;NOX5;TXNDC8;FOXO1;TXN2;SNCA
response to interferon-gamma (GO:0034341),6/68,0.12385227423087532,1,0,0,1.7647058823529411,3.685880753701308,CITED1;CCL3L1;KYNU;CCL5;AQP4;SNCA
positive regulation of interleukin-1 beta secretion (GO:0050718),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,GSDMD;NLRP7;NLRP3
cellular response to metal ion (GO:0071248),8/100,0.12742605989598135,1,0,0,1.5999999999999999,3.2963504079810266,ITPKB;CYP11B2;HFE;GUCA1A;MCOLN1;CACNA1H;MT1HL1;SNCA
clathrin-dependent endocytosis (GO:0072583),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,SYT2;INPP5F;DNAJC6;SNCA
positive regulation of peptide hormone secretion (GO:0090277),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,GHRHR;HFE;FGG;ISL1
regulation of G0 to G1 transition (GO:0070316),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,RRM2;EHMT2;MGA;PHC3
acyl-CoA metabolic process (GO:0006637),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,THEM4;SUCLG1;GLYAT;HMGCS2
cellular response to organic substance (GO:0071310),10/133,0.12962027533045753,1,0,0,1.5037593984962405,3.0724000930063378,PTPN18;MAPK11;TBK1;AVPR1B;CYP11B2;CCL5;IL18;HTRA2;CACNA1H;ZNF16
protein localization to cell periphery (GO:1990778),9/117,0.13158332870735787,1,0,0,1.5384615384615385,3.120176845647289,PLEKHF1;PACS1;SLMAP;MAP7;FLOT1;PKP3;FGF13;PIGW;CLASP2
positive regulation of immune response (GO:0050778),5/54,0.13177730633611895,1,0,0,1.8518518518518516,3.7530404709585476,PLSCR1;CCL5;POLR3F;NLRP3;IL6ST
response to iron ion (GO:0010039),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,HFE;SNCA
regulation of granulocyte chemotaxis (GO:0071622),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,CCL5;KIF20B
renal absorption (GO:0070293),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,WNK4;SGK1
muscle cell development (GO:0055001),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,SGCD;SGCG
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,IL18;ISL1
cardiocyte differentiation (GO:0035051),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,AKAP13;PROX1
poly(A)+ mRNA export from nucleus (GO:0016973),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,NXF3;ZC3H3
establishment of chromosome localization (GO:0051303),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,CENPF;FAM83D
cranial nerve development (GO:0021545),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ATOH7;ISL1
regulation of fibrinolysis (GO:0051917),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,F12;F11
"energy coupled proton transport, down electrochemical gradient (GO:0015985)",2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ATP6V0A2;TCIRG1
endothelial cell differentiation (GO:0045446),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,EDF1;PROX1
regulation of synaptic vesicle transport (GO:1902803),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,RIMS4;SNCA
ameboidal-type cell migration (GO:0001667),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,SGPL1;SEMA3E;SEMA3F;AMOTL1
negative regulation of ERK1 and ERK2 cascade (GO:0070373),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,RPS6KA6;PSCA;SPRY2;C3ORF33
sodium ion homeostasis (GO:0055078),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,CYP11B2;CYP4A11;SLC9A1
regulation of transcription regulatory region DNA binding (GO:2000677),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,HEY1;MSX2;ANKRD33
positive regulation of interferon-beta production (GO:0032728),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,TBK1;FLOT1;POLR3F
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,DHFR;KLF11;RRM2
internal peptidyl-lysine acetylation (GO:0018393),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,CREBBP;MSL3;CPA4
regulation of cardiac muscle cell contraction (GO:0086004),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,CTNNA3;FGF13;DSC2
cation transmembrane transport (GO:0098655),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,CHRNB3;MMGT1;CACNA1H
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,CTC1;TNKS2;SLX1A
positive regulation of lymphocyte proliferation (GO:0050671),6/71,0.14360927069584972,1,0,0,1.6901408450704225,3.2799871526003956,CCDC88B;VCAM1;IL7;CCL5;IL18;IL6ST
mesenchymal cell differentiation (GO:0048762),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,DLG5;FAM83D;ISL1;BMP7
telomere maintenance via telomere lengthening (GO:0010833),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,CTC1;SLX1A;SMG6
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,INPP5F;MVP;SH3BP5
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,EYA1;EYA2;HTRA2
transcription from RNA polymerase III promoter (GO:0006383),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,GTF3C3;POLR3K;POLR2K
microtubule polymerization (GO:0046785),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,TPPP3;FGF13;CLASP2
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,MYOC;FGG;OLFM4
regulation of neuron death (GO:1901214),6/72,0.15049803689681743,1,0,0,1.6666666666666665,3.1563420645887432,GRM4;TBK1;CCL5;PCSK9;HTRA2;SNCA
positive regulation of neural precursor cell proliferation (GO:2000179),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PROX1;INSM1
intermediate filament organization (GO:0045109),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,KRT14;PKP1
regulation of lipase activity (GO:0060191),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,FURIN;SNCA
positive regulation of response to cytokine stimulus (GO:0060760),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,IL7;AGPAT1
negative regulation of interleukin-1 beta production (GO:0032691),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,NLRP7;NLRP3
hydrogen peroxide catabolic process (GO:0042744),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PRDX3;MPO
regulation of neural precursor cell proliferation (GO:2000177),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PROX1;INSM1
positive regulation of muscle hypertrophy (GO:0014742),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,IL6ST;SLC9A1
positive regulation of transporter activity (GO:0032411),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,WNK4;SGK1
regulation of mRNA catabolic process (GO:0061013),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PKP1;PKP3
establishment of protein localization to chromosome (GO:0070199),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,NIPBL;PIH1D1
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,TPR;CDK5RAP2
chloride transmembrane transport (GO:1902476),5/57,0.15514033768438892,1,0,0,1.7543859649122806,3.2691669601382802,CLIC5;SLC12A5;SLC26A8;CLCNKA;SLC26A7
regulation of interleukin-6 production (GO:0032675),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,NLRC3;LBP;ISL1;SLAMF1
glycolipid biosynthetic process (GO:0009247),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,PIGO;ST8SIA1;GLT6D1;PIGW
regulation of ion transmembrane transporter activity (GO:0032412),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,FXYD6-FXYD2;TCAF1;WNK4;SCN1B
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),7/89,0.15706487379765424,1,0,0,1.5730337078651684,2.9118369551802306,RPL4;RPS9;RPL32;RPL21;RPL36;SRP14;SRP9
regulation of protein complex assembly (GO:0043254),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,VCP;BBS10;NCLN;TAL1;PIH1D1;INSM1
chloride transport (GO:0006821),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,CLIC5;SLC12A5;SLC26A8;ANO9;CLCNKA;SLC26A7
negative regulation of proteasomal protein catabolic process (GO:1901799),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,USP25;HFE;LAMP3
production of miRNAs involved in gene silencing by miRNA (GO:0035196),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,AGO3;AGO1;DROSHA
cell-matrix adhesion (GO:0007160),7/90,0.16349418407909133,1,0,0,1.5555555555555556,2.8170766721365488,COL17A1;BCAM;VCAM1;CTTN;STRC;FGG;THBS3
"regulation of gene expression, epigenetic (GO:0040029)",6/74,0.1647057705275506,1,0,0,1.6216216216216217,2.924748009429989,DNMT1;PRMT7;WBP2;POLR2E;DDX21;POLR2K
positive regulation of defense response (GO:0031349),6/74,0.1647057705275506,1,0,0,1.6216216216216217,2.924748009429989,PLSCR1;CCL3L1;CCL5;IL18;POLR3F;SNCA
ncRNA processing (GO:0034470),15/227,0.16592418268754489,1,0,0,1.3215859030837003,2.3738647476962065,RPL4;RPS9;RPL32;RPL21;POP1;PIH1D1;DIS3L;WDR43;SAMD15;AGO3;AGO1;XRN2;RPL36;DROSHA;UTP20
cardiac ventricle morphogenesis (GO:0003208),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,HEY1;PROX1;ISL1;MYH6
RNA catabolic process (GO:0006401),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,STK31;AGO3;DIS3L;XRN2
pseudouridine synthesis (GO:0001522),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,TRUB1;RPUSD1
positive regulation of vasoconstriction (GO:0045907),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,AVPR1B;FGG
endocardial cushion morphogenesis (GO:0003203),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,HEY1;ISL1
mitotic sister chromatid cohesion (GO:0007064),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NIPBL;BOD1
positive regulation of protein import (GO:1904591),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,TPR;ZIC1
regulation of interleukin-4 production (GO:0032673),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RARA;NLRP3
anterograde synaptic vesicle transport (GO:0048490),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,BLOC1S6;BLOC1S1
cardiac muscle cell differentiation (GO:0055007),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,AKAP13;PROX1
glycerophospholipid catabolic process (GO:0046475),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,INPP5F;ENPP2
mesenchyme morphogenesis (GO:0072132),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,HEY1;ISL1
positive regulation of acute inflammatory response (GO:0002675),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,F12;IL6ST
N-terminal protein amino acid acetylation (GO:0006474),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,CREBBP;NAA35
regulation of delayed rectifier potassium channel activity (GO:1902259),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,KCNE3;KCNRG
negative regulation of axon extension involved in axon guidance (GO:0048843),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SEMA3E;SEMA3F
amide transport (GO:0042886),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SLC5A6;FOLR2
cofactor transport (GO:0051181),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SLC5A6;FOLR2
positive regulation of interleukin-4 production (GO:0032753),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RARA;NLRP3
protein O-linked fucosylation (GO:0036066),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SLC35C1;RFNG
synaptic vesicle transport along microtubule (GO:0099517),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,BLOC1S6;BLOC1S1
sulfate transport (GO:0008272),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SLC26A8;SLC26A7
keratinocyte differentiation (GO:0030216),5/59,0.17159602546898528,1,0,0,1.694915254237288,2.987478396269761,LCE1A;LCE2A;CASP3;TXNIP;LCE1F
C-terminal protein lipidation (GO:0006501),6/75,0.17201595491043623,1,0,0,1.5999999999999999,2.8162688725816674,PSCA;VNN2;XPNPEP2;FOLR2;PRSS21;ATG4D
positive regulation of cell differentiation (GO:0045597),13/194,0.17457490590345454,1,0,0,1.3402061855670102,2.3391977113709883,IL18;ISL1;BMP7;RPS6KA3;MAPK11;BLOC1S6;DAB2;GPC1;TMEM119;WDFY2;INSM1;IL6ST;ZNF385A
dicarboxylic acid transport (GO:0006835),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,SLC26A8;SLC26A7;FOLR2
synaptic vesicle endocytosis (GO:0048488),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,SYT2;DNAJC6;SNCA
regulation of vasoconstriction (GO:0019229),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,AVPR1B;FGG;ECE1
positive regulation of myeloid cell differentiation (GO:0045639),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,FAM210B;TAL1;ZNF16
regulation of embryonic development (GO:0045995),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,RPS6KA6;NIPBL;CLASP2
positive regulation of interleukin-1 secretion (GO:0050716),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,GSDMD;NLRP7;NLRP3
coenzyme biosynthetic process (GO:0009108),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,DHFR;PPCDC;COASY
synaptic vesicle recycling (GO:0036465),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,SYT2;SYT7;SNCA
carbohydrate derivative biosynthetic process (GO:1901137),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,GK5;RRM2;GLT6D1
striated muscle tissue development (GO:0014706),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,SGCD;BMP7;SGCG
unsaturated fatty acid metabolic process (GO:0033559),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,FADS2;ACSL1;CYP4A11;FADS1
positive regulation of transport (GO:0051050),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,DAB2;FLOT1;SGK1;SNCA
heart contraction (GO:0060047),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,SGCD;SGCG;SCN1B;MYH6
response to interleukin-1 (GO:0070555),6/76,0.17945756311992533,1,0,0,1.5789473684210524,2.712341867627267,MAPK11;CITED1;CCL3L1;NLRP7;CCL5;SNCA
regulation of stress fiber assembly (GO:0051492),5/60,0.18006686918004597,1,0,0,1.6666666666666665,2.8573783360576237,MYOC;ASAP3;EPHA1;SLC9A1;CLASP2
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),7/93,0.18346339954975327,1,0,0,1.5053763440860215,2.552727015512764,RPS6KA3;PDCD6;LAMP3;HTRA2;NLRP3;SNCA;TNFRSF10D
cotranslational protein targeting to membrane (GO:0006613),7/93,0.18346339954975327,1,0,0,1.5053763440860215,2.552727015512764,RPL4;RPS9;RPL32;RPL21;RPL36;SRP14;SRP9
cellular response to peptide hormone stimulus (GO:0071375),8/110,0.18515647013830153,1,0,0,1.4545454545454544,2.453169493595112,TBC1D4;PRKDC;CYP11B2;PRKAR2A;PCSK9;INHBB;FOXO1;PCK2
protein lipidation (GO:0006497),9/127,0.18537679054393458,1,0,0,1.4173228346456692,2.388706043433952,VNN2;PIGO;PSCA;XPNPEP2;WIPI2;PIGW;FOLR2;PRSS21;ATG4D
protein polymerization (GO:0051258),4/45,0.18643368284604128,1,0,0,1.7777777777777777,2.98609722860718,TPPP3;FGG;FGF13;WASF3
protein complex subunit organization (GO:0071822),4/45,0.18643368284604128,1,0,0,1.7777777777777777,2.98609722860718,ST13;COL11A1;TPR;P3H4
metal ion homeostasis (GO:0055065),4/45,0.18643368284604128,1,0,0,1.7777777777777777,2.98609722860718,SLC12A5;CYP11B2;CYP4A11;CNNM2
regulation of actin cytoskeleton reorganization (GO:2000249),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,BAIAP2L2;ABL2;SEMA3E
negative regulation of cation channel activity (GO:2001258),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,KCNE3;GSTO1;DRD4
hippo signaling (GO:0035329),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,CASP3;AMOTL1;MAP3K14
regulation of cation transmembrane transport (GO:1904062),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,BPIFA1;KCNE3;SLMAP
positive regulation of T cell proliferation (GO:0042102),5/61,0.18868988871127926,1,0,0,1.6393442622950818,2.733853134392278,CCDC88B;VCAM1;CCL5;IL18;IL6ST
regulation of tumor necrosis factor production (GO:0032680),5/61,0.18868988871127926,1,0,0,1.6393442622950818,2.733853134392278,RARA;NLRC3;LBP;ISL1;SLAMF1
negative regulation of NF-kappaB import into nucleus (GO:0042347),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,NLRP3;BMP7
regulation of dopamine secretion (GO:0014059),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,DRD3;SNCA
embryonic digit morphogenesis (GO:0042733),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CREBBP;ECE1
phosphatidylinositol acyl-chain remodeling (GO:0036149),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PLA2G12A;PLA2G4E
sympathetic nervous system development (GO:0048485),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,SEMA3F;INSM1
regulation of histone H3-K4 methylation (GO:0051569),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,DNMT1;PIH1D1
positive regulation of cardiac muscle hypertrophy (GO:0010613),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,IL6ST;SLC9A1
cellular response to pH (GO:0071467),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,MCOLN1;SLC9A1
positive regulation of cilium assembly (GO:0045724),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CROCC;CEP120
positive regulation of triglyceride metabolic process (GO:0090208),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,AADAC;NR1H2
aorta morphogenesis (GO:0035909),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,HEY1;PROX1
protein localization to chromatin (GO:0071168),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,NIPBL;PIH1D1
mesenchyme development (GO:0060485),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,ISL1;BMP7
regulation of interferon-alpha production (GO:0032647),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,TBK1;NLRC3
sensory perception of mechanical stimulus (GO:0050954),6/78,0.19471584243590756,1,0,0,1.5384615384615385,2.5172523099552775,CLIC5;NIPBL;EYA1;STRC;COL11A1;TIMM10
protein methylation (GO:0006479),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,VCP;PRMT7;EHMT2;PRMT3
positive regulation of ion transport (GO:0043270),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,CRACR2A;CCL5;DRD4;SCN1B
regulation of T cell proliferation (GO:0042129),5/62,0.19745752815386772,1,0,0,1.6129032258064515,2.616502846917968,CCDC88B;VCAM1;CCL5;DLG5;IL6ST
regulation of protein export from nucleus (GO:0046825),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,ZC3H3;TPR;IWS1
protein destabilization (GO:0031648),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,CREBBP;NCLN;SNCA
response to calcium ion (GO:0051592),6/79,0.20252260341125683,1,0,0,1.5189873417721518,2.425676623110086,ITPKB;CASR;PDCD6;FGG;GUCA1A;MCOLN1
protein localization to plasma membrane (GO:0072659),9/130,0.20317246774459144,1,0,0,1.3846153846153846,2.206661629625701,PLEKHF1;PACS1;SLMAP;MAP7;FLOT1;PKP3;FGF13;PIGW;CLASP2
positive regulation of cell projection organization (GO:0031346),5/63,0.20636211070548938,1,0,0,1.5873015873015872,2.504956879983314,RETREG3;AVIL;STMN2;ABL2;SCN1B
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,NLRP3;NLRC3;TRIM59;BMP7
postreplication repair (GO:0006301),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,VCP;RFC2;UBE2NL;FAAP20
negative regulation of JAK-STAT cascade (GO:0046426),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,LRRC15;INPP5F;LRTM2;LRRTM1
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,DAB2;HFE;INHBB;BMP7
positive regulation of cholesterol transport (GO:0032376),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,NR1H2;LIPG
regulation of tissue remodeling (GO:0034103),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,IL18;SYT7
cellular glucuronidation (GO:0052695),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,UGT1A1;UGT2B28
negative regulation of axon guidance (GO:1902668),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SEMA3E;SEMA3F
response to interferon-alpha (GO:0035455),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,LAMP3;TPR
glycosphingolipid biosynthetic process (GO:0006688),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ST8SIA1;ST6GALNAC3
positive regulation of hormone secretion (GO:0046887),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,HFE;FGG
N-glycan processing (GO:0006491),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MGAT4A;MGAT4B
spindle assembly checkpoint (GO:0071173),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,CENPF;TPR
negative regulation of stress fiber assembly (GO:0051497),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MYOC;CLASP2
pharyngeal system development (GO:0060037),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ISL1;BMP7
phospholipid catabolic process (GO:0009395),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,LIPG;ENPP2
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,GSTO1;SLC9A1
macrophage activation (GO:0042116),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,LBP;SNCA
regulation of transcription from RNA polymerase I promoter (GO:0006356),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,WDR43;POLR2K
serine family amino acid metabolic process (GO:0009069),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,GCLC;GLYAT
chaperone-mediated protein complex assembly (GO:0051131),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,THEG;BBS10
synaptic vesicle transport (GO:0048489),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SPG11;SYT7
cellular response to inorganic substance (GO:0071241),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MTR;FOXO1
cellular response to glucocorticoid stimulus (GO:0071385),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ISL1;PCK2
mitotic spindle assembly checkpoint (GO:0007094),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,CENPF;TPR
mitotic spindle checkpoint (GO:0071174),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,CENPF;TPR
RNA transport (GO:0050658),6/80,0.21044099394584637,1,0,0,1.4999999999999998,2.337824968427116,NPAP1;POM121L2;TST;TPR;FLOT1;EIF4E
negative regulation of MAPK cascade (GO:0043409),6/80,0.21044099394584637,1,0,0,1.4999999999999998,2.337824968427116,RPS6KA6;PSCA;SPRY2;C3ORF33;BMP7;FOXO1
positive regulation of neuron projection development (GO:0010976),7/97,0.21155364258994297,1,0,0,1.4432989690721647,2.241842635816865,RETREG3;SYT2;AVIL;STMN2;ABL2;BMP7;SCN1B
protein targeting to ER (GO:0045047),7/97,0.21155364258994297,1,0,0,1.4432989690721647,2.241842635816865,RPL4;RPS9;RPL32;RPL21;RPL36;SRP14;SRP9
heart development (GO:0007507),10/149,0.21263497715518503,1,0,0,1.3422818791946307,2.0780916854371307,AKAP13;NIPBL;SGCD;SHOX2;RARA;ECE1;ISL1;BMP7;SGCG;MYH6
protein deacetylation (GO:0006476),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,HDAC3;TBL1XR1;MSL3
central nervous system neuron differentiation (GO:0021953),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,KNDC1;PROX1;ISL1
ATP biosynthetic process (GO:0006754),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,ATP6V0A2;TCIRG1;NIPSNAP2
negative regulation of receptor activity (GO:2000272),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,GSTO1;HFE;PCSK9
positive regulation of TOR signaling (GO:0032008),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,HTR6;HDAC3;PIH1D1
endodermal cell differentiation (GO:0035987),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,COL11A1;LAMB1;MMP8
regulation of erythrocyte differentiation (GO:0045646),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,FAM210B;TAL1;ZNF16
inorganic anion transmembrane transport (GO:0098661),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,CLIC5;SLC12A5;SLC26A8;CLCNKA;SLC26A7
positive regulation of endocytosis (GO:0045807),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,DAB2;SFTPA2;HFE;FLOT1;SNCA
pattern recognition receptor signaling pathway (GO:0002221),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,RPS6KA3;SFTPA2;FGG;LBP
cellular macromolecule catabolic process (GO:0044265),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,STK31;DIS3L;XRN2;HTRA2
sensory perception of sound (GO:0007605),6/81,0.21846581133310103,1,0,0,1.4814814814814814,2.253519624534179,CLIC5;NIPBL;EYA1;STRC;COL11A1;TIMM10
anterograde trans-synaptic signaling (GO:0098916),15/240,0.22212953151061135,1,0,0,1.25,1.8806182399904328,GRIA1;GABBR2;DTNA;CHRNB3;SLC12A5;OR10J5;OR10H2;HTR1A;NRXN2;HTR6;GRM4;SYPL1;NPBWR2;SPG11;SCN1B
glycolipid metabolic process (GO:0006664),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,ARSA;PSAP;GLT6D1;PIGW;ST6GALNAC3
regulation of JAK-STAT cascade (GO:0046425),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,LRRC15;LRRTM1;LRTM2;CCL5;CRLF3
steroid metabolic process (GO:0008202),7/99,0.2261619520902503,1,0,0,1.414141414141414,2.1021267756043183,HSD11B1;UGT1A1;DHRS9;CYP11B2;UGT2B28;CYP46A1;CYP3A5
small GTPase mediated signal transduction (GO:0007264),7/99,0.2261619520902503,1,0,0,1.414141414141414,2.1021267756043183,ARHGAP33;CNKSR1;MAPK11;DNMT1;DNMBP;NTN1;RASGRP3
establishment of melanosome localization (GO:0032401),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,BLOC1S6;SHROOM2
posttranscriptional gene silencing by RNA (GO:0035194),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,AGO3;AGO1
regulation of dephosphorylation (GO:0035303),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PPP1R14B;SMG6
positive regulation of metabolic process (GO:0009893),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,ABL2;AGPAT1
insulin secretion (GO:0030073),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PTPRN2;KLRG1
heart trabecula morphogenesis (GO:0061384),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,HEY1;BMP7
acute-phase response (GO:0006953),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PLSCR1;LBP
negative regulation of protein transport (GO:0051224),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,DRD3;DRD4
positive regulation of DNA metabolic process (GO:0051054),6/82,0.22659177650802834,1,0,0,1.4634146341463412,2.172593007559255,CTC1;DNMT1;TMEM161A;EYA1;EYA2;APLF
intracellular pH reduction (GO:0051452),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,DMXL1;ATP6V0A2;TCIRG1
carboxylic acid metabolic process (GO:0019752),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,GSTO2;GSTO1;GLYAT
positive regulation of nucleocytoplasmic transport (GO:0046824),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,RBM27;TPR;ZIC1
regulation of intracellular protein transport (GO:0033157),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,TPR;KIF20B;OAZ1
organic hydroxy compound biosynthetic process (GO:1901617),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,CYP11B2;OSBPL2;CYP46A1;CACNA1H
glutathione metabolic process (GO:0006749),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,GCLC;GSTO2;GSTO1;OPLAH
regulation of megakaryocyte differentiation (GO:0045652),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,L3MBTL1;AGO3;AGO1;ZNF16
spermatogenesis (GO:0007283),10/153,0.2362142323082741,1,0,0,1.3071895424836601,1.8862955839307176,RPL39L;NPAP1;ADAM29;XRN2;TMEM119;TDRP;VCX;TXNDC8;CYLC1;PRSS21
protein complex assembly (GO:0006461),12/189,0.23760332269252368,1,0,0,1.2698412698412698,1.8249558186606787,GRIA1;GSDMD;CREBBP;TRAPPC6A;SEC24A;SAR1B;ST13;PDCD6;RAB1B;PPP6R3;NLRP3;SLC9A1
plasma membrane bounded cell projection organization (GO:0120036),8/118,0.23800829236656018,1,0,0,1.3559322033898304,1.9463725614119634,CFAP61;BLOC1S6;MYOC;CTTN;BLOC1S1;STMN2;LAMB1;FRYL
regulation of ion transport (GO:0043269),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,HTR1A;NOX5;DRD3;SNCA
blood circulation (GO:0008015),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,GCLC;SGCD;LPA;SGCG
fatty acid beta-oxidation (GO:0006635),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,ACAA2;HADH;ACADS;CRAT
embryonic limb morphogenesis (GO:0030326),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,NIPBL;CREBBP;ECE1
negative regulation of DNA binding (GO:0043392),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,HEY1;MSX2;ANKRD33
response to peptide (GO:1901652),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,EIF2B2;AVPR1B;GNAI1
positive regulation of DNA binding (GO:0043388),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,NIPBL;EDF1;NME1
bone development (GO:0060348),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,AKAP13;MYOC;RARA
ventricular cardiac muscle tissue morphogenesis (GO:0055010),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,PROX1;ISL1;MYH6
regulation of interleukin-1 beta secretion (GO:0050706),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,GSDMD;NLRP7;NLRP3
cellular macromolecular complex assembly (GO:0034622),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,MIA;BIN1;FGG
male gamete generation (GO:0048232),10/154,0.24225595112447437,1,0,0,1.2987012987012985,1.8412473538541556,RPL39L;NPAP1;ADAM29;XRN2;TMEM119;TDRP;VCX;TXNDC8;CYLC1;PRSS21
regulation of mitotic nuclear division (GO:0007088),6/84,0.2431257250643128,1,0,0,1.4285714285714284,2.020252260491723,L3MBTL1;TPR;MAD2L1BP;KIF20B;DRD3;BMP7
epidermal cell differentiation (GO:0009913),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,LCE1A;LCE2A;CASP3;TXNIP;LCE1F
regulation of gene silencing by miRNA (GO:0060964),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,AGO1;DND1;TPR;POLR2E;POLR2K
regulation of TOR signaling (GO:0032006),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,HTR6;HDAC3;PDCD6;FAM83D;FBXO9
positive regulation of autophagy (GO:0010508),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,BNIP3L;PLEKHF1;TBK1;FOXO1;TPCN1
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,DAB2;CITED1
primary alcohol metabolic process (GO:0034308),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,DHRS9;LRAT
error-free translesion synthesis (GO:0070987),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,VCP;RFC2
negative regulation of protein localization to plasma membrane (GO:1903077),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,LRRC15;DAB2
positive regulation of STAT cascade (GO:1904894),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CCL5;CRLF3
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,HFE;LAMP3
endocardial cushion development (GO:0003197),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,HEY1;ISL1
folic acid metabolic process (GO:0046655),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,DHFR;FOLR2
striated muscle cell differentiation (GO:0051146),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,AKAP13;PROX1
negative regulation of protein localization to cell periphery (GO:1904376),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,LRRC15;DAB2
positive regulation of phospholipase activity (GO:0010518),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CCL5;ABL2
telomere capping (GO:0016233),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CTC1;PRKDC
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,DAB2;CITED1
response to interferon-beta (GO:0035456),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,PLSCR1;HTRA2
telomere maintenance (GO:0000723),4/51,0.2504443908625444,1,0,0,1.5686274509803921,2.171793530456325,CTC1;PRKDC;SMC5;SLX1A
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,RPS6KA3;LAMP3;PIH1D1;SNCA;TNFRSF10D
negative regulation of phosphatase activity (GO:0010923),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,PPP1R26;SH3RF2;PLEKHF1;BOD1;RIMBP2
cholesterol metabolic process (GO:0008203),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,ACAA2;CYP11B2;SNX17;CYP46A1;HSD17B7
positive regulation of T cell activation (GO:0050870),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,CCDC88B;VCAM1;IL7;CCL5;IL6ST
response to cytokine (GO:0034097),9/138,0.2537482567127218,1,0,0,1.3043478260869563,1.7887990679313746,PTPN18;PLSCR1;TBK1;CITED1;LAMP3;CASP3;KYNU;IL6ST;SNCA
negative regulation of cell-substrate adhesion (GO:0010812),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,MYOC;RASA1;SEMA3E
negative regulation of protein kinase B signaling (GO:0051898),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PDCD6;THEM4;DRD3
regulation of microtubule polymerization (GO:0031113),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,STMN2;CDK5RAP2;SNCA
carboxylic acid transmembrane transport (GO:1905039),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,SLC5A6;SLC7A9;SLC38A5
flagellated sperm motility (GO:0030317),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,SMCP;TEKT4;AKAP4
neural crest cell development (GO:0014032),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PDCD6;SEMA3E;SEMA3F
positive regulation of osteoblast differentiation (GO:0045669),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,TMEM119;IL6ST;BMP7
protein kinase B signaling (GO:0043491),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,CCL5;THEM4;FOXO1
plasma membrane bounded cell projection morphogenesis (GO:0120039),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,CTTN;KIF20B;SGK1;BMP7
positive regulation of cell-substrate adhesion (GO:0010811),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,MYOC;FGG;OLFM4;EPHA1
positive regulation of mitotic cell cycle (GO:0045931),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,TAL1;TPR;EIF4E;DRD3
hydrogen peroxide metabolic process (GO:0042743),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,PRDX3;MPO
negative regulation of actin filament bundle assembly (GO:0032232),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,MYOC;CLASP2
negative regulation of ion transport (GO:0043271),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,WNK4;SNCA
regulation of lipoprotein lipase activity (GO:0051004),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,NR1H2;FURIN
regulation of cholesterol transport (GO:0032374),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,NR1H2;LIPG
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,CLDN19;CLDN18
autophagy of nucleus (GO:0044804),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,WIPI2;ATG4D
striated muscle cell development (GO:0055002),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,TMOD2;MYH6
aromatic amino acid family catabolic process (GO:0009074),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,HGD;KYNU
steroid hormone mediated signaling pathway (GO:0043401),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,RHOXF1;BMP7
adrenergic receptor signaling pathway (GO:0071875),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,AKAP13;ADRB3
melanosome localization (GO:0032400),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,BLOC1S6;SHROOM2
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,GPC1;SPRY2
sphingosine-1-phosphate signaling pathway (GO:0003376),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SPNS1
cellular response to lipoteichoic acid (GO:0071223),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LBP
positive regulation of nucleobase-containing compound transport (GO:0032241),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RBM27
positive regulation of DNA-directed DNA polymerase activity (GO:1900264),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RFC2
negative regulation of cholesterol storage (GO:0010887),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NR1H2
smooth muscle tissue development (GO:0048745),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PROX1
positive regulation of adaptive immune response (GO:0002821),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL6ST
vocal learning (GO:0042297),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRXN2
succinyl-CoA metabolic process (GO:0006104),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SUCLG1
positive regulation of growth hormone secretion (GO:0060124),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GHRHR
mesodermal cell fate commitment (GO:0001710),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EYA2
negative regulation of transforming growth factor beta production (GO:0071635),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FURIN
tRNA transcription from RNA polymerase III promoter (GO:0042797),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GTF3C3
COPI coating of Golgi vesicle (GO:0048205),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED9
regulation of extent of cell growth (GO:0061387),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CTTN
cellular response to iron ion (GO:0071281),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HFE
"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SRP9
striated muscle hypertrophy (GO:0014897),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MYOC
positive regulation of icosanoid secretion (GO:0032305),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CYP4A11
regulation of skeletal muscle satellite cell proliferation (GO:0014842),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ANGPT1
peripheral nervous system neuron development (GO:0048935),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ISL1
spinal cord motor neuron differentiation (GO:0021522),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ISL1
prepulse inhibition (GO:0060134),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DRD3
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LRPPRC
positive regulation of ATP biosynthetic process (GO:2001171),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,VCP
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FOXO1
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ANGPT1
negative regulation of acute inflammatory response (GO:0002674),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NLRP3
negative regulation of oligodendrocyte differentiation (GO:0048715),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DRD3
indolalkylamine metabolic process (GO:0006586),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TPH1
ventricular cardiac muscle cell development (GO:0055015),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PROX1
regulation of digestive system process (GO:0044058),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SGK1
response to lipoteichoic acid (GO:0070391),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LBP
positive regulation of receptor binding (GO:1900122),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HFE
5S class rRNA transcription from RNA polymerase III type 1 promoter (GO:0042791),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GTF3C3
ceramide transport (GO:0035627),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PSAP
negative regulation of muscle cell apoptotic process (GO:0010656),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMP7
Golgi transport vesicle coating (GO:0048200),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED9
collagen biosynthetic process (GO:0032964),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,P3H4
phagosome-lysosome fusion (GO:0090385),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SYT7
rRNA transport (GO:0051029),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TST
iron ion import (GO:0097286),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HFE
positive regulation of cGMP biosynthetic process (GO:0030828),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GUCA1A
positive regulation of mitochondrial membrane potential (GO:0010918),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,VCP
iron ion import across plasma membrane (GO:0098711),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HFE
"regulation of wound healing, spreading of epidermal cells (GO:1903689)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CLASP2
platelet dense granule organization (GO:0060155),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BLOC1S1
positive regulation of osteoblast proliferation (GO:0033690),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMEM119
COPI-coated vesicle budding (GO:0035964),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED9
gap junction assembly (GO:0016264),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GJD3
membrane raft assembly (GO:0001765),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FLOT1
rescue of stalled ribosome (GO:0072344),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LTN1
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NR1H2
centromeric sister chromatid cohesion (GO:0070601),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BOD1
negative regulation of response to interferon-gamma (GO:0060331),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NR1H2
regulation of renal sodium excretion (GO:0035813),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CORIN
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SCN1B
negative regulation of complement activation (GO:0045916),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,C4BPA
spinal cord dorsal/ventral patterning (GO:0021513),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RFX8
negative regulation of vasculature development (GO:1901343),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BMP7
lens fiber cell development (GO:0070307),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PROX1
regulation of protein localization to cell cortex (GO:1904776),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GNAI1
chemical homeostasis within a tissue (GO:0048875),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SFTPA2
lipid hydroxylation (GO:0002933),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CYP3A5
regulation of interleukin-12 secretion (GO:2001182),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MAPK11
trigeminal nerve development (GO:0021559),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ISL1
positive regulation of RNA export from nucleus (GO:0046833),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RBM27
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway (GO:0007196),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GRM4
positive regulation of microtubule motor activity (GO:2000576),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MTCL1
mRNA 5'-splice site recognition (GO:0000395),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SFSWAP
corticosteroid receptor signaling pathway (GO:0031958),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ARID1A
hormone transport (GO:0009914),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SERPINA7
regulation of mitotic spindle checkpoint (GO:1903504),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CDK5RAP2
bile acid secretion (GO:0032782),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC51A
protein geranylgeranylation (GO:0018344),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CHM
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FLOT1
folic acid-containing compound biosynthetic process (GO:0009396),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DHFR
NADH metabolic process (GO:0006734),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,VCP
regulation of aldosterone biosynthetic process (GO:0032347),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DKK3
negative regulation of systemic arterial blood pressure (GO:0003085),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ADRB3
regulation of respiratory system process (GO:0044065),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MTG2
regulation of cortisol biosynthetic process (GO:2000064),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DKK3
positive regulation of activation of Janus kinase activity (GO:0010536),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CCL5
heart trabecula formation (GO:0060347),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HEY1
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FOXO1
regulation of anion channel activity (GO:0010359),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TCAF1
regulation of inositol phosphate biosynthetic process (GO:0010919),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SNCA
imitative learning (GO:0098596),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRXN2
regulation of biosynthetic process (GO:0009889),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SNCA
positive regulation of megakaryocyte differentiation (GO:0045654),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ZNF16
glomerulus vasculature development (GO:0072012),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ANGPT1
positive regulation of centrosome cycle (GO:0046607),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CEP120
regulation of natural killer cell proliferation (GO:0032817),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,IL18
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,VCP
venous blood vessel morphogenesis (GO:0048845),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PROX1
surfactant homeostasis (GO:0043129),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SFTPA2
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,WBP2
cellular response to cold (GO:0070417),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FOXO1
tRNA catabolic process (GO:0016078),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,POP1
insulin secretion involved in cellular response to glucose stimulus (GO:0035773),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PTPRN2
regulation of DNA-directed DNA polymerase activity (GO:1900262),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RFC2
single strand break repair (GO:0000012),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,APLF
amine metabolic process (GO:0009308),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,VCAM1
regulation of t-circle formation (GO:1904429),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLX1A
glucocorticoid receptor signaling pathway (GO:0042921),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ARID1A
regulation of smoothened signaling pathway (GO:0008589),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,CREBBP;DLG5;ZIC1
endoderm formation (GO:0001706),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,COL11A1;LAMB1;MMP8
regulation of blood circulation (GO:1903522),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,ECE1;CACNA1H;MYH6
vesicle-mediated transport in synapse (GO:0099003),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,SYT2;SPG11;SNCA
cardiac muscle tissue morphogenesis (GO:0055008),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,PROX1;ISL1;MYH6
phospholipid metabolic process (GO:0006644),5/70,0.2718688550208947,1,0,0,1.4285714285714284,1.860622113738027,PLA2G4E;LIPG;ENPP2;AGPAT1;FADS1
positive regulation of protein import into nucleus (GO:0042307),4/53,0.272750159994601,1,0,0,1.5094339622641508,1.9610551964847422,DAB2;HDAC3;ZIC1;TPR
DNA repair (GO:0006281),17/288,0.27472021233636473,1,0,0,1.1805555555555554,1.5252802674679904,VCP;EYA1;PRKDC;MPG;RFC2;RAD21L1;FAAP20;RAD23B;NEIL3;NIPBL;RECQL5;UBE2NL;MSH5;APLF;FBXO6;SLX1A;POLL
chemical synaptic transmission (GO:0007268),17/289,0.2794068430649466,1,0,0,1.176470588235294,1.5001015770102055,GRIA1;GABBR2;DTNA;CHRNB3;SLC12A5;OR10J5;OR10H2;HTR1A;NRXN2;SLC5A7;HTR6;GRM4;SYPL1;NPBWR2;RIMBP2;SPG11;SCN1B
protein localization to membrane (GO:0072657),10/160,0.27958919759892664,1,0,0,1.25,1.5930423807072653,PLEKHF1;PACS1;SLMAP;MAP7;FLOT1;NRXN2;PKP3;FGF13;PIGW;CLASP2
phosphatidylcholine metabolic process (GO:0046470),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,PLA2G12A;PLA2G4E;CHAT;ENPP2;MFSD2A
spliceosomal snRNP assembly (GO:0000387),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,SART3;PRMT7;PRPF8
base-excision repair (GO:0006284),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,NEIL3;MPG;POLL
myelination (GO:0042552),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,EIF2B2;MYOC;GPC1
regulation of DNA repair (GO:0006282),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,TMEM161A;EYA1;EYA2
positive regulation of transcription from RNA polymerase I promoter (GO:0045943),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,PIH1D1;WDR43
energy reserve metabolic process (GO:0006112),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,ADRB3;PYGL
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,GSTO1;SLC9A1
regulation of cardiac muscle hypertrophy (GO:0010611),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,IL6ST;SLC9A1
positive regulation of histone acetylation (GO:0035066),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,WBP2;PIH1D1
negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CCL5;SNCA
negative regulation of protein tyrosine kinase activity (GO:0061099),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,MVP;SH3BP5
regulation of nuclear division (GO:0051783),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,L3MBTL1;KIF20B
non-motile cilium assembly (GO:1905515),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,BBS10;TBC1D32
ventricular septum morphogenesis (GO:0060412),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,HEY1;PROX1
cellular response to misfolded protein (GO:0071218),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,VCP;KLHL15
cellular response to copper ion (GO:0071280),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,SNCA;MT1HL1
phosphatidylserine acyl-chain remodeling (GO:0036150),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,PLA2G12A;PLA2G4E
negative regulation of supramolecular fiber organization (GO:1902904),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,STMN2;FGF13;SNCA;CLASP2
glycosphingolipid metabolic process (GO:0006687),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,ARSA;ST8SIA1;PSAP;ST6GALNAC3
proteolysis (GO:0006508),17/291,0.28886104534173856,1,0,0,1.1683848797250858,1.450911464871029,USP25;TPSB2;CPQ;F12;SPPL2A;KLK4;HTRA2;CELA1;ECE1;FURIN;MMP8;PRSS21;CAPN8;PRSS50;CASP3;FBXO6;CPA4
regulation of phosphatase activity (GO:0010921),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,PPP1R26;SH3RF2;PLEKHF1;PPP6R3;RIMBP2
regulation of Ras protein signal transduction (GO:0046578),6/90,0.29459151170537495,1,0,0,1.3333333333333333,1.6295541177562636,RASA4B;ACAP1;RASA1;ASAP3;SPRY2;STAMBP
long-chain fatty acid metabolic process (GO:0001676),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,FADS2;ACSL1;CYP4A11;FADS1
regulation of gene silencing by RNA (GO:0060966),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,AGO1;TPR;POLR2E;POLR2K
regulation of posttranscriptional gene silencing (GO:0060147),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,AGO1;TPR;POLR2E;POLR2K
fat cell differentiation (GO:0045444),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,EGR2;INHBB;OSBPL11;FOXO1
mitochondrion disassembly (GO:0061726),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,FUNDC1;WIPI2;ATG4D
membrane depolarization during action potential (GO:0086010),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,CACNA1H;SCN1B;TPCN1
DNA damage checkpoint (GO:0000077),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,FBXO6;CEP63;MAP3K14
homotypic cell-cell adhesion (GO:0034109),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,FGG;TLN1;DSC2
regulation of cellular pH (GO:0030641),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,SLC26A8;SLC26A7;SLC9A1
positive regulation of DNA repair (GO:0045739),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,TMEM161A;EYA1;EYA2
negative regulation of nucleic acid-templated transcription (GO:1903507),25/444,0.298110423171342,1,0,0,1.1261261261261262,1.3629406684208154,L3MBTL1;HDAC3;CITED1;BHLHE41;FOXO1;NIPBL;HEY1;NKRF;BAHD1;SCMH1;MLX;ZBTB14;MSX2;NR1H2;ARID5B;KCTD1;PROX1;COMMD7;BMP7;DKK3;GATAD2A;CENPF;DAB2;GCLC;RARA
positive regulation of inflammatory response (GO:0050729),5/73,0.30120905235381457,1,0,0,1.36986301369863,1.6437681222088858,CCL3L1;IL18;LBP;IL6ST;SNCA
regulation of peptide hormone secretion (GO:0090276),5/73,0.30120905235381457,1,0,0,1.36986301369863,1.6437681222088858,ABCC8;HFE;CCL5;FGG;SYT7
positive regulation of multicellular organism growth (GO:0040018),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GHRHR
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GHRHR
"substrate-dependent cell migration, cell extension (GO:0006930)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NTN1
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ACAA2
tRNA pseudouridine synthesis (GO:0031119),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RPUSD1
venous blood vessel development (GO:0060841),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PROX1
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NCOR2
interleukin-18-mediated signaling pathway (GO:0035655),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL18
cellular response to interleukin-18 (GO:0071351),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL18
regulation of interleukin-13 production (GO:0032656),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RARA
progesterone receptor signaling pathway (GO:0050847),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,WBP2
positive regulation of lamellipodium morphogenesis (GO:2000394),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ENPP2
regulation of chromatin assembly or disassembly (GO:0001672),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TAL1
cellular response to interferon-alpha (GO:0035457),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TPR
response to misfolded protein (GO:0051788),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,F12
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC9A1
postsynaptic density assembly (GO:0097107),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NRXN2
regulation of endocytic recycling (GO:2001135),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INPP5F
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RECQL5
regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC9A1
cellular ion homeostasis (GO:0006873),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC12A5
dorsal aorta development (GO:0035907),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HEY1
bone cell development (GO:0098751),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ZNF385A
sulfur amino acid biosynthetic process (GO:0000097),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MTR
positive regulation of extracellular matrix disassembly (GO:0090091),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CLASP2
melanocyte differentiation (GO:0030318),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CITED1
regulation of low-density lipoprotein particle clearance (GO:0010988),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PCSK9
positive regulation of histone H4 acetylation (GO:0090240),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PIH1D1
leukocyte aggregation (GO:0070486),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BMP7
regulation of natural killer cell chemotaxis (GO:2000501),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCL5
positive regulation of apoptotic cell clearance (GO:2000427),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,C4A
pteridine-containing compound biosynthetic process (GO:0042559),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DHFR
negative regulation of telomere capping (GO:1904354),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SMG6
valine metabolic process (GO:0006573),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ALDH6A1
lymphatic endothelial cell differentiation (GO:0060836),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PROX1
box C/D snoRNP assembly (GO:0000492),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PIH1D1
retinoic acid receptor signaling pathway (GO:0048384),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RARA
phosphorylated carbohydrate dephosphorylation (GO:0046838),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INPP1
norepinephrine biosynthetic process (GO:0042421),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INSM1
heme catabolic process (GO:0042167),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,UGT1A1
chromatin-mediated maintenance of transcription (GO:0048096),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ARID1A
adenine nucleotide transport (GO:0051503),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC25A42
positive regulation of lymphocyte apoptotic process (GO:0070230),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCL5
glycosylceramide metabolic process (GO:0006677),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ST6GALNAC3
porphyrin-containing compound catabolic process (GO:0006787),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,UGT1A1
positive regulation of macrophage migration (GO:1905523),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCL5
positive regulation of NK T cell activation (GO:0051135),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL18
inositol phosphate dephosphorylation (GO:0046855),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INPP1
regulation of high voltage-gated calcium channel activity (GO:1901841),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NIPSNAP2
regulation of collateral sprouting (GO:0048670),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FGF13
positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SNCA
positive regulation of triglyceride catabolic process (GO:0010898),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AADAC
tRNA transcription (GO:0009304),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GTF3C3
negative regulation of T cell mediated immunity (GO:0002710),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HFE
regulation of pinocytosis (GO:0048548),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NR1H2
negative regulation of alpha-beta T cell activation (GO:0046636),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HFE
pericardium morphogenesis (GO:0003344),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BMP7
positive regulation of striated muscle contraction (GO:0045989),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GSTO1
purine ribonucleotide transport (GO:0015868),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC25A42
regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FLOT1
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,UTP20
negative regulation of axon regeneration (GO:0048681),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INPP5F
positive regulation of sequestering of triglyceride (GO:0010890),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,OSBPL11
negative regulation of transporter activity (GO:0032410),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SNCA
regulation of growth hormone secretion (GO:0060123),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GHRHR
dorsal aorta morphogenesis (GO:0035912),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HEY1
positive regulation of interleukin-5 production (GO:0032754),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RARA
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CASP3
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TPR
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DRD3
cell differentiation in spinal cord (GO:0021515),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ISL1
xenobiotic catabolic process (GO:0042178),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GSTO1
noradrenergic neuron differentiation (GO:0003357),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INSM1
positive regulation of isomerase activity (GO:0010912),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PLSCR1
alditol metabolic process (GO:0019400),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GK5
regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCL5
regulation of activation of Janus kinase activity (GO:0010533),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCL5
negative regulation of T cell cytokine production (GO:0002725),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HFE
positive regulation of membrane depolarization (GO:1904181),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MYOC
regulation of cell projection organization (GO:0031344),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SPRY2
positive regulation of macrophage chemotaxis (GO:0010759),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCL5
response to increased oxygen levels (GO:0036296),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ATP6V0A2
sensory organ morphogenesis (GO:0090596),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NIPBL
"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DAB2
myoblast fusion (GO:0007520),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CACNA1H
store-operated calcium entry (GO:0002115),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CRACR2A
T-helper 1 type immune response (GO:0042088),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IL18
detection of molecule of bacterial origin (GO:0032490),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,LBP
regulation of transcription involved in cell fate commitment (GO:0060850),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PROX1
neuron fate specification (GO:0048665),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ISL1
folic acid transport (GO:0015884),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FOLR2
long-chain fatty acid import (GO:0044539),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ACSL1
microglial cell activation (GO:0001774),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SNCA
negative regulation of protein polymerization (GO:0032272),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,STMN2;SNCA
glutathione derivative biosynthetic process (GO:1901687),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GSTO2;GSTO1
regulation of catecholamine secretion (GO:0050433),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,DRD3;SNCA
positive regulation of protein targeting to membrane (GO:0090314),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,TCAF1;MTCL1
nuclear transport (GO:0051169),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,EIF5A;CITED1
peripheral nervous system development (GO:0007422),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,EGR2;GPC1
sulfur amino acid metabolic process (GO:0000096),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GCLC;MTR
regulation of cytokine production involved in inflammatory response (GO:1900015),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NLRP7;NLRC3
C21-steroid hormone metabolic process (GO:0008207),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,DHRS9;CYP11B2
ncRNA catabolic process (GO:0034661),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,POP1;DIS3L
glutathione derivative metabolic process (GO:1901685),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GSTO2;GSTO1
regulation of protein catabolic process (GO:0042176),6/91,0.303383440861158,1,0,0,1.3186813186813187,1.5728674181927342,VCP;C4BPA;FURIN;FAM83D;OAZ1;FOXO1
cellular response to lipopolysaccharide (GO:0071222),6/91,0.303383440861158,1,0,0,1.3186813186813187,1.5728674181927342,NLRP7;CCL5;NR1H2;IL18;NLRP3;LBP
regulation of cell motility (GO:2000145),7/109,0.3035915104348741,1,0,0,1.2844036697247707,1.5311019042060257,HACE1;INPP5F;ENPP2;ABL2;AMOTL1;SGK1;NTN1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),7/109,0.3035915104348741,1,0,0,1.2844036697247707,1.5311019042060257,BCL2L13;VCP;PDCD6;CASP3;HTRA2;NLRP3;SNCA
negative regulation of programmed cell death (GO:0043069),23/408,0.30601044111876097,1,0,0,1.1274509803921569,1.3350553576029847,BNIP3L;AREL1;HDAC3;ANGPT1;PRKDC;MPO;FOXO1;ZNF16;TNFRSF10D;PRDX3;RPS6KA3;DAB2;GCLC;TMBIM4;IL7;CASP3;RASA1;CLEC5A;NAA35;SPRY2;IL6ST;EPHA1;SNCA
anion transport (GO:0006820),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,SLC26A8;SLC26A7;SLC22A31;SLC17A3
chordate embryonic development (GO:0043009),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,PROX1;ISL1;BMP7;MYH6
positive regulation of protein transport (GO:0051222),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,FGG;TPR;KIF20B;OAZ1
autophagosome organization (GO:1905037),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,RAB1B;WIPI2;EMC6;ATG4D
positive regulation of epithelial cell migration (GO:0010634),5/74,0.31110059336369467,1,0,0,1.3513513513513513,1.577890496988918,ANGPT1;PDCD6;ENPP2;PROX1;CLASP2
viral gene expression (GO:0019080),7/110,0.3116404927590689,1,0,0,1.2727272727272725,1.4838791193422005,RPL4;RPS9;RPL32;RPL21;TPR;RPL36;FURIN
nuclear export (GO:0051168),6/92,0.31222205200130426,1,0,0,1.3043478260869563,1.5183138771942595,NPAP1;EIF5A;POM121L2;EGR2;TPR;EIF4E
positive regulation of cell migration (GO:0030335),13/221,0.3134222374811857,1,0,0,1.176470588235294,1.3649458776349923,LRRC15;MYOC;SEMA3E;LAMB1;SEMA3F;NIPBL;DAB2;CCL5;ENPP2;SPRY2;KIF20B;EPHA1;CLASP2
response to retinoic acid (GO:0032526),4/57,0.31821716196314576,1,0,0,1.4035087719298245,1.6070473403738648,TMEM161A;RARA;HTRA2;ABL2
regulation of axon extension involved in axon guidance (GO:0048841),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,SEMA3E;SEMA3F
cellular response to catecholamine stimulus (GO:0071870),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,SLC9A1;SNCA
regulation of telomere capping (GO:1904353),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,TNKS2;SMG6
vitamin transport (GO:0051180),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,SLC5A6;FOLR2
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,COPS6;RAD23B
membrane assembly (GO:0071709),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,FLOT1;NRXN2
negative regulation of signal transduction in absence of ligand (GO:1901099),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,EYA1;EYA2
positive regulation of blood circulation (GO:1903524),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,AVPR1B;FGG
folic acid-containing compound metabolic process (GO:0006760),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,DHFR;FOLR2
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,EYA1;EYA2
response to alkaloid (GO:0043279),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,CHRNB3;DRD3
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,GSTO1;DHRS7C
negative regulation of transcription factor import into nucleus (GO:0042992),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,NLRP3;BMP7
positive regulation of ion transmembrane transporter activity (GO:0032414),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,TCAF1;WNK4
positive regulation of cell junction assembly (GO:1901890),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,MYOC;FLOT1
NAD metabolic process (GO:0019674),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,VCP;KYNU
regulation of ion homeostasis (GO:2000021),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,WNK4;CORIN
negative regulation of axon extension (GO:0030517),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,SEMA3E;SEMA3F
autophagy of mitochondrion (GO:0000422),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,FUNDC1;WIPI2;ATG4D
positive regulation of mitotic nuclear division (GO:0045840),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,NIPBL;SMC5;DRD3
neuron projection development (GO:0031175),10/167,0.32505196093432853,1,0,0,1.1976047904191616,1.3458326103399743,BLOC1S6;MYOC;CTTN;BLOC1S1;STMN2;LAMB1;KIF20B;SGK1;BMP7;FRYL
cholesterol homeostasis (GO:0042632),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,NR1H2;LIPG;IL18;PCSK9
autophagosome assembly (GO:0000045),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,RAB1B;WIPI2;EMC6;ATG4D
sterol homeostasis (GO:0055092),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,NR1H2;LIPG;IL18;PCSK9
sodium ion transport (GO:0006814),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,SGK1;FGF13;SCN1B;SLC17A3
double-strand break repair via homologous recombination (GO:0000724),5/76,0.3310054642700082,1,0,0,1.3157894736842104,1.4547636781220141,NIPBL;RECQL5;SMC5;POLL;SLX1A
peptidyl-cysteine modification (GO:0018198),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRDX3
Golgi to lysosome transport (GO:0090160),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CCDC91
neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SEMA3F
positive regulation of extracellular matrix assembly (GO:1901203),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CLASP2
positive regulation of tissue remodeling (GO:0034105),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IL18
regulation of chaperone-mediated autophagy (GO:1904714),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SNCA
negative regulation of glial cell differentiation (GO:0045686),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DRD3
positive regulation of membrane potential (GO:0045838),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,VCP
cellular response to forskolin (GO:1904322),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GNAI1
response to magnesium ion (GO:0032026),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SNCA
phenol-containing compound biosynthetic process (GO:0046189),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CITED1
negative regulation of platelet aggregation (GO:0090331),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,C1QTNF1
negative regulation of potassium ion transmembrane transporter activity (GO:1901017),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KCNE3
positive regulation of DNA recombination (GO:0045911),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRDM9
negative regulation of monooxygenase activity (GO:0032769),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SNCA
desmosome organization (GO:0002934),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PKP3
regulation of muscle organ development (GO:0048634),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CENPF
protein localization to microtubule (GO:0035372),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KIF20B
regulation of ATP biosynthetic process (GO:2001169),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,VCP
phagolysosome assembly (GO:0001845),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SYT7
benzene-containing compound metabolic process (GO:0042537),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KYNU
positive regulation of early endosome to late endosome transport (GO:2000643),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DAB2
axon extension involved in axon guidance (GO:0048846),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SEMA3F
response to forskolin (GO:1904321),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GNAI1
multi-ciliated epithelial cell differentiation (GO:1903251),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CEP63
Schwann cell development (GO:0014044),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MYOC
plasma membrane to endosome transport (GO:0048227),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RAB5B
desensitization of G-protein coupled receptor protein signaling pathway (GO:0002029),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DRD3
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GSTO1
positive regulation of spindle checkpoint (GO:0090232),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TPR
regulation of striated muscle cell differentiation (GO:0051153),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AKAP13
glycosyl compound metabolic process (GO:1901657),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LCT
genetic imprinting (GO:0071514),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRMT7
kynurenine metabolic process (GO:0070189),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KYNU
kinetochore assembly (GO:0051382),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CENPF
negative regulation of centriole replication (GO:0046600),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CDK5RAP2
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BIN1
heterochromatin assembly (GO:0031507),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BAHD1
inositol phosphate catabolic process (GO:0071545),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,INPP1
phospholipid homeostasis (GO:0055091),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LIPG
cardiac muscle hypertrophy (GO:0003300),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,INPP5F
ketone body biosynthetic process (GO:0046951),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HMGCS2
phospholipid scrambling (GO:0017121),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PLSCR1
regulation of lipid transport (GO:0032368),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NR1H2
negative regulation of exocytosis (GO:0045920),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SNCA
membrane lipid catabolic process (GO:0046466),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SGPL1
rRNA pseudouridine synthesis (GO:0031118),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RPUSD1
peripheral nervous system axon ensheathment (GO:0032292),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MYOC
pyrimidine nucleobase metabolic process (GO:0006206),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ALDH6A1
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LBP
negative regulation of neuron projection regeneration (GO:0070571),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,INPP5F
granulocyte differentiation (GO:0030851),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TAL1
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BNIP3L
actin filament network formation (GO:0051639),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PLS1
positive regulation of respiratory burst (GO:0060267),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LBP
negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKAR2A
asymmetric protein localization (GO:0008105),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SHROOM2
negative regulation of vascular permeability (GO:0043116),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ANGPT1
norepinephrine metabolic process (GO:0042415),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,INSM1
regulation of ERAD pathway (GO:1904292),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,USP25
bone resorption (GO:0045453),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IL7
positive regulation of chromatin silencing (GO:0031937),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DNMT1
positive regulation of TORC1 signaling (GO:1904263),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PIH1D1
positive regulation of lipoprotein lipase activity (GO:0051006),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NR1H2
osteoblast development (GO:0002076),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CLEC5A
regulation of dopamine receptor signaling pathway (GO:0060159),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DRD3
glycerol-3-phosphate metabolic process (GO:0006072),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GK5
nose development (GO:0043584),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PROX1
telomeric D-loop disassembly (GO:0061820),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SLX1A
regulation of T-helper 2 cell cytokine production (GO:2000551),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NLRP3
positive regulation of non-canonical Wnt signaling pathway (GO:2000052),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DAB2
regulation of receptor binding (GO:1900120),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HFE
succinate metabolic process (GO:0006105),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SUCLG1
tRNA aminoacylation for mitochondrial protein translation (GO:0070127),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AARS2
cellular monovalent inorganic anion homeostasis (GO:0030320),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SLC12A5
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FGF13
regulation of apoptotic cell clearance (GO:2000425),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,C4A
negative regulation of double-strand break repair via homologous recombination (GO:2000042),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KLHL15
bicarbonate transport (GO:0015701),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,CA3;SLC26A8;SLC26A7
regulation of phagocytosis (GO:0050764),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,SFTPA2;C4BPA;SYT7
positive regulation of cell division (GO:0051781),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,TAL1;KIF20B;DRD3
regulation of substrate adhesion-dependent cell spreading (GO:1900024),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,MYOC;FGG;OLFM4
negative regulation of STAT cascade (GO:1904893),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,LRRC15;LRTM2;LRRTM1
cellular lipid catabolic process (GO:0044242),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,LIPG;ENPP2
negative regulation of protein localization to membrane (GO:1905476),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,LRRC15;DAB2
response to glucocorticoid (GO:0051384),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,GHRHR;ISL1
ear morphogenesis (GO:0042471),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,NIPBL;ZIC1
regulation of actin filament bundle assembly (GO:0032231),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,ASAP3;SLC9A1
macromolecule modification (GO:0043412),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,ST6GALNAC3;LRPPRC
positive regulation of microtubule polymerization or depolymerization (GO:0031112),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,STMN2;CDK5RAP2
eosinophil chemotaxis (GO:0048245),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CCL3L1;CCL5
negative regulation of endothelial cell apoptotic process (GO:2000352),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,ANGPT1;FGG
eosinophil migration (GO:0072677),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CCL3L1;CCL5
cilium-dependent cell motility (GO:0060285),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,DNAH2;TEKT4
positive regulation of vascular endothelial growth factor production (GO:0010575),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,IL6ST;ISL1
negative regulation of interleukin-6 production (GO:0032715),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,NLRC3;SLAMF1
fatty acid derivative biosynthetic process (GO:1901570),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,HMGCS2;FADS1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,TMEM161A;ZNF385A
organic cation transport (GO:0015695),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,SLC5A7;SLC25A42
regulation of protein metabolic process (GO:0051246),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,ABTB1;FURIN;FAM83D;FOLR2
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,DAB2;HFE;INHBB;BMP7
dicarboxylic acid metabolic process (GO:0043648),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,DHFR;GCLC;SUCLG1;FOLR2
positive regulation of protein metabolic process (GO:0051247),6/96,0.3479363200566363,1,0,0,1.25,1.3196697553688395,VCP;RAB1B;NR1H2;C4BPA;OAZ1;FOXO1
cellular metal ion homeostasis (GO:0006875),6/96,0.3479363200566363,1,0,0,1.25,1.3196697553688395,CASR;CALCB;CCL5;DRD3;DRD4;SLC9A1
extracellular matrix disassembly (GO:0022617),5/78,0.3510237868632946,1,0,0,1.282051282051282,1.3421811397066412,FLOT1;KLK4;FURIN;TLL1;MMP8
cellular response to calcium ion (GO:0071277),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,ITPKB;GUCA1A;MCOLN1
negative regulation of protein secretion (GO:0050709),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,INHBB;DRD3;DRD4
ceramide metabolic process (GO:0006672),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,FUT5;SGPL1;ST6GALNAC3
cellular response to retinoic acid (GO:0071300),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,RARA;HTRA2;ABL2
translesion synthesis (GO:0019985),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,VCP;RFC2;FAAP20
muscle organ development (GO:0007517),4/60,0.3527005497730227,1,0,0,1.3333333333333333,1.3895145106479536,SGCD;SGCG;MYH6;CACNA1H
heterotypic cell-cell adhesion (GO:0034113),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CTNNA3;DSC2
signal peptide processing (GO:0006465),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SPPL2A;FURIN
response to copper ion (GO:0046688),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SNCA;MT1HL1
inorganic cation import across plasma membrane (GO:0098659),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,HFE;SLC9A1
potassium ion homeostasis (GO:0055075),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SLC12A5;CYP11B2
neutral amino acid transport (GO:0015804),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SLC7A9;SLC38A5
positive regulation of interleukin-12 production (GO:0032735),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,MAPK11;ISL1
misfolded or incompletely synthesized protein catabolic process (GO:0006515),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,VCP;KLHL15
peptide catabolic process (GO:0043171),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CPQ;ECE1
long-chain fatty-acyl-CoA metabolic process (GO:0035336),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,ACSL1;THEM4
L-amino acid transport (GO:0015807),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SLC7A9;SLC38A5
regulation of protein import into nucleus (GO:0042306),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,TPR;ZIC1
extracellular matrix organization (GO:0030198),13/229,0.3593599084724989,1,0,0,1.1353711790393013,1.1619739045994106,VCAM1;COL11A1;FGG;KLK4;P3H4;FURIN;LAMB1;MMP8;MFAP2;FLOT1;ITGB8;TLL1;ITGB6
cellular response to interferon-gamma (GO:0071346),7/116,0.3606196265526343,1,0,0,1.206896551724138,1.2309518612816097,VCAM1;CCL3L1;HFE;CCL5;HLA-C;AQP4;GBP2
cation transport (GO:0006812),5/79,0.36105764852361333,1,0,0,1.2658227848101267,1.2895160027815111,CHRNB3;MMGT1;MCOLN1;SLC38A5;CNGB1
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),5/79,0.36105764852361333,1,0,0,1.2658227848101267,1.2895160027815111,ZNF451;DAB2;CITED1;WFIKKN1;DKK3
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,INPP5F;CCL5;IL18;IL6ST
protein targeting to membrane (GO:0006612),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,RTP3;CHM;SRP14;ATG4D
membrane depolarization (GO:0051899),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,CACNA1H;SCN1B;TPCN1
nucleobase-containing compound catabolic process (GO:0034655),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,STK31;DIS3L;XRN2
regulation of interferon-gamma production (GO:0032649),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,IL18;RARA;ISL1
positive regulation of neuron differentiation (GO:0045666),6/98,0.3659360545830404,1,0,0,1.2244897959183672,1.2309755205294757,RETREG3;AVIL;STMN2;ABL2;PROX1;SCN1B
response to molecule of bacterial origin (GO:0002237),6/98,0.3659360545830404,1,0,0,1.2244897959183672,1.2309755205294757,PRDX3;RPS6KA3;CITED1;LBP;TNFRSF10D;SNCA
type B pancreatic cell differentiation (GO:0003309),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,INSM1
secretory granule organization (GO:0033363),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BLOC1S1
negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NLRC3
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PIH1D1
adult heart development (GO:0007512),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MYH6
L-fucose metabolic process (GO:0042354),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT5
actin filament reorganization (GO:0090527),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FRYL
neuronal ion channel clustering (GO:0045161),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MYOC
positive regulation of triglyceride biosynthetic process (GO:0010867),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NR1H2
microtubule anchoring at centrosome (GO:0034454),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCDC68
postsynaptic membrane assembly (GO:0097104),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NRXN2
negative regulation of T cell apoptotic process (GO:0070233),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCL5
positive regulation of coagulation (GO:0050820),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,F12
pericardium development (GO:0060039),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BMP7
negative regulation of mitotic nuclear division (GO:0045839),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BMP7
negative regulation of catenin import into nucleus (GO:0035414),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DACT3
vasodilation (GO:0042311),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ADRB3
regulation of mast cell activation (GO:0033003),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PLSCR1
embryonic digestive tract morphogenesis (GO:0048557),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NIPBL
embryonic forelimb morphogenesis (GO:0035115),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NIPBL
neurotrophin TRK receptor signaling pathway (GO:0048011),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CASP3
L-fucose catabolic process (GO:0042355),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT5
adipose tissue development (GO:0060612),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ARID5B
Cdc42 protein signal transduction (GO:0032488),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NTN1
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,INPP5F
indolalkylamine catabolic process (GO:0046218),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KYNU
positive regulation of ion transmembrane transport (GO:0034767),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,WNK4
small nucleolar ribonucleoprotein complex assembly (GO:0000491),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PIH1D1
response to muscle stretch (GO:0035994),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC9A1
myelin assembly (GO:0032288),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GPC1
endosome to pigment granule transport (GO:0043485),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BLOC1S6
nicotinamide nucleotide biosynthetic process (GO:0019359),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KYNU
heterochromatin organization (GO:0070828),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BAHD1
virion attachment to host cell (GO:0019062),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,LRRC15
regulation of skeletal muscle cell differentiation (GO:2001014),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GPC1
nucleoside phosphate biosynthetic process (GO:1901293),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SUCLG1
positive regulation of T cell chemotaxis (GO:0010820),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCL5
cellular response to oxygen levels (GO:0071453),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ATP6V0A2
positive regulation of astrocyte differentiation (GO:0048711),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BIN1
negative regulation of histone methylation (GO:0031061),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DNMT1
regulation of striated muscle tissue development (GO:0016202),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CENPF
nucleoside triphosphate biosynthetic process (GO:0009142),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SUCLG1
production of siRNA involved in RNA interference (GO:0030422),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DROSHA
glycine transport (GO:0015816),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC38A5
positive regulation of ribosome biogenesis (GO:0090070),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,WDR43
membrane disruption in other organism (GO:0051673),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GSDMD
Notch signaling involved in heart development (GO:0061314),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HEY1
omega-hydroxylase P450 pathway (GO:0097267),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CYP4A11
positive regulation of hemostasis (GO:1900048),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,F12
regulation of bile acid biosynthetic process (GO:0070857),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PROX1
positive regulation of rRNA processing (GO:2000234),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,WDR43
negative regulation of lymphocyte apoptotic process (GO:0070229),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCL5
regulation of methylation-dependent chromatin silencing (GO:0090308),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DNMT1
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDCD6
flavonoid glucuronidation (GO:0052696),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,UGT1A1
postsynaptic density organization (GO:0097106),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NRXN2
regulation of cell-cell adhesion mediated by cadherin (GO:2000047),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FLOT1
regulation of leukocyte activation (GO:0002694),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PLSCR1
negative regulation of interferon-beta production (GO:0032688),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NLRC3
response to interleukin-4 (GO:0070670),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CITED1
fucose catabolic process (GO:0019317),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT5
glucose import (GO:0046323),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC2A12
granulocyte activation (GO:0036230),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCL5
regulation of hair cycle (GO:0042634),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NIPBL
regulation of oxidative phosphorylation (GO:0002082),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,VCP
negative regulation of lipid localization (GO:1905953),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NR1H2
regulation of homotypic cell-cell adhesion (GO:0034110),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCL5
endosome to melanosome transport (GO:0035646),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BLOC1S6
negative regulation of amyloid-beta formation (GO:1902430),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BIN1
negative regulation of transcription by competitive promoter binding (GO:0010944),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BHLHE41
cellular response to acidic pH (GO:0071468),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC9A1
detection of mechanical stimulus involved in sensory perception (GO:0050974),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,COL11A1
lipoprotein biosynthetic process (GO:0042158),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,WIPI2
cytoskeletal anchoring at plasma membrane (GO:0007016),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TLN1
positive regulation of triglyceride lipase activity (GO:0061365),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NR1H2
"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RECQL5
negative regulation of peptidyl-lysine acetylation (GO:2000757),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SNCA
response to vitamin (GO:0033273),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KYNU
vitamin transmembrane transport (GO:0035461),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC5A6
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,MYOC;CCL5;IL18;NLRC3;STAMBP
response to lipopolysaccharide (GO:0032496),9/155,0.37149900230097443,1,0,0,1.1612903225806452,1.1499202456539444,PRDX3;RPS6KA3;CITED1;NLRP7;NR1H2;NLRP3;LBP;TNFRSF10D;SNCA
positive regulation of catabolic process (GO:0009896),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,VCP;C4BPA;OAZ1;FOXO1
cellular amide metabolic process (GO:0043603),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,SLC5A6;FUT5;SGPL1;VNN2
cellular protein catabolic process (GO:0044257),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,BNIP3L;PCSK9;HTRA2;TCIRG1
bile acid biosynthetic process (GO:0006699),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,OSBPL2;CYP46A1
positive regulation of synapse assembly (GO:0051965),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,DLG5;VSTM5
cytoskeleton-dependent intracellular transport (GO:0030705),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,CCDC88B;MYO10
lipid modification (GO:0030258),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,DGKB;CYP3A5
regulation of NF-kappaB import into nucleus (GO:0042345),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,NLRP3;BMP7
negative chemotaxis (GO:0050919),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,SEMA3E;SEMA3F
regulation of histone acetylation (GO:0035065),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,IWS1;SNCA
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PLA2G12A;PLA2G4E
GPI anchor metabolic process (GO:0006505),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PIGO;PIGW
endocrine system development (GO:0035270),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TG;DKK3
regulation of rhodopsin mediated signaling pathway (GO:0022400),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,GUCA1A;CNGB1
regulation of focal adhesion assembly (GO:0051893),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,MYOC;SLC9A1;CLASP2
sprouting angiogenesis (GO:0002040),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,ANGPT1;SEMA3E;JMJD6
positive regulation of intracellular transport (GO:0032388),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,TPR;KIF20B;OAZ1
regulation of smooth muscle cell proliferation (GO:0048660),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,PRKDC;CCL5;IL18
negative regulation of type I interferon production (GO:0032480),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,TBK1;RNF216;NLRC3
regulation of intracellular pH (GO:0051453),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,SLC26A8;SLC26A7;SLC9A1
metaphase plate congression (GO:0051310),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,CENPF;BOD1;FAM83D
negative regulation of immune response (GO:0050777),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,NLRP7;NLRP3;NLRC3
myeloid cell differentiation (GO:0030099),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,PRDX3;TAL1;CASP3
regulation of apoptotic process (GO:0042981),43/815,0.3791041395700734,1,0,0,1.0552147239263803,1.0234995458464005,PXT1;VCP;HDAC3;CITED1;PRKDC;MAGED1;PCSK9;HTRA2;CHM;MPO;FOXO1;PRDX3;AKAP13;RPS6KA3;GRM4;CASP3;CLEC5A;ABL2;ZNF420;SNCA;BNIP3L;KLF11;CREBBP;AREL1;ANGPT1;INHBB;BMP7;ZNF16;TNFRSF10D;NME1;GCLC;DAB2;TMBIM4;IL7;BIN1;RASA1;JMY;NAA35;SPRY2;IL6ST;EPHA1;SGK1;MAP3K14
negative regulation of cell cycle process (GO:0010948),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,RRM2;EHMT2;MGA;BMP7;PHC3
positive regulation of binding (GO:0051099),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,HFE;FLOT1;RARA;EDF1;NME1
positive regulation of protein catabolic process (GO:0045732),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,VCP;C4BPA;FURIN;OAZ1;FOXO1
negative regulation of apoptotic process (GO:0043066),26/485,0.38531204842867156,1,0,0,1.0721649484536082,1.022525595761703,HDAC3;CITED1;PRKDC;MPO;FOXO1;PRDX3;RPS6KA3;LAMP3;CASP3;CLEC5A;SNCA;BNIP3L;AREL1;ANGPT1;ISL1;ZNF16;TNFRSF10D;DAB2;GCLC;TMBIM4;IL7;RASA1;NAA35;SPRY2;IL6ST;EPHA1
regulation of neuron projection development (GO:0010975),7/119,0.3853715393039042,1,0,0,1.176470588235294,1.1218204386945247,RETREG3;AVIL;ULK4;STMN2;ABL2;KNDC1;SCN1B
RNA export from nucleus (GO:0006405),7/119,0.3853715393039042,1,0,0,1.176470588235294,1.1218204386945247,NPAP1;EIF5A;POM121L2;NXF3;TPR;EIF4E;SMG6
regulation of signal transduction by p53 class mediator (GO:1901796),8/138,0.38588815366024015,1,0,0,1.1594202898550725,1.1040089378109808,L3MBTL1;MAPK11;RFC2;TAF13;EHMT2;JMY;CHD4;ZNF385A
negative regulation of dephosphorylation (GO:0035305),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,PPP1R26;SH3RF2;PLEKHF1;RIMBP2
negative regulation of NF-kappaB transcription factor activity (GO:0032088),5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,NLRP7;NLRP3;NLRC3;COMMD7;BMP7
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,DAB2;CITED1;HFE;INHBB;BMP7
protein processing (GO:0016485),6/101,0.39300017337866283,1,0,0,1.188118811881188,1.109637892212941,F12;SPPL2A;HTRA2;PCSK9;ECE1;FURIN
cellular divalent inorganic cation homeostasis (GO:0072503),6/101,0.39300017337866283,1,0,0,1.188118811881188,1.109637892212941,CASR;CALCB;CCL5;DRD3;DRD4;MT1HL1
regulation of kinase activity (GO:0043549),6/101,0.39300017337866283,1,0,0,1.188118811881188,1.109637892212941,PRDX3;SPDYE16;SPDYE6;EPHA1;DRD4;ZNF16
macromolecular complex assembly (GO:0065003),7/120,0.39363540297261096,1,0,0,1.1666666666666665,1.0877185331509394,CREBBP;ST13;SLC7A9;HFE;FGG;REPS2;WASF3
phosphatidylcholine acyl-chain remodeling (GO:0036151),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,PLA2G12A;PLA2G4E
ATP synthesis coupled proton transport (GO:0015986),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,ATP6V0A2;TCIRG1
regulation of cilium assembly (GO:1902017),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,CROCC;CEP120
response to hexose (GO:0009746),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,EIF2B2;KLRG1
leukocyte cell-cell adhesion (GO:0007159),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,VCAM1;CCL5
phagosome acidification (GO:0090383),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,ATP6V0A2;TCIRG1
negative regulation of myeloid leukocyte differentiation (GO:0002762),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,RARA;TCTA
regulation of neurotransmitter secretion (GO:0046928),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,RIMS4;PNKD
regulation of protein targeting to membrane (GO:0090313),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,TCAF1;MTCL1
regulation of vascular endothelial growth factor production (GO:0010574),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,IL6ST;ISL1
cargo loading into vesicle (GO:0035459),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,SEC24A;MIA
protein localization to chromosome (GO:0034502),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,TNKS2;BOD1
cellular response to glucose stimulus (GO:0071333),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,PTPRN2;PCK2
positive regulation of protein polymerization (GO:0032273),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,BAIAP2L2;TPPP3;CTTN;CDK5RAP2
positive regulation of JAK-STAT cascade (GO:0046427),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,CCL5;IL18;IL6ST;CRLF3
negative regulation of neuron death (GO:1901215),5/83,0.40119924980674115,1,0,0,1.2048192771084336,1.1003579430959414,CITED1;RASA1;HTRA2;ISL1;SNCA
positive regulation of homeostatic process (GO:0032846),5/83,0.40119924980674115,1,0,0,1.2048192771084336,1.1003579430959414,FAM210B;TAL1;PIH1D1;PLEKHM1;ZNF16
inorganic cation transmembrane transport (GO:0098662),8/140,0.4012246378411757,1,0,0,1.1428571428571428,1.04369578789494,TRPA1;TCIRG1;MCOLN1;SCN1B;CACNA1H;SLC17A3;SLC39A3;SLC9A1
regulation of phospholipase C activity (GO:1900274),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ABL2
low-density lipoprotein particle receptor catabolic process (GO:0032802),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PCSK9
membrane raft organization (GO:0031579),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,FLOT1
negative regulation of cellular protein catabolic process (GO:1903363),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,FURIN
endothelium development (GO:0003158),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EDF1
negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PCSK9
thyroid gland development (GO:0030878),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TG
regulation of cellular respiration (GO:0043457),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,VCP
superoxide anion generation (GO:0042554),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NOX5
macrophage chemotaxis (GO:0048246),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL5
positive regulation of cytoplasmic transport (GO:1903651),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DAB2
chloride ion homeostasis (GO:0055064),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC12A5
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,KNSTRN
protein K11-linked deubiquitination (GO:0035871),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,OTUD6A
positive regulation of alcohol biosynthetic process (GO:1902932),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SNCA
cellular biogenic amine metabolic process (GO:0006576),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,OAZ1
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SNCA
response to acidic pH (GO:0010447),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC9A1
skeletal muscle thin filament assembly (GO:0030240),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PROX1
pyroptosis (GO:0070269),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GSDMD
detection of light stimulus involved in sensory perception (GO:0050962),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CNGB1
regulation of triglyceride catabolic process (GO:0010896),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,AADAC
L-glutamate transport (GO:0015813),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC25A18
positive regulation of bone remodeling (GO:0046852),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PLEKHM1
regulation of NLRP3 inflammasome complex assembly (GO:1900225),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NLRC3
glutamine metabolic process (GO:0006541),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LGSN
mesenchymal to epithelial transition (GO:0060231),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CITED1
positive regulation of glial cell differentiation (GO:0045687),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BIN1
positive regulation of acrosome reaction (GO:2000344),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CACNA1H
"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,POP1
"base-excision repair, AP site formation (GO:0006285)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MPG
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,WBP2
tryptophan metabolic process (GO:0006568),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,KYNU
peptidyl-lysine dimethylation (GO:0018027),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EHMT2
creatine metabolic process (GO:0006600),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CKM
mitotic G1 DNA damage checkpoint (GO:0031571),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PRKDC
DNA dealkylation involved in DNA repair (GO:0006307),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MPG
positive regulation of fertilization (GO:1905516),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CACNA1H
regulation of granulocyte differentiation (GO:0030852),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RARA
regulation of pH (GO:0006885),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC9A1
positive regulation of natural killer cell activation (GO:0032816),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IL18
glycerolipid metabolic process (GO:0046486),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DGKB
primary miRNA processing (GO:0031053),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DROSHA
positive regulation of T cell apoptotic process (GO:0070234),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL5
negative regulation of cell activation (GO:0050866),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,C1QTNF1
macrophage migration (GO:1905517),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL5
protein localization to synapse (GO:0035418),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NRXN2
regulation of cytoplasmic translation (GO:2000765),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ZNF385A
positive regulation of reproductive process (GO:2000243),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,INHBB
DNA dealkylation (GO:0035510),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MPG
IRES-dependent viral translational initiation (GO:0075522),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EIF3F
complement receptor mediated signaling pathway (GO:0002430),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GPR32
protein deneddylation (GO:0000338),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,COPS6
negative regulation of protein maturation (GO:1903318),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NLRP7
positive regulation of smooth muscle cell migration (GO:0014911),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL5
negative regulation of centrosome duplication (GO:0010826),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CDK5RAP2
regulation of gene expression by genetic imprinting (GO:0006349),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PRMT7
positive regulation of bone resorption (GO:0045780),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PLEKHM1
telomere maintenance via recombination (GO:0000722),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SMC5
regulation of phospholipase activity (GO:0010517),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SNCA
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ISL1
ganglioside biosynthetic process (GO:0001574),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ST6GALNAC3
negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PCSK9
negative regulation of embryonic development (GO:0045992),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RPS6KA6
detection of light stimulus involved in visual perception (GO:0050908),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CNGB1
regulation of mitochondrial depolarization (GO:0051900),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MYOC
cilium movement involved in cell motility (GO:0060294),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TEKT4
regulation of astrocyte differentiation (GO:0048710),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BIN1
negative regulation of protein autophosphorylation (GO:0031953),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MVP
positive regulation of interleukin-13 production (GO:0032736),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RARA
chaperone-mediated protein transport (GO:0072321),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TIMM10
dicarboxylic acid biosynthetic process (GO:0043650),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,KYNU
urate transport (GO:0015747),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC17A3
negative regulation of homotypic cell-cell adhesion (GO:0034111),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,C1QTNF1
tryptophan catabolic process (GO:0006569),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,KYNU
telomeric loop disassembly (GO:0090657),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLX1A
regulation of plasminogen activation (GO:0010755),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,F12
forelimb morphogenesis (GO:0035136),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NIPBL
pulmonary valve development (GO:0003177),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,HEY1
regulation of T cell apoptotic process (GO:0070232),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL5
smooth muscle cell differentiation (GO:0051145),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,HEY1
protein prenylation (GO:0018342),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CHM
intracellular cholesterol transport (GO:0032367),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SYT7
regulation of axon regeneration (GO:0048679),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,INPP5F
thyroid hormone generation (GO:0006590),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CPQ
regulation of T cell chemotaxis (GO:0010819),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL5
regulation of cell differentiation (GO:0045595),7/121,0.40189970418865884,1,0,0,1.1570247933884297,1.054689090068788,RPS6KA3;CREBBP;HEY1;INSM1;ISL1;FADS1;CLASP2
central nervous system development (GO:0007417),12/217,0.4022049425089577,1,0,0,1.1059907834101383,1.0073292310058564,RPS6KA3;RPS6KA6;EGR2;NIPBL;EIF2B2;ZIC1;RARA;SHROOM2;VCX;PROX1;EML1;CDK5RAP2
positive regulation of cell motility (GO:2000147),10/179,0.4057408879304794,1,0,0,1.1173184357541899,1.007866514177665,LRRC15;DAB2;MYOC;CCL5;SPRY2;SEMA3E;LAMB1;SEMA3F;EPHA1;NTN1
regulation of myeloid cell differentiation (GO:0045637),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,L3MBTL1;CREBBP;AGO3;AGO1
defense response to Gram-positive bacterium (GO:0050830),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,GSDMD;SPACA1;DROSHA;LBP
positive regulation of supramolecular fiber organization (GO:1902905),5/84,0.41120390033692134,1,0,0,1.1904761904761902,1.0579358090845326,BAIAP2L2;CTTN;STMN2;PROX1;CDK5RAP2
protein modification process (GO:0036211),5/84,0.41120390033692134,1,0,0,1.1904761904761902,1.0579358090845326,USP25;PRKDC;QPCT;ABL2;UBE2M
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,DAB2;ISL1
cellular response to ketone (GO:1901655),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GNAI1;PCK2
hydrogen ion transmembrane transport (GO:1902600),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,TCIRG1;SLC9A1
RNA phosphodiester bond hydrolysis (GO:0090501),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,POP1;RNASE1
acute inflammatory response (GO:0002526),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,PLSCR1;LBP
"synaptic transmission, cholinergic (GO:0007271)",2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,SLC5A7;CHRNB3
positive regulation of phosphate metabolic process (GO:0045937),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CCL5;SNCA
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,BMP7;DKK3
positive regulation of calcium-mediated signaling (GO:0050850),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GSTO1;SLC9A1
neural crest cell migration (GO:0001755),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,SEMA3E;SEMA3F
dopamine receptor signaling pathway (GO:0007212),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,DRD3;DRD4
ventricular septum development (GO:0003281),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,HEY1;PROX1
calcium ion import (GO:0070509),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CASR;CACNA1H
protein K63-linked deubiquitination (GO:0070536),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,USP25;STAMBP
protein export from nucleus (GO:0006611),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,EIF5A;EGR2
transcription elongation from RNA polymerase I promoter (GO:0006362),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,POLR2E;POLR2K
ER to Golgi vesicle-mediated transport (GO:0006888),10/180,0.41252988449997713,1,0,0,1.111111111111111,0.9838295872876737,GRIA1;TMED9;TRAPPC6A;SEC24A;MIA;SAR1B;PDCD6;RAB1B;SPTAN1;COPE
rRNA metabolic process (GO:0016072),11/200,0.41689792194259356,1,0,0,1.0999999999999999,0.9624052665196619,RPL4;RPS9;SAMD15;RPL32;RPL21;PIH1D1;XRN2;DIS3L;RPL36;UTP20;WDR43
response to glucose (GO:0009749),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,EIF2B2;PCK2;KLRG1
peptide cross-linking (GO:0018149),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,LCE1A;LCE2A;LCE1F
polyol metabolic process (GO:0019751),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,ITPKB;INPP1;PLCH2
positive regulation of organelle assembly (GO:1902117),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,CROCC;CEP120;PROX1
inositol phosphate metabolic process (GO:0043647),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,ITPKB;INPP1;PLCH2
cellular response to heat (GO:0034605),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,PDCD6;TPR;HTRA2
peptide metabolic process (GO:0006518),6/104,0.4200266801120024,1,0,0,1.1538461538461537,1.0008888988224178,GSTO2;CPQ;GSTO1;SPPL2A;FURIN;OPLAH
positive regulation of cellular protein localization (GO:1903829),4/66,0.421430857889875,1,0,0,1.2121212121212122,1.0473933978386722,CROCC;TPR;KIF20B;OAZ1
organic anion transport (GO:0015711),7/124,0.42665940706055616,1,0,0,1.129032258064516,0.9616749321100159,CA3;PITPNA;SLC26A8;SLC26A7;SLC25A42;SLC22A31;SLC17A3
mRNA export from nucleus (GO:0006406),6/105,0.4290058391536542,1,0,0,1.1428571428571428,0.9671825703611097,EIF5A;NXF3;ZC3H3;TPR;EIF4E;SMG6
regulation of macrophage derived foam cell differentiation (GO:0010743),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,NR1H2;IL18
collagen fibril organization (GO:0030199),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,COL11A1;P3H4
protein alkylation (GO:0008213),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,VCP;PRMT3
positive regulation of histone modification (GO:0031058),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,NIPBL;SART3
lysosome localization (GO:0032418),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,BLOC1S1;PLEKHM1
regulation of chromosome segregation (GO:0051983),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SMC5;KNSTRN
negative regulation of epithelial cell apoptotic process (GO:1904036),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,ANGPT1;FGG
semaphorin-plexin signaling pathway (GO:0071526),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SEMA3E;SEMA3F
amino acid transmembrane transport (GO:0003333),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SLC7A9;SLC38A5
rRNA processing (GO:0006364),11/202,0.42979691813582577,1,0,0,1.089108910891089,0.9196898136500707,RPL4;RPS9;SAMD15;RPL32;RPL21;PIH1D1;XRN2;DIS3L;RPL36;UTP20;WDR43
positive regulation of multicellular organismal process (GO:0051240),11/202,0.42979691813582577,1,0,0,1.089108910891089,0.9196898136500707,CCDC88B;GHRHR;DAB2;IL18;ENPP2;TMEM119;FLOT1;INHBB;LBP;AGPAT1;CLASP2
sensory perception of smell (GO:0007608),13/241,0.42987351634062676,1,0,0,1.0788381742738589,0.9108245145995734,OR8I2;OR1D2;OR2G3;OR5J2;OR2F1;OR2L3;OR2T6;OR2T11;OR5H15;OR2T2;OR13C9;OR8B3;OR52A5
toll-like receptor signaling pathway (GO:0002224),5/86,0.4311336138274714,1,0,0,1.1627906976744184,0.9782991023729873,RPS6KA3;SFTPA2;FGG;LBP;TLR5
formation of extrachromosomal circular DNA (GO:0001325),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SLX1A
L-phenylalanine metabolic process (GO:0006558),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HGD
negative regulation of morphogenesis of an epithelium (GO:1905331),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CLASP2
atrial septum morphogenesis (GO:0060413),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ISL1
L-phenylalanine catabolic process (GO:0006559),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HGD
regulation of histone H3-K9 methylation (GO:0051570),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,DNMT1
microtubule anchoring at microtubule organizing center (GO:0072393),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCDC68
nitric oxide biosynthetic process (GO:0006809),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GCHFR
regulation of histone deacetylation (GO:0031063),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NIPBL
postsynapse assembly (GO:0099068),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NRXN2
carnitine metabolic process (GO:0009437),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CRAT
morphogenesis of an epithelial sheet (GO:0002011),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BMP7
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GSTO1
intracellular protein transmembrane transport (GO:0065002),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SRP9
regulation of leukocyte cell-cell adhesion (GO:1903037),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCL5
regulation of lamellipodium morphogenesis (GO:2000392),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ENPP2
positive regulation of extracellular matrix organization (GO:1903055),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CLASP2
negative regulation of nuclear division (GO:0051784),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BMP7
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HFE
embryonic eye morphogenesis (GO:0048048),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MFAP2
protein localization to pre-autophagosomal structure (GO:0034497),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,WIPI2
mesonephros development (GO:0001823),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BMP7
positive regulation of cytolysis (GO:0045919),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LBP
positive regulation of protein deacetylation (GO:0090312),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NIPBL
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,UTP20
biotin metabolic process (GO:0006768),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SLC5A6
positive regulation of histone deacetylation (GO:0031065),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NIPBL
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BOD1
regulation of protein kinase C signaling (GO:0090036),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ULK4
positive regulation of myoblast fusion (GO:1901741),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FLOT1
calcium ion regulated exocytosis (GO:0017156),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SYT7
phosphatidylinositol dephosphorylation (GO:0046856),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,INPP5F
regulation of hemopoiesis (GO:1903706),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CREBBP
mitochondrion distribution (GO:0048311),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MSTO1
organic cyclic compound catabolic process (GO:1901361),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HSD11B1
negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BIN1
negative regulation of myotube differentiation (GO:0010832),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BHLHE41
positive regulation of chromosome segregation (GO:0051984),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SMC5
sphingolipid catabolic process (GO:0030149),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SGPL1
synaptonemal complex assembly (GO:0007130),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,P3H4
transcytosis (GO:0045056),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MFSD2A
negative regulation of cell division (GO:0051782),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TXNIP
rhodopsin mediated signaling pathway (GO:0016056),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CNGB1
negative regulation of nucleocytoplasmic transport (GO:0046823),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TPR
icosanoid biosynthetic process (GO:0046456),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FADS1
cellular response to interferon-beta (GO:0035458),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HTRA2
positive regulation of fatty acid biosynthetic process (GO:0045723),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NR1H2
protein kinase C signaling (GO:0070528),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FLOT1
methionine metabolic process (GO:0006555),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MTR
camera-type eye morphogenesis (GO:0048593),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SHROOM2
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ZNF385A
t-circle formation (GO:0090656),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SLX1A
negative regulation of cardiac muscle hypertrophy (GO:0010614),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FOXO1
establishment of synaptic vesicle localization (GO:0097480),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SPG11
glycerol metabolic process (GO:0006071),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GK5
magnesium ion transport (GO:0015693),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MMGT1
low-density lipoprotein receptor particle metabolic process (GO:0032799),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PCSK9
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GSTO1
oxidative phosphorylation (GO:0006119),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NIPSNAP2
embryonic hemopoiesis (GO:0035162),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TAL1
aspartate family amino acid biosynthetic process (GO:0009067),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MTR
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HGD
telomere maintenance via telomere trimming (GO:0090737),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SLX1A
response to corticosteroid (GO:0031960),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GHRHR
urate metabolic process (GO:0046415),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SLC17A3
synaptonemal complex organization (GO:0070193),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,P3H4
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,UAP1L1
insulin receptor signaling pathway (GO:0008286),4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,BAIAP2L2;ATP6V0A2;TCIRG1;FOXO1
endosome to lysosome transport (GO:0008333),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,VCP;BIN1;SCYL2
protein K48-linked ubiquitination (GO:0070936),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,HACE1;RNF216;UBE2Q2
regulation of cell cycle arrest (GO:0071156),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,BIN1;INSM1;CRLF3
glycoprotein metabolic process (GO:0009100),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,MGAT4A;MGAT4B;ST6GALNAC3
cellular response to mechanical stimulus (GO:0071260),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,TLR5;MAP3K14;SLC9A1
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",7/125,0.4348899664469206,1,0,0,1.1199999999999999,0.9325816982581239,HTR6;OR10J5;ADRB3;OR10H2;NPBWR2;HTR1A;GNAI1
positive regulation of cellular catabolic process (GO:0031331),6/106,0.43796290568349927,1,0,0,1.1320754716981132,0.9346653536744506,PLEKHF1;AADAC;FURIN;FOXO1;SNCA;TPCN1
peptidyl-serine phosphorylation (GO:0018105),8/145,0.4395232982954594,1,0,0,1.103448275862069,0.9071057129387737,RPS6KA3;TBK1;MAST4;PRKDC;DCLK2;SGK1;CAMKK1;CSNK1A1L
calcium ion homeostasis (GO:0055074),5/87,0.44104723204673524,1,0,0,1.1494252873563218,0.9409233415212925,CASR;CALCB;CCL5;DRD3;DRD4
non-recombinational repair (GO:0000726),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,HERC2;PRKDC;POLL
cilium movement (GO:0003341),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,CFAP61;RSPH4A;TEKT4
positive regulation of response to DNA damage stimulus (GO:2001022),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,TMEM161A;EYA1;EYA2
regulation of release of sequestered calcium ion into cytosol (GO:0051279),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,GSTO1;DHRS7C;SNCA
ribosomal large subunit assembly (GO:0000027),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,MRPL20;SAMD15
negative regulation of stress-activated MAPK cascade (GO:0032873),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,HDAC3;FOXO1
connective tissue development (GO:0061448),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,ITGB8;ARID5B
negative regulation of transferase activity (GO:0051348),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,PRDX3;NIPSNAP2
regulation of ARF protein signal transduction (GO:0032012),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,ACAP1;ASAP3
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,WBP2;ISL1
regulation of developmental growth (GO:0048638),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,NIPBL;CTTN
positive regulation of phospholipase C activity (GO:0010863),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,AVPR1B;ABL2
aminoglycan metabolic process (GO:0006022),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,GPC1;XYLT1
regulation of protein polymerization (GO:0032271),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,TPPP3;RASA1
bile acid metabolic process (GO:0008206),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,OSBPL2;CYP46A1
cellular response to starvation (GO:0009267),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,PLEKHF1;EHMT2;PCSK9;INHBB;FADS1;FOXO1
positive regulation of cell cycle process (GO:0090068),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,TPR;INSM1;KIF20B;CRLF3;DRD3;ZNF16
negative regulation of response to external stimulus (GO:0032102),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,INPP5F;NLRP7;NLRP3;NLRC3;ISL1;DRD3
regulation of protein secretion (GO:0050708),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,ABCC8;CCL5;FGG;DRD3;DRD4;SYT7
regulation of intracellular signal transduction (GO:1902531),22/422,0.4512333833362595,1,0,0,1.0426540284360188,0.8297134151744756,L3MBTL1;MYOC;RFC2;TAF13;EHMT2;ULK4;INHBB;CHD4;AKAP4;BMP7;GNAI1;ARHGAP33;AKAP13;MAPK11;ARHGAP20;TMBIM4;NLRP7;JMY;NLRP3;FAM83D;ZNF385A;FBXO9
regulation of innate immune response (GO:0045088),4/69,0.45518892642326336,1,0,0,1.1594202898550725,0.9125133023815558,PLSCR1;CCL5;POLR3F;NLRC3
regulation of osteoblast differentiation (GO:0045667),4/69,0.45518892642326336,1,0,0,1.1594202898550725,0.9125133023815558,CITED1;TMEM119;IL6ST;BMP7
nucleotide-excision repair (GO:0006289),6/108,0.45579415117862115,1,0,0,1.111111111111111,0.8730155491595808,COPS6;RFC2;POLR2E;POLL;RAD23B;POLR2K
regulation of cytokine production (GO:0001817),6/108,0.45579415117862115,1,0,0,1.111111111111111,0.8730155491595808,CCDC88B;TBK1;NLRP7;FLOT1;NLRP3;AGPAT1
ribosome biogenesis (GO:0042254),12/226,0.45757057761515396,1,0,0,1.0619469026548671,0.8302557219327945,RPL4;RPS9;SAMD15;RPL32;RPL21;PIH1D1;XRN2;DIS3L;RPL36;VCX;UTP20;WDR43
regulation of bone mineralization (GO:0030500),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,BMP2K;TMEM119;BMP7
fatty acid oxidation (GO:0019395),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,ACAA2;HADH;ACADS
negative regulation of viral genome replication (GO:0045071),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,PLSCR1;CCL5;PROX1
heart morphogenesis (GO:0003007),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,NIPBL;HEY1;ISL1
receptor internalization (GO:0031623),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,DRD3;SCYL2;SNCA
double-strand break repair via nonhomologous end joining (GO:0006303),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,HERC2;PRKDC;POLL
pulmonary valve morphogenesis (GO:0003184),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HEY1
positive regulation of protein depolymerization (GO:1901881),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,STMN2
positive regulation of lyase activity (GO:0051349),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GUCA1A
cardiac right ventricle morphogenesis (GO:0003215),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ISL1
regulation of vasculogenesis (GO:2001212),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HEY1
regulation of myoblast fusion (GO:1901739),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,FLOT1
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PIH1D1
histone H3-K9 demethylation (GO:0033169),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,KDM4E
peptidyl-arginine modification (GO:0018195),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PRMT7
positive regulation of interleukin-1 production (GO:0032732),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ISL1
regulation of oligodendrocyte differentiation (GO:0048713),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DRD3
skeletal myofibril assembly (GO:0014866),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PROX1
regulation of viral life cycle (GO:1903900),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,LAMP3
negative regulation of ERAD pathway (GO:1904293),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,USP25
negative regulation of oxidoreductase activity (GO:0051354),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SNCA
mitochondrial outer membrane permeabilization (GO:0097345),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BNIP3L
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ZNF385A
cellular modified amino acid catabolic process (GO:0042219),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GGACT
amino sugar biosynthetic process (GO:0046349),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UAP1L1
UDP-N-acetylglucosamine metabolic process (GO:0006047),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UAP1L1
protein insertion into membrane (GO:0051205),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RTP3
regulation of cholesterol storage (GO:0010885),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NR1H2
oligodendrocyte development (GO:0014003),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EIF2B2
regulation of rRNA processing (GO:2000232),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,WDR43
mitochondrion transport along microtubule (GO:0047497),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,LRPPRC
regulation of cholesterol homeostasis (GO:2000188),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NR1H2
regulation of histone methylation (GO:0031060),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PIH1D1
cell wall macromolecule catabolic process (GO:0016998),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SPACA1
regulation of bone remodeling (GO:0046850),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SYT7
exit from mitosis (GO:0010458),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CLASP2
polyamine metabolic process (GO:0006595),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,OAZ1
cellular glucan metabolic process (GO:0006073),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PYGL
somatic hypermutation of immunoglobulin genes (GO:0016446),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,POLL
positive regulation of ruffle assembly (GO:1900029),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PLEKHM1
nitric oxide metabolic process (GO:0046209),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GCHFR
tRNA 5'-leader removal (GO:0001682),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,POP1
negative regulation by host of viral transcription (GO:0043922),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CCL5
cargo loading into COPII-coated vesicle (GO:0090110),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SEC24A
cellular response to fluid shear stress (GO:0071498),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HDAC3
regulation of skeletal muscle tissue development (GO:0048641),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,FLOT1
kinetochore organization (GO:0051383),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CENPF
regulation of mononuclear cell migration (GO:0071675),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CCL5
negative regulation of histone modification (GO:0031057),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SNCA
response to interleukin-6 (GO:0070741),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CITED1
regulation of sequestering of triglyceride (GO:0010889),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,OSBPL11
collagen metabolic process (GO:0032963),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,P3H4
cardiac muscle fiber development (GO:0048739),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MYH6
regulation of angiotensin levels in blood (GO:0002002),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ECE1
protein hydroxylation (GO:0018126),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,P3H4
regulation of blood vessel size (GO:0050880),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GCLC
positive regulation of cyclase activity (GO:0031281),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GUCA1A
endosome transport via multivesicular body sorting pathway (GO:0032509),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,VCP
negative regulation of interleukin-12 production (GO:0032695),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SLAMF1
negative regulation of androgen receptor signaling pathway (GO:0060766),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DAB2
positive regulation of T cell cytokine production (GO:0002726),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NLRP3
microtubule anchoring (GO:0034453),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CLASP2
positive regulation of SMAD protein import into nucleus (GO:0060391),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DAB2
positive regulation of cell proliferation (GO:0008284),22/424,0.46022063335192964,1,0,0,1.0377358490566038,0.8053341447580155,EIF5A;RPS9;HTR1A;IL18;LAMB1;TCIRG1;PROX1;ZNF16;NME1;PRDX3;GHRHR;IL7;CCL5;RARA;TMEM119;STAMBP;INSM1;IL6ST;FOLR2;KIF20B;EPHA1;SLAMF1
regulation of neuron apoptotic process (GO:0043523),5/89,0.460744839318766,1,0,0,1.1235955056179774,0.8706863855115896,GRM4;CITED1;RASA1;PCSK9;ISL1
cellular protein metabolic process (GO:0044267),25/484,0.46277612297750825,1,0,0,1.0330578512396693,0.7959833445482524,RPL4;RPL32;SFTPA2;PRKDC;SPPL2A;PCSK9;HTRA2;FURIN;GGA1;C4A;GGA3;RPL36;ABL2;SNCA;RPL39L;USP25;RPS9;RPL21;FGG;LAMB1;MRPS5;MGAT4A;PAPPA;QPCT;UBE2M
alpha-amino acid metabolic process (GO:1901605),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,ALDH6A1;CKM
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,GSTO1;SNCA
regulation of protein tyrosine kinase activity (GO:0061097),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,MVP;SH3BP5
anterograde axonal transport (GO:0008089),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,BLOC1S6;BLOC1S1
cofactor biosynthetic process (GO:0051188),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,PPCDC;COASY
nucleobase-containing small molecule interconversion (GO:0015949),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,RRM2;NME1
termination of RNA polymerase I transcription (GO:0006363),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,POLR2E;POLR2K
positive regulation of bone mineralization (GO:0030501),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,TMEM119;BMP7
gene silencing by miRNA (GO:0035195),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,AGO3;AGO1
proton transport (GO:0015992),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,TCIRG1;SLC9A1
circulatory system development (GO:0072359),6/109,0.4646603211324838,1,0,0,1.1009174311926606,0.8437966596577015,AKAP13;NIPBL;SHOX2;RARA;ECE1;ISL1
negative regulation of protein kinase activity (GO:0006469),6/109,0.4646603211324838,1,0,0,1.1009174311926606,0.8437966596577015,LRRC15;LRRTM1;MVP;LRTM2;SH3BP5;EPHA1
protein transport (GO:0015031),17/326,0.4647303908602855,1,0,0,1.0429447852760736,0.7992063426083489,TMED9;RAB5B;PDCD6;HFE;RAB1B;TIMM10;TCIRG1;MCOLN1;GGA1;CENPF;HERC2;GGA3;CTTN;TBC1D4;SNX17;ATP6V0A2;RAB9B
regulation of Notch signaling pathway (GO:0008593),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,CREBBP;HEY1;BMP2K;RFNG
cytoskeleton-dependent cytokinesis (GO:0061640),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,RASA1;NOX5;STAMBP;KIF20A
snRNA transcription (GO:0009301),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,TAF13;POLR2E;GTF2E2;POLR2K
interferon-gamma-mediated signaling pathway (GO:0060333),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,VCAM1;HFE;HLA-C;GBP2
snRNA transcription from RNA polymerase II promoter (GO:0042795),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,TAF13;POLR2E;GTF2E2;POLR2K
regulation of cell cycle process (GO:0010564),5/90,0.4705185605943169,1,0,0,1.111111111111111,0.8376887467502594,L3MBTL1;BIN1;KIF20A;KIF20B;KNSTRN
regulation of programmed cell death (GO:0043067),14/268,0.472217021741417,1,0,0,1.044776119402985,0.7839128732393905,BNIP3L;CREBBP;VCP;CITED1;MAGED1;CHM;INHBB;BMP7;NME1;TNFRSF10D;ABL2;SGK1;MAP3K14;ZNF420
regulation of exocytosis (GO:0017157),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,FGG;SNCA;CLASP2
carboxylic acid transport (GO:0046942),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,SLC7A9;PSAP;SLC38A5
regulation of telomere maintenance via telomerase (GO:0032210),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,CTC1;TNKS2;SMG6
positive regulation of developmental growth (GO:0048639),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,GHRHR;SYT2;NTN1
macroautophagy (GO:0016236),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,VCP;PLEKHF1;FUNDC1;TCIRG1;WIPI2;TOMM6
negative regulation of cytokine production (GO:0001818),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,TBK1;RNF216;NLRP7;RARA;NLRC3;SLAMF1
recombinational repair (GO:0000725),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,RECQL5;SMC5;POLL;SLX1A
defense response to Gram-negative bacterium (GO:0050829),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,GSDMD;SPACA1;DROSHA;LBP
organelle membrane fusion (GO:0090174),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,SYT2;SYTL1;SYT13;SYT7
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,GSTO1;DRD4
7-methylguanosine mRNA capping (GO:0006370),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,POLR2E;POLR2K
phosphatidylcholine biosynthetic process (GO:0006656),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CHAT;MFSD2A
positive regulation of dendrite development (GO:1900006),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,DLG5;BMP7
7-methylguanosine RNA capping (GO:0009452),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,POLR2E;POLR2K
GPI anchor biosynthetic process (GO:0006506),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,PIGO;PIGW
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,LBP;ISL1
phagosome maturation (GO:0090382),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,ATP6V0A2;TCIRG1
mitochondrial transmembrane transport (GO:1990542),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,TIMM29;TIMM10
purine ribonucleoside triphosphate metabolic process (GO:0009205),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,GIMAP7;MYH6
substrate adhesion-dependent cell spreading (GO:0034446),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,LAMB1;EPHA1
positive regulation of telomere maintenance (GO:0032206),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,TNKS2;SLX1A
lipid transport (GO:0006869),5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,PITPNA;PSAP;LBP;SLC51A;MFSD2A
negative regulation of kinase activity (GO:0033673),5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,PRDX3;LRRC15;LRRTM1;LRTM2;EPHA1
positive regulation of ossification (GO:0045778),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,TMEM119;IL6ST;BMP7
regulation of calcium ion transport (GO:0051924),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,CASR;CRACR2A;CCL5
regulation of interleukin-1 beta production (GO:0032651),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ISL1
positive regulation of histone H3-K4 methylation (GO:0051571),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DNMT1
negative regulation of macrophage derived foam cell differentiation (GO:0010745),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NR1H2
regulation of acyl-CoA biosynthetic process (GO:0050812),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PDP2
sodium ion export from cell (GO:0036376),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLC9A1
regulation of plasma membrane bounded cell projection organization (GO:0120035),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ULK4
cellular response to exogenous dsRNA (GO:0071360),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,FLOT1
positive regulation of sodium ion transport (GO:0010765),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SCN1B
regulation of lymphocyte activation (GO:0051249),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CCL5
positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SNCA
steroid catabolic process (GO:0006706),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,HSD11B1
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SFSWAP
viral translation (GO:0019081),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,EIF3F
synaptic vesicle cycle (GO:0099504),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SYT7
regulation of DNA-templated transcription in response to stress (GO:0043620),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RPS6KA3
regulation of biomineral tissue development (GO:0070167),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BMP2K
regulation of macromolecule biosynthetic process (GO:0010556),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,FOLR2
regulation of triglyceride biosynthetic process (GO:0010866),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NR1H2
myelination in peripheral nervous system (GO:0022011),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MYOC
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PDP2
placenta development (GO:0001890),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CITED1
sodium ion export (GO:0071436),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLC9A1
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RPS6KA6
atrial septum development (GO:0003283),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ISL1
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NCOR2
positive regulation of cholesterol efflux (GO:0010875),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NR1H2
negative regulation of voltage-gated calcium channel activity (GO:1901386),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DRD4
glutamine family amino acid biosynthetic process (GO:0009084),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,LGSN
phosphate ion transport (GO:0006817),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLC17A3
tetrahydrofolate metabolic process (GO:0046653),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DHFR
synaptic vesicle localization (GO:0097479),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SPG11
neuron fate commitment (GO:0048663),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ISL1
ER-associated misfolded protein catabolic process (GO:0071712),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,VCP
mRNA modification (GO:0016556),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TRUB1
positive regulation of muscle contraction (GO:0045933),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CTTN
protein neddylation (GO:0045116),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,UBE2M
regulation of oxidoreductase activity (GO:0051341),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ABL2
RNA interference (GO:0016246),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DROSHA
secretion (GO:0046903),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DRD3
regulation of cAMP-dependent protein kinase activity (GO:2000479),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PRKAR2A
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SEMA3F
regulation of T cell cytokine production (GO:0002724),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,HFE
negative regulation of blood pressure (GO:0045776),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DRD3
positive regulation of alpha-beta T cell proliferation (GO:0046641),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL18
regulation of cytolysis (GO:0042268),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,LBP
positive regulation of interleukin-17 production (GO:0032740),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL18
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ZNF451
positive regulation of smoothened signaling pathway (GO:0045880),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DLG5
detection of calcium ion (GO:0005513),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CASR
lysosomal transport (GO:0007041),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,CCDC91;BIN1;PCSK9;SCYL2
negative regulation of cysteine-type endopeptidase activity (GO:2000117),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,RPS6KA3;LAMP3;SNCA;TNFRSF10D
response to metal ion (GO:0010038),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,PDCD6;HFE;FGG;SNCA
regulation of epithelial cell proliferation (GO:0050678),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,MAGED1;NLRC3;LAMB1;NME1
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",6/112,0.49101551898111034,1,0,0,1.0714285714285714,0.7620852265724269,RPL4;RPS9;RPL32;RPL21;RPL36;SMG6
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),26/512,0.4964682100881265,1,0,0,1.015625,0.7111770103411564,L3MBTL1;HDAC3;CITED1;BHLHE41;FOXO1;NIPBL;HEY1;NKRF;BAHD1;SCMH1;MLX;ZBTB14;MSX2;NR1H2;ARID5B;KCTD1;PROX1;COMMD7;BMP7;DKK3;GATAD2A;DHFR;CENPF;DAB2;GCLC;RARA
positive regulation of cytokine-mediated signaling pathway (GO:0001961),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,IL7;AGPAT1
positive regulation of calcium ion transport (GO:0051928),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CRACR2A;CCL5
positive regulation of cell-matrix adhesion (GO:0001954),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,MYOC;EPHA1
platelet aggregation (GO:0070527),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,FGG;TLN1
embryonic organ morphogenesis (GO:0048562),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,NIPBL;MFAP2
transcription initiation from RNA polymerase I promoter (GO:0006361),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,POLR2E;POLR2K
positive regulation of biomineral tissue development (GO:0070169),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,TMEM119;BMP7
transcription from RNA polymerase I promoter (GO:0006360),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,POLR2E;POLR2K
positive regulation of Notch signaling pathway (GO:0045747),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CREBBP;BMP2K
cellular glucose homeostasis (GO:0001678),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,FOXO1;PCK2
positive regulation of organelle organization (GO:0010638),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,TMED9;HTRA2
regulation of interleukin-12 production (GO:0032655),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,ISL1;SLAMF1
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,MYOC;CCL5;IL18
monocarboxylic acid transport (GO:0015718),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,SLC5A6;SLC51A;MFSD2A
embryonic organ development (GO:0048568),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,HEY1;TAL1;RARA
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,CCL5;IL18;IL6ST
transcription-coupled nucleotide-excision repair (GO:0006283),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,COPS6;RFC2;POLR2E;POLR2K
viral transcription (GO:0019083),6/113,0.4997075653239782,1,0,0,1.0619469026548671,0.7367067833785346,RPL4;RPS9;RPL32;RPL21;TPR;RPL36
regulation of translation (GO:0006417),11/213,0.5001763192159705,1,0,0,1.0328638497652582,0.7155625020839014,DHFR;RPS6KA3;EIF2B2;AGO1;MTG2;TPR;LTN1;POLR2E;EIF4E;ZNF385A;POLR2K
skin development (GO:0043588),5/94,0.509002443009079,1,0,0,1.0638297872340425,0.7184068753385349,LCE1A;LCE2A;CASP3;TXNIP;LCE1F
cell morphogenesis involved in differentiation (GO:0000904),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,LAMB1;PROX1;EPHA1
RNA modification (GO:0009451),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,TRUB1;AARS2;LRPPRC
cytoplasmic translation (GO:0002181),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,RPL4;RPL32;RPL36
neuron cell-cell adhesion (GO:0007158),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NRXN2
branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SEMA3E
positive regulation of cell adhesion mediated by integrin (GO:0033630),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CCL5
acetyl-CoA metabolic process (GO:0006084),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HMGCS2
negative regulation of receptor-mediated endocytosis (GO:0048261),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PCSK9
myeloid dendritic cell activation (GO:0001773),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLAMF1
establishment of mitotic spindle orientation (GO:0000132),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CDK5RAP2
stem cell development (GO:0048864),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PDCD6
regulation of phosphate metabolic process (GO:0019220),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SMG6
"retrograde transport, endosome to plasma membrane (GO:1990126)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SNX17
pore complex assembly (GO:0046931),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GSDMD
regulation of platelet aggregation (GO:0090330),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,C1QTNF1
neurotransmitter biosynthetic process (GO:0042136),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC5A7
regulation of extracellular matrix disassembly (GO:0010715),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CLASP2
regulation of secretion (GO:0051046),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SGK1
negative regulation of Rho protein signal transduction (GO:0035024),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MYOC
regulation of calcineurin-NFAT signaling cascade (GO:0070884),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC9A1
glucuronate metabolic process (GO:0019585),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,UGT1A1
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ZNF385A
negative regulation of focal adhesion assembly (GO:0051895),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CLASP2
cell surface receptor signaling pathway involved in heart development (GO:0061311),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HEY1
oligodendrocyte differentiation (GO:0048709),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EIF2B2
regulation of defense response to virus (GO:0050688),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,RNF216
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SCN1B
monosaccharide transport (GO:0015749),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC2A12
neutrophil activation (GO:0042119),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CCL5
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ZNF385A
Golgi to vacuole transport (GO:0006896),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CCDC91
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,RPS6KA6
DNA modification (GO:0006304),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MPG
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,IL18
regulation of transferase activity (GO:0051338),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SMG6
fatty acid transport (GO:0015908),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MFSD2A
regulation of gastrulation (GO:0010470),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CLASP2
nucleoside triphosphate metabolic process (GO:0009141),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SUCLG1
interleukin-6-mediated signaling pathway (GO:0070102),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,IL6ST
histone H4-K16 acetylation (GO:0043984),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MSL3
positive regulation of calcium ion-dependent exocytosis (GO:0045956),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CACNA1H
regulation of adaptive immune response (GO:0002819),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,IL6ST
estrogen metabolic process (GO:0008210),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,UGT1A1
negative regulation of T cell receptor signaling pathway (GO:0050860),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PVRIG
positive regulation of smooth muscle contraction (GO:0045987),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CTTN
regulation of interleukin-8 production (GO:0032677),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,LBP;TLR5
positive regulation of exocytosis (GO:0045921),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,FGG;CLASP2
positive regulation of cytokinesis (GO:0032467),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,KIF20B;DRD3
regulation of axon extension (GO:0030516),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,CTTN;NTN1
regulation of cell migration (GO:0030334),16/316,0.5159714088282917,1,0,0,1.0126582278481011,0.6700799233247796,LRRC15;TCAF1;HACE1;MYOC;ULK4;SEMA3E;LAMB1;SEMA3F;DAB2;DLG5;CCL5;ENPP2;SPRY2;AMOTL1;EPHA1;SGK1
transcription elongation from RNA polymerase II promoter (GO:0006368),5/95,0.5184489993734346,1,0,0,1.0526315789473684,0.6914880189626921,TAF13;POLR2E;IWS1;GTF2E2;POLR2K
retinoid metabolic process (GO:0001523),4/75,0.520490485053102,1,0,0,1.0666666666666667,0.6965159162578138,UGT1A1;DHRS9;GPC1;LRAT
negative regulation of phosphorylation (GO:0042326),4/75,0.520490485053102,1,0,0,1.0666666666666667,0.6965159162578138,PRDX3;PRKDC;INSM1;BMP7
regulation of cellular catabolic process (GO:0031329),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,LAMP3;PSAP;ABL2
positive regulation of cysteine-type endopeptidase activity (GO:2001056),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,PDCD6;HTRA2;NLRP3
negative regulation of cellular response to growth factor stimulus (GO:0090288),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,PDCD6;GPC1;SPRY2
positive regulation of cellular process (GO:0048522),26/519,0.5250403685575837,1,0,0,1.0019267822736029,0.6455215143836143,HTRA2;SMC5;TCIRG1;AGPAT1;PRDX3;GHRHR;RPS6KA3;FLOT1;LBP;SLAMF1;EIF5A;RPS9;HTR1A;PROX1;ISL1;ZNF16;DAB2;TAL1;IL7;RARA;STAMBP;INSM1;IL6ST;FOLR2;KIF20B;EPHA1
chromatin remodeling (GO:0006338),6/116,0.5254581276778527,1,0,0,1.0344827586206895,0.6656739028524064,PIH1D1;BAHD1;HMG20B;MSL3;CHD4;ARID1A
neutrophil degranulation (GO:0043312),24/479,0.5259864526432697,1,0,0,1.0020876826722338,0.6438211159988143,GSDMD;KCMF1;ARSA;RAB5B;VCP;CANT1;PTPRN2;HFE;MVP;PYGL;TCIRG1;OLFM4;SRP14;MMP8;C6ORF120;MPO;CRACR2A;COMMD9;QPCT;CLEC5A;PSAP;PKP1;SPTAN1;RAB9B
regulation of cell death (GO:0010941),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,BNIP3L;TBK1;CCL5;HTRA2;BMP7
positive regulation of peptide secretion (GO:0002793),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,HFE;FGG
regulation of endothelial cell apoptotic process (GO:2000351),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,ANGPT1;FGG
erythrocyte differentiation (GO:0030218),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,TAL1;CASP3
regulation of mitotic spindle organization (GO:0060236),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,TPR;GNAI1
cholesterol biosynthetic process (GO:0006695),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,ACAA2;HSD17B7
regulation of synapse assembly (GO:0051963),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,DLG5;SNCA
regulation of mitochondrial membrane potential (GO:0051881),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,PRDX3;VCP
regulation of phosphoprotein phosphatase activity (GO:0043666),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,BOD1;PPP6R3
actin filament bundle organization (GO:0061572),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,BAIAP2L2;PLS1
muscle contraction (GO:0006936),7/137,0.5314567341654012,1,0,0,1.021897810218978,0.645975826925556,MYL7;DTNA;TMOD2;TLN1;ACTG2;CACNA1H;MYH6
cellular response to lipid (GO:0071396),9/178,0.5347004634884791,1,0,0,1.0112359550561796,0.6330828238059982,FAM210B;NLRP7;NR1H2;RARA;HTRA2;NLRP3;ABL2;LBP;GNAI1
ribosome assembly (GO:0042255),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,MRPL20;SAMD15;VCX
myotube differentiation (GO:0014902),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CACNA1H
atrioventricular valve morphogenesis (GO:0003181),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HEY1
myeloid cell development (GO:0061515),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ZNF385A
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CRAT
apoptotic DNA fragmentation (GO:0006309),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CASP3
retinoic acid metabolic process (GO:0042573),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,UGT1A1
nuclear pore organization (GO:0006999),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TPR
negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SPRY2
digestive tract morphogenesis (GO:0048546),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NIPBL
negative regulation of adherens junction organization (GO:1903392),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CLASP2
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SNCA
response to X-ray (GO:0010165),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NIPBL
"protein localization to chromosome, telomeric region (GO:0070198)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TNKS2
"phototransduction, visible light (GO:0007603)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CNGB1
substrate-dependent cell migration (GO:0006929),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NTN1
transport along microtubule (GO:0010970),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SPG11
L-alpha-amino acid transmembrane transport (GO:1902475),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC25A18
G-protein coupled glutamate receptor signaling pathway (GO:0007216),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GRM4
"protein localization to chromosome, centromeric region (GO:0071459)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,BOD1
negative regulation of insulin secretion (GO:0046676),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,INHBB
regulation of establishment of cell polarity (GO:2000114),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KIF20B
sodium ion import (GO:0097369),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC9A1
unsaturated fatty acid biosynthetic process (GO:0006636),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,FADS1
regulation of centriole replication (GO:0046599),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CDK5RAP2
mitochondrion localization (GO:0051646),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MSTO1
regulation of cell-substrate junction assembly (GO:0090109),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC9A1
nitric oxide mediated signal transduction (GO:0007263),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KLRG1
mitotic chromosome condensation (GO:0007076),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NIPBL
cellular response to virus (GO:0098586),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MAPK11
cellular biogenic amine biosynthetic process (GO:0042401),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TPH1
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACADS
neural crest cell differentiation (GO:0014033),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDCD6
ganglioside metabolic process (GO:0001573),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ST6GALNAC3
regulation of mitotic sister chromatid separation (GO:0010965),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TPR
regulation of exit from mitosis (GO:0007096),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MAD2L1BP
mesenchymal cell development (GO:0014031),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDCD6
sodium ion import across plasma membrane (GO:0098719),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC9A1
regulation of mitochondrial translation (GO:0070129),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MTG2
positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,FURIN
regulation of macrophage chemotaxis (GO:0010758),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CCL5
negative regulation of platelet activation (GO:0010544),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,C1QTNF1
negative regulation of cytokine production involved in immune response (GO:0002719),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HFE
filopodium assembly (GO:0046847),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,VSTM5
microtubule depolymerization (GO:0007019),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,STMN2
negative regulation of RNA metabolic process (GO:0051253),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NCOR2
monovalent inorganic anion homeostasis (GO:0055083),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC12A5
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,FLOT1
negative regulation of mRNA processing (GO:0050686),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SFSWAP
negative regulation of protein processing (GO:0010955),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NLRP7
toll-like receptor 4 signaling pathway (GO:0034142),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,LBP
regulation of fertilization (GO:0080154),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NOX5
embryonic cranial skeleton morphogenesis (GO:0048701),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NIPBL
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HTRA2
positive regulation of protein export from nucleus (GO:0046827),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TPR
regulation of cell junction assembly (GO:1901888),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,FLOT1
cellular sodium ion homeostasis (GO:0006883),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC9A1
establishment of protein localization to endoplasmic reticulum (GO:0072599),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SRP14
cellular response to corticosteroid stimulus (GO:0071384),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ISL1
ion transmembrane transport (GO:0034220),11/219,0.5376682698087102,1,0,0,1.004566210045662,0.6233469028772605,CHRNB3;MMGT1;AQP8;ATP6V0A2;CLCNKA;ANO9;AQP4;TCIRG1;SGK1;SLC17A3;TPCN1
calcium ion transport (GO:0006816),6/118,0.5423234836595405,1,0,0,1.0169491525423728,0.6222636836506547,CASR;CRACR2A;TRPA1;CCL5;MCOLN1;CACNA1H
neutrophil activation involved in immune response (GO:0002283),24/483,0.5427846009403516,1,0,0,0.9937888198757763,0.6072474246946159,GSDMD;KCMF1;ARSA;RAB5B;VCP;CANT1;PTPRN2;HFE;MVP;PYGL;TCIRG1;OLFM4;SRP14;MMP8;C6ORF120;MPO;CRACR2A;COMMD9;QPCT;CLEC5A;PSAP;PKP1;SPTAN1;RAB9B
protein acylation (GO:0043543),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,CREBBP;FOXO1
muscle cell differentiation (GO:0042692),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SGCD;SGCG
sodium ion transmembrane transport (GO:0035725),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SLC17A3;SCN1B
organophosphate biosynthetic process (GO:0090407),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,GK5;FADS1
mRNA catabolic process (GO:0006402),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,AGO3;AGO1
histone deacetylation (GO:0016575),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,TBL1XR1;MSL3
plasma membrane organization (GO:0007009),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,PLSCR1;SYT7
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,AGO3;AGO1
cardiac muscle contraction (GO:0060048),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SCN1B;MYH6
axonal transport (GO:0098930),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,BLOC1S6;BLOC1S1
inner mitochondrial membrane organization (GO:0007007),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,TIMM29;TIMM10
secondary alcohol biosynthetic process (GO:1902653),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,ACAA2;HSD17B7
viral process (GO:0016032),11/220,0.5438260533680036,1,0,0,1,0.6091258380969016,RPL4;RPS9;VCP;RPL32;RPL21;PACS1;RAB1B;TPR;RPL36;FURIN;EIF3F
regulation of protein phosphorylation (GO:0001932),13/261,0.546078898833694,1,0,0,0.9961685823754788,0.6026738340336778,HDAC3;MYOC;PRKDC;ULK4;SPDYE16;KNDC1;INHBB;SPDYE6;BMP7;DAB2;FLOT1;WDFY2;INSM1
regulation of insulin secretion (GO:0050796),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,ABCC8;CCL5;INHBB;ISL1;SYT7
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),28/565,0.5475505974828295,1,0,0,0.9911504424778761,0.5969703139786818,ZNF451;HDAC3;EHMT2;ANKRD33;BHLHE41;ZBTB5;NIPBL;RECQL5;HEY1;TPR;MLX;SNCA;KLF11;CREBBP;TGIF2;MSX2;NR1H2;ARID5B;KCTD1;PROX1;ISL1;GATAD2A;NCOR2;ETV7;ZEB2;TBL1XR1;RARA;INSM1
I-kappaB kinase/NF-kappaB signaling (GO:0007249),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,TBK1;NLRC3;MAP3K14
regulation of neurogenesis (GO:0050767),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,BIN1;ULK4;CDK5RAP2
adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,GHRHR;GPR78;ADRB3;DRD3
positive regulation of translation (GO:0045727),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,EIF5A;RPS9;CCL5;DND1
visual perception (GO:0007601),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,COL11A1;PITPNA;CNGB1;IMPG2
negative regulation of inflammatory response (GO:0050728),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,NLRP7;NLRP3;NLRC3;ISL1
negative regulation of intracellular signal transduction (GO:1902532),8/161,0.558318098786369,1,0,0,0.9937888198757763,0.5792063697084223,PDCD6;DLG5;THEM4;TRIM59;NLRC3;STAMBP;MARK3;DRD3
positive regulation of receptor activity (GO:2000273),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,GSTO1;HFE
regulation of dendrite development (GO:0050773),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,KNDC1;BMP7
positive regulation of smooth muscle cell proliferation (GO:0048661),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,CCL5;IL18
regulation of peptidyl-threonine phosphorylation (GO:0010799),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,SPRY2;BMP7
positive regulation of stress fiber assembly (GO:0051496),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,MYOC;EPHA1
actin filament bundle assembly (GO:0051017),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,BAIAP2L2;PLS1
response to steroid hormone (GO:0048545),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,PAQR9;WBP2
actin filament organization (GO:0007015),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,BAIAP2L2;TMOD2;SHROOM2;PROX1;FRYL;PLS1
neutrophil mediated immunity (GO:0002446),24/487,0.5594149167429713,1,0,0,0.9856262833675564,0.5725146608215005,GSDMD;KCMF1;ARSA;RAB5B;VCP;CANT1;PTPRN2;HFE;MVP;PYGL;TCIRG1;OLFM4;SRP14;MMP8;C6ORF120;MPO;CRACR2A;COMMD9;QPCT;CLEC5A;PSAP;PKP1;SPTAN1;RAB9B
tRNA modification (GO:0006400),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,TRUB1;AARS2;RPUSD1
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,MYOC;FGG;OLFM4
neural tube development (GO:0021915),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PROX1
postsynaptic membrane organization (GO:0001941),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NRXN2
dendritic cell chemotaxis (GO:0002407),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CCL5
positive regulation of secretion (GO:0051047),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CYP4A11
fibrinolysis (GO:0042730),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FGG
cellular response to dsRNA (GO:0071359),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FLOT1
regulation of membrane depolarization (GO:0003254),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SCN1B
sialylation (GO:0097503),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ST6GALNAC3
regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,LBP
positive regulation of regulated secretory pathway (GO:1903307),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CACNA1H
leukocyte tethering or rolling (GO:0050901),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,VCAM1
negative regulation of response to wounding (GO:1903035),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,INPP5F
hyaluronan catabolic process (GO:0030214),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SLC9A1
histone H2A acetylation (GO:0043968),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,MSL3
regulation of cell cycle phase transition (GO:1901987),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ZNF16
regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SNCA
cardiac ventricle development (GO:0003231),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,HEY1
protein deacylation (GO:0035601),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,HDAC3
negative regulation of striated muscle cell differentiation (GO:0051154),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,BHLHE41
negative regulation of steroid biosynthetic process (GO:0010894),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PROX1
leukocyte adhesion to vascular endothelial cell (GO:0061756),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,VCAM1
positive regulation of lymphocyte differentiation (GO:0045621),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,IL7
guanosine-containing compound metabolic process (GO:1901068),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GIMAP7
regulation of energy homeostasis (GO:2000505),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FOXO1
negative regulation of translational initiation (GO:0045947),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TPR
positive regulation of macrophage derived foam cell differentiation (GO:0010744),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,IL18
hexose transport (GO:0008645),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SLC2A12
positive regulation of myotube differentiation (GO:0010831),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FLOT1
peptidyl-lysine methylation (GO:0018022),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,EHMT2
negative regulation of DNA recombination (GO:0045910),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,KLHL15
miRNA metabolic process (GO:0010586),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DROSHA
rRNA transcription (GO:0009303),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GTF3C3
regulation of osteoblast proliferation (GO:0033688),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TMEM119
regulation of steroid metabolic process (GO:0019218),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,UGT1A1
bone morphogenesis (GO:0060349),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,RARA
regulation of SMAD protein import into nucleus (GO:0060390),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DAB2
positive regulation of nitric-oxide synthase activity (GO:0051000),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DHFR
negative regulation of peptide hormone secretion (GO:0090278),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,INHBB
regulation of protein homodimerization activity (GO:0043496),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ISL1
cardiac epithelial to mesenchymal transition (GO:0060317),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,HEY1
regulation of stem cell proliferation (GO:0072091),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,AGO3
regulation of acrosome reaction (GO:0060046),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CACNA1H
activation of protein kinase A activity (GO:0034199),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PRKAR2A
regulation of membrane repolarization (GO:0060306),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,KCNE3
detection of visible light (GO:0009584),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CNGB1
positive regulation of leukocyte activation (GO:0002696),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,LBP
endoplasmic reticulum to cytosol transport (GO:1903513),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,VCP
negative regulation of lipid storage (GO:0010888),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NR1H2
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TMEM161A
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,BCL2L13;VCP;CASP3;SNCA
steroid biosynthetic process (GO:0006694),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,HSD11B1;CYP11B2;OSBPL2;CYP46A1
cell-cell junction assembly (GO:0007043),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,GJD3;PKP3;TLN1;CDH9
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),5/100,0.5644459548061124,1,0,0,1,0.5719106399118082,EIF5A;NXF3;TPR;EIF4E;SMG6
regulation of acute inflammatory response (GO:0002673),6/121,0.567113949602328,1,0,0,0.9917355371900827,0.5625074639303184,C4A;NLRP3;C4BPA;IL6ST;CFB;CPN2
renal system development (GO:0072001),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,CENPF;PCSK9;PROX1
mitotic cytokinesis (GO:0000281),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,RASA1;STAMBP;KIF20A
ERBB signaling pathway (GO:0038127),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,PTPN18;MVP;REPS2;ABL2
nucleic acid metabolic process (GO:0090304),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,RECQL5;XRN2;POLR2E;POLR2K
negative regulation of defense response (GO:0031348),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,NLRP7;NLRP3;NLRC3;ISL1
cellular protein localization (GO:0034613),16/327,0.5719928511281699,1,0,0,0.9785932721712538,0.5466703713351585,TMED9;RAB5B;RTP3;ANGPT1;PDCD6;RAB1B;WIPI2;GGA1;NIPBL;HERC2;GGA3;CTTN;TBC1D4;SNX17;CROCC;RAB9B
sensory perception of chemical stimulus (GO:0007606),16/327,0.5719928511281699,1,0,0,0.9785932721712538,0.5466703713351585,OR8I2;OR1D2;OR2G3;OR5J2;OR2F1;OR2L3;OR8S1;OR2T6;OR2T11;OR5H15;OR2T2;OR13C9;OR4C11;OR8B3;OR4F6;OR52A5
positive regulation of neuron death (GO:1901216),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,PCSK9;SNCA
retina homeostasis (GO:0001895),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,BBS10;CNGB1
chemical homeostasis (GO:0048878),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,NR1H2;WNK4
sensory perception of light stimulus (GO:0050953),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,COL11A1;PITPNA;CNGB1;IMPG2
negative regulation of cell death (GO:0060548),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,BNIP3L;HTRA2;BMP7;SNCA
positive regulation of protein processing (GO:0010954),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,F12
cardiac myofibril assembly (GO:0055003),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PROX1
regulation of multicellular organism growth (GO:0040014),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GHRHR
high-density lipoprotein particle remodeling (GO:0034375),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,LIPG
reverse cholesterol transport (GO:0043691),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,LIPG
positive regulation of focal adhesion assembly (GO:0051894),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MYOC
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PVRIG
DNA catabolic process (GO:0006308),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,XRN2
positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,DRD3
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GHRHR
positive regulation of lymphocyte migration (GO:2000403),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CCL5
microtubule nucleation (GO:0007020),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CLASP2
ureteric bud development (GO:0001657),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,BMP7
cardiac muscle cell contraction (GO:0086003),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SCN1B
preassembly of GPI anchor in ER membrane (GO:0016254),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PIGW
positive regulation of fatty acid metabolic process (GO:0045923),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NR1H2
N-terminal protein amino acid modification (GO:0031365),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NAA35
positive regulation of monocyte chemotaxis (GO:0090026),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CCL5
DNA packaging (GO:0006323),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NIPBL
"mRNA cis splicing, via spliceosome (GO:0045292)",1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SFSWAP
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ACAA2
positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PROX1
positive regulation of dendrite extension (GO:1903861),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SYT2
pigment granule transport (GO:0051904),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,BLOC1S6
negative regulation of intracellular transport (GO:0032387),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ACAA2
positive regulation of cellular protein catabolic process (GO:1903364),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PCSK9
negative regulation of phosphoprotein phosphatase activity (GO:0032515),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,BOD1
rRNA catabolic process (GO:0016075),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,DIS3L
response to purine-containing compound (GO:0014074),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CITED1
positive regulation of macrophage activation (GO:0043032),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,LBP
long-term memory (GO:0007616),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SGK1
virion assembly (GO:0019068),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RAB1B
regulation of synaptic vesicle exocytosis (GO:2000300),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RIMS4
nucleotide catabolic process (GO:0009166),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,VCP
neurotrophin signaling pathway (GO:0038179),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CASP3
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GSTO1
regulation of T cell migration (GO:2000404),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CCL5
positive chemotaxis (GO:0050918),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ANGPT1
regulation of establishment or maintenance of cell polarity (GO:0032878),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,KIF20B
purine-containing compound metabolic process (GO:0072521),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SLC17A3
positive regulation of telomere capping (GO:1904355),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TNKS2
mesonephric tubule development (GO:0072164),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,BMP7
melanosome transport (GO:0032402),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,BLOC1S6
regulation of early endosome to late endosome transport (GO:2000641),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,DAB2
nucleobase-containing compound biosynthetic process (GO:0034654),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,POLL
platelet-derived growth factor receptor signaling pathway (GO:0048008),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ABL2
positive regulation of transcription of Notch receptor target (GO:0007221),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CREBBP
cellular monovalent inorganic cation homeostasis (GO:0030004),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SLC9A1
membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SCN1B
neuron development (GO:0048666),7/144,0.5847203579347515,1,0,0,0.9722222222222222,0.521715412033393,BLOC1S6;MYOC;BLOC1S1;STMN2;LAMB1;INSM1;FRYL
regulation of mitotic cell cycle (GO:0007346),8/165,0.5863836234120163,1,0,0,0.9696969696969696,0.5176058726133539,L3MBTL1;BTG3;CDK11A;TAL1;KIF20B;MAP3K14;EIF4E;GNAI1
signal transduction by p53 class mediator (GO:0072331),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,JMY;ZNF385A
regulation of proteasomal protein catabolic process (GO:0061136),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,LAMP3;RAD23B
positive regulation of phagocytosis (GO:0050766),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,C4A;SFTPA2
ERBB2 signaling pathway (GO:0038128),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,PTPN18;MYOC
positive regulation of fat cell differentiation (GO:0045600),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,WDFY2;ZNF385A
alpha-amino acid catabolic process (GO:1901606),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,ALDH6A1;KYNU
regulation of anatomical structure morphogenesis (GO:0022603),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,AKAP13;ZMYM2;HEY1;CLASP2
positive regulation of cell cycle (GO:0045787),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,TAL1;RARA;PROX1;EIF4E
regulation of inflammatory response (GO:0050727),8/166,0.5932663115812061,1,0,0,0.963855421686747,0.503240374702222,CCL3L1;NLRP7;CCL5;IL18;NLRP3;NLRC3;ISL1;SNCA
negative regulation of gene expression (GO:0010629),30/618,0.5939011629438702,1,0,0,0.9708737864077669,0.5058663745773028,L3MBTL1;DNMT1;HDAC3;CITED1;BHLHE41;FOXO1;NIPBL;HEY1;NKRF;BAHD1;SCMH1;MLX;ITGB8;ZBTB14;MSX2;NR1H2;ARID5B;KCTD1;PROX1;COMMD7;BMP7;DKK3;GATAD2A;DHFR;NCOR2;CENPF;DAB2;GCLC;AGO3;RARA
negative regulation of viral life cycle (GO:1903901),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,PLSCR1;CCL5;PROX1
striated muscle contraction (GO:0006941),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,DTNA;SCN1B;MYH6
positive regulation of phosphorylation (GO:0042327),10/208,0.5961799610220619,1,0,0,0.9615384615384616,0.49731991295223416,VCP;DAB2;HDAC3;CCL5;FLOT1;KNDC1;WDFY2;EPHA1;DRD4;ZNF16
skeletal system development (GO:0001501),7/146,0.599384156291076,1,0,0,0.958904109589041,0.4908175204714428,RPS6KA3;AKAP13;MYOC;SHOX2;ITGB8;TLL1;BMP7
mRNA transport (GO:0051028),5/104,0.599573857726415,1,0,0,0.9615384615384616,0.49186164733317733,EIF5A;NXF3;TPR;EIF4E;SMG6
negative regulation of transport (GO:0051051),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,NR1H2;SNCA
regulation of protein dephosphorylation (GO:0035304),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,PPP1R14B;PPP6R3
sensory organ development (GO:0007423),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,SHROOM2;ECE1
response to cAMP (GO:0051591),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,CITED1;AQP8
sterol biosynthetic process (GO:0016126),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,ACAA2;HSD17B7
phosphatidic acid biosynthetic process (GO:0006654),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,PLA2G12A;AGPAT1
regulation of viral transcription (GO:0046782),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,POLR2E;POLR2K
glucan catabolic process (GO:0009251),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PYGL
regulation of adherens junction organization (GO:1903391),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SLC9A1
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ACSL1
membrane lipid metabolic process (GO:0006643),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SGPL1
membrane protein ectodomain proteolysis (GO:0006509),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SPPL2A
regulation of viral process (GO:0050792),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,LAMP3
homologous chromosome segregation (GO:0045143),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,MSH5
mitotic recombination (GO:0006312),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SMC5
regulation of amyloid-beta formation (GO:1902003),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,BIN1
regulation of spindle organization (GO:0090224),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GNAI1
actin filament polymerization (GO:0030041),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,WASF3
anion transmembrane transport (GO:0098656),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SLC25A42
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DKK3
negative regulation of osteoclast differentiation (GO:0045671),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TCTA
calcium-mediated signaling using intracellular calcium source (GO:0035584),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,VCAM1
positive regulation of lipid catabolic process (GO:0050996),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,AADAC
negative regulation of fibroblast proliferation (GO:0048147),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,NLRC3
regulation of mitochondrial membrane permeability (GO:0046902),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,THEM4
establishment of mitotic spindle localization (GO:0040001),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CDK5RAP2
regulation of chemokine production (GO:0032642),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,IL7
establishment or maintenance of apical/basal cell polarity (GO:0035088),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,MTCL1
negative regulation of RNA splicing (GO:0033119),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SFSWAP
anion homeostasis (GO:0055081),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,LIPG
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,HTRA2
negative regulation of protein dephosphorylation (GO:0035308),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,BOD1
"retrograde protein transport, ER to cytosol (GO:0030970)",1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,VCP
regulation of cholesterol efflux (GO:0010874),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,NR1H2
regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SCN1B
tRNA metabolic process (GO:0006399),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,POP1
positive regulation of actin cytoskeleton reorganization (GO:2000251),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,BAIAP2L2
glycogen catabolic process (GO:0005980),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PYGL
phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PLA2G12A
regulation of cAMP-mediated signaling (GO:0043949),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GNAI1
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,HTRA2
regulation of cellular response to growth factor stimulus (GO:0090287),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,FBN3
regulation of microtubule polymerization or depolymerization (GO:0031110),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CLASP2
regulation of peptidase activity (GO:0052547),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,FURIN
cell-substrate adherens junction assembly (GO:0007045),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CTTN
regulation of dendrite extension (GO:1903859),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SYT2
regulation of smooth muscle cell migration (GO:0014910),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CCL5
response to organophosphorus (GO:0046683),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CITED1
focal adhesion assembly (GO:0048041),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CTTN
negative regulation of calcium-mediated signaling (GO:0050849),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GSTO1
tRNA processing (GO:0008033),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,TRUB1;AARS2;POP1
regulation of translational initiation (GO:0006446),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,EIF2B2;CCL5;TPR
regulation of protein kinase activity (GO:0045859),7/147,0.6066150016024487,1,0,0,0.9523809523809523,0.4760580508568352,LRRC15;LRRTM1;LRTM2;SPDYE16;SPDYE6;EPHA1;CAMKK1
G1/S transition of mitotic cell cycle (GO:0000082),5/105,0.6081022529852088,1,0,0,0.9523809523809523,0.47372593514716843,DHFR;KLF11;RRM2;CRLF3;EIF4E
organelle assembly (GO:0070925),18/376,0.6097850182682767,1,0,0,0.9574468085106382,0.47359992734128553,HDAC3;AVIL;RAB1B;TMOD2;VCX;WIPI2;GOLGA6A;CENPF;TRAPPC6A;TBC1D32;WDR5B;B9D1;TEKT4;TRIM59;CEP63;EMC6;MYH6;ATG4D
regulation of neuron differentiation (GO:0045664),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,BIN1;ULK4;BMP7;CDK5RAP2
cellular response to molecule of bacterial origin (GO:0071219),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,NLRP7;NR1H2;NLRP3;LBP
phosphatidic acid metabolic process (GO:0046473),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,PLA2G12A;AGPAT1
DNA duplex unwinding (GO:0032508),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,RECQL5;RAD23B
regulation of stress-activated MAPK cascade (GO:0032872),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,ULK4;FOXO1
negative regulation of cell projection organization (GO:0031345),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,STMN2;SPRY2
positive regulation of viral transcription (GO:0050434),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,POLR2E;POLR2K
monocyte chemotaxis (GO:0002548),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,CCL3L1;CCL5
regulation of cellular metabolic process (GO:0031323),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,FLOT1;AGPAT1
negative regulation of protein modification process (GO:0031400),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,CRTAP;PRKDC;INSM1
iron ion homeostasis (GO:0055072),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,ABCB7;HFE;ATP6V0A2
regulation of viral genome replication (GO:0045069),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,PLSCR1;CCL5;PROX1
negative regulation of neuron apoptotic process (GO:0043524),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,CITED1;RASA1;ISL1
post-translational protein modification (GO:0043687),17/357,0.6173598002318067,1,0,0,0.9523809523809523,0.4593364575404279,ARSA;RAB1B;FGG;CHM;PCSK9;LAMB1;FBXO32;ASB17;ASB15;C4A;COPS6;GAN;ASB10;MGAT4A;FBXO6;FBXO9;UBE2M
peptidyl-serine modification (GO:0018209),8/170,0.6202201527232523,1,0,0,0.9411764705882353,0.4495819095842526,RPS6KA3;TBK1;MAST4;PRKDC;DCLK2;SGK1;CAMKK1;CSNK1A1L
regulation of mitotic spindle assembly (GO:1901673),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TPR
negative regulation of smoothened signaling pathway (GO:0045879),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RFX8
regulation of protein kinase A signaling (GO:0010738),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,AKAP4
protein ADP-ribosylation (GO:0006471),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TNKS2
negative regulation of phosphate metabolic process (GO:0045936),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,BMP7
negative regulation of cell junction assembly (GO:1901889),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CLASP2
cellular polysaccharide catabolic process (GO:0044247),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PYGL
negative regulation of double-strand break repair (GO:2000780),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,KLHL15
protein exit from endoplasmic reticulum (GO:0032527),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,VCP
positive regulation of activated T cell proliferation (GO:0042104),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,IL18
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,UTP20
regulation of myotube differentiation (GO:0010830),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,BHLHE41
muscle tissue morphogenesis (GO:0060415),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PROX1
positive regulation of mononuclear cell migration (GO:0071677),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CCL5
Rac protein signal transduction (GO:0016601),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HACE1
cellular response to zinc ion (GO:0071294),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MT1HL1
positive regulation of oxidoreductase activity (GO:0051353),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ABL2
negative regulation of lipid metabolic process (GO:0045833),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,UGT1A1
positive regulation of lipid storage (GO:0010884),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,OSBPL11
nucleosome disassembly (GO:0006337),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ARID1A
regulation of transcription factor import into nucleus (GO:0042990),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HDAC3
chromatin disassembly (GO:0031498),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ARID1A
leukotriene metabolic process (GO:0006691),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CYP4A11
intracellular estrogen receptor signaling pathway (GO:0030520),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ARID1A
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CASP3
gamma-aminobutyric acid signaling pathway (GO:0007214),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GABBR2
positive regulation of interferon-alpha production (GO:0032727),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TBK1
cellular response to interleukin-7 (GO:0098761),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,IL7
fatty-acyl-CoA metabolic process (GO:0035337),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,THEM4
macromolecule biosynthetic process (GO:0009059),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,P3H4
nucleotide-sugar biosynthetic process (GO:0009226),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,UAP1L1
positive regulation of blood coagulation (GO:0030194),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,F12
regulation of platelet activation (GO:0010543),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,C1QTNF1
DNA double-strand break processing (GO:0000729),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SLX1A
interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,IL7
drug transport (GO:0015893),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SLC17A3
positive regulation of adherens junction organization (GO:1903393),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MYOC
hexose transmembrane transport (GO:0035428),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SLC2A12
triglyceride biosynthetic process (GO:0019432),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PCK2
regulation of catenin import into nucleus (GO:0035412),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,DACT3
activin receptor signaling pathway (GO:0032924),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,INHBB
positive regulation of neuron apoptotic process (GO:0043525),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PCSK9
positive regulation of axon extension (GO:0045773),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NTN1
cellular response to decreased oxygen levels (GO:0036294),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,BNIP3L;ACAA2;BMP7
positive regulation of protein localization to nucleus (GO:1900182),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,TPR;ZIC1
"negative regulation of transcription, DNA-templated (GO:0045892)",39/813,0.6304898632199725,1,0,0,0.959409594095941,0.4425355434654634,L3MBTL1;HDAC3;CITED1;EHMT2;ANKRD33;BHLHE41;ZBTB5;FOXO1;NIPBL;HEY1;NKRF;BAHD1;SCMH1;TPR;MLX;SNCA;KLF11;CREBBP;TGIF2;ZBTB14;MSX2;NR1H2;ARID5B;KCTD1;PROX1;ISL1;COMMD7;BMP7;GATAD2A;DKK3;ETV7;NCOR2;CENPF;GCLC;ZEB2;DAB2;TBL1XR1;RARA;INSM1
"DNA-templated transcription, elongation (GO:0006354)",5/108,0.6330463554564062,1,0,0,0.9259259259259258,0.4233441001393671,TAF13;POLR2E;GTF2E2;IWS1;POLR2K
negative regulation of hydrolase activity (GO:0051346),5/108,0.6330463554564062,1,0,0,0.9259259259259258,0.4233441001393671,PPP1R26;GCHFR;SH3RF2;PLEKHF1;RIMBP2
generation of neurons (GO:0048699),6/130,0.6372700870903559,1,0,0,0.9230769230769231,0.41590312126152085,CASP3;DCLK2;FZD8;PCSK9;PROX1;FGF13
cellular response to type I interferon (GO:0071357),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,HFE;HLA-C;GBP2
cellular response to reactive oxygen species (GO:0034614),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,PRDX3;MTR;FOXO1
negative regulation of blood vessel morphogenesis (GO:2000181),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,AGO1;SPRY2;SEMA3E
DNA synthesis involved in DNA repair (GO:0000731),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,VCP;RFC2;FAAP20
regulation of cell division (GO:0051302),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,TAL1;TXNIP;KIF20A
type I interferon signaling pathway (GO:0060337),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,HFE;HLA-C;GBP2
negative regulation of cell adhesion (GO:0007162),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,ADAMDEC1;ANGPT1;RASA1
fatty acid catabolic process (GO:0009062),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,ACAA2;HADH;ACADS
organic substance transport (GO:0071702),4/87,0.6384210161989183,1,0,0,0.9195402298850575,0.41265040301361416,SLC25A26;PSAP;SLC22A31;SLC17A3
positive regulation of interferon-gamma production (GO:0032729),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,IL18;ISL1
negative regulation of ERBB signaling pathway (GO:1901185),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,PTPN18;SPRY2
male gonad development (GO:0008584),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,KLHL26;LHB
eye development (GO:0001654),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,NIPBL;SHROOM2
protein transmembrane import into intracellular organelle (GO:0044743),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,TIMM29;TIMM10
development of primary male sexual characteristics (GO:0046546),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,KLHL26;LHB
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,JMY;ZNF385A
positive regulation of interleukin-6 production (GO:0032755),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,LBP;ISL1
branching morphogenesis of an epithelial tube (GO:0048754),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,CITED1;SEMA3E
digestive tract development (GO:0048565),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,NIPBL;CLMP
regulation of multicellular organismal development (GO:2000026),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,NIPBL;CLASP2
negative regulation of innate immune response (GO:0045824),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NLRC3
regulation of vacuole organization (GO:0044088),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RAB1B
proteoglycan metabolic process (GO:0006029),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CANT1
ureteric bud morphogenesis (GO:0060675),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CITED1
positive regulation of dendritic spine development (GO:0060999),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DLG5
synapsis (GO:0007129),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,P3H4
embryonic digestive tract development (GO:0048566),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NIPBL
response to progesterone (GO:0032570),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,WBP2
negative regulation of cyclase activity (GO:0031280),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GABBR2
error-prone translesion synthesis (GO:0042276),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RFC2
"regulation of DNA-templated transcription, elongation (GO:0032784)",1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,IWS1
mitochondrial respiratory chain complex IV assembly (GO:0033617),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,COX16
axon extension (GO:0048675),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SEMA3F
androgen metabolic process (GO:0008209),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DHRS9
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ADRB3
Arp2/3 complex-mediated actin nucleation (GO:0034314),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,JMY
regulation of cell development (GO:0060284),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,AKAP13
glial cell development (GO:0021782),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,EIF2B2
branching involved in ureteric bud morphogenesis (GO:0001658),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CITED1
negative regulation of telomere maintenance via telomerase (GO:0032211),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CTC1
regulation of toll-like receptor signaling pathway (GO:0034121),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TLR5
positive regulation of T cell migration (GO:2000406),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CCL5
telomere maintenance via telomerase (GO:0007004),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SMG6
heparan sulfate proteoglycan metabolic process (GO:0030201),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GPC1
negative regulation of adenylate cyclase activity (GO:0007194),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GABBR2
negative regulation of interferon-gamma production (GO:0032689),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RARA
cellular response to estradiol stimulus (GO:0071392),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,FAM210B
cellular response to steroid hormone stimulus (GO:0071383),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,BMP7
immune response-activating cell surface receptor signaling pathway (GO:0002429),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GPR32
positive regulation of intracellular protein transport (GO:0090316),7/152,0.6417021441357289,1,0,0,0.9210526315789472,0.4086075302976567,TCAF1;MTCL1;TPR;ZIC1;HTRA2;KIF20B;OAZ1
nuclear-transcribed mRNA catabolic process (GO:0000956),8/174,0.6461933813797057,1,0,0,0.9195402298850575,0.40152318897970674,RPL4;RPS9;RPL32;RPL21;AGO1;RPL36;EIF4E;SMG6
peptide biosynthetic process (GO:0043043),8/174,0.6461933813797057,1,0,0,0.9195402298850575,0.40152318897970674,RPL4;RPL39L;RPS9;RPL32;RPL21;RPL36;FURIN;MRPS5
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,VCP;DAB2;HFE;RAD23B
positive regulation of protein complex assembly (GO:0031334),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,VCP;TPPP3;TAL1;PIH1D1
cellular response to light stimulus (GO:0071482),3/66,0.6476960862533626,1,0,0,0.9090909090909091,0.3948488139467768,CREBBP;TMEM161A;CNGB1
intracellular steroid hormone receptor signaling pathway (GO:0030518),3/66,0.6476960862533626,1,0,0,0.9090909090909091,0.3948488139467768,RHOXF1;WBP2;ARID1A
lymphocyte chemotaxis (GO:0048247),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,CCL3L1;CCL5
negative regulation of immune system process (GO:0002683),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,NLRP7;NLRP3
positive regulation of macroautophagy (GO:0016239),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,BNIP3L;TBK1
positive regulation of interleukin-8 production (GO:0032757),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,LBP;TLR5
regulation of T cell activation (GO:0050863),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,CCDC88B;CCL5
protein N-linked glycosylation via asparagine (GO:0018279),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,VCP;ST6GALNAC3
microtubule cytoskeleton organization involved in mitosis (GO:1902850),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,EML1;CLASP2
posttranscriptional regulation of gene expression (GO:0010608),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,EIF4E;ZNF385A
positive regulation of actin filament bundle assembly (GO:0032233),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,MYOC;EPHA1
positive regulation of viral process (GO:0048524),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,POLR2E;POLR2K
negative regulation of protein serine/threonine kinase activity (GO:0071901),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,PRKAR2A;SPRY2;BMP7
negative regulation of protein binding (GO:0032091),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,DAB2;HFE;ISL1
regulation of protein localization to plasma membrane (GO:1903076),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,LRRC15;DAB2;PLS1
cobalamin metabolic process (GO:0009235),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MTR
hyaluronan metabolic process (GO:0030212),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SLC9A1
positive regulation of cellular component movement (GO:0051272),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,NTN1
epoxygenase P450 pathway (GO:0019373),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CYP4A11
GTP metabolic process (GO:0046039),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GIMAP7
RNA-dependent DNA biosynthetic process (GO:0006278),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SMG6
regulation of interleukin-17 production (GO:0032660),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,IL18
positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CCDC88B
regulation of ruffle assembly (GO:1900027),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PLEKHM1
cellular response to hexose stimulus (GO:0071331),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PCK2
histone lysine demethylation (GO:0070076),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,KDM4E
establishment of spindle orientation (GO:0051294),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CDK5RAP2
tetrapyrrole metabolic process (GO:0033013),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MTR
negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PCSK9
zinc II ion transport (GO:0006829),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SLC39A3
positive regulation of translational initiation (GO:0045948),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CCL5
positive regulation of lamellipodium organization (GO:1902745),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ENPP2
negative regulation of cytokine biosynthetic process (GO:0042036),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,INHBB
regulation of macrophage activation (GO:0043030),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,LBP
branched-chain amino acid catabolic process (GO:0009083),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ALDH6A1
response to nicotine (GO:0035094),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CHRNB3
limb morphogenesis (GO:0035108),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,NIPBL
meiosis I (GO:0007127),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MSH5
protein-DNA complex disassembly (GO:0032986),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ARID1A
cellular response to alkaloid (GO:0071312),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CASP3
negative regulation of cAMP biosynthetic process (GO:0030818),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GABBR2
mitochondrial respiratory chain complex IV biogenesis (GO:0097034),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,COX16
lipid catabolic process (GO:0016042),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,HSD11B1
"synaptic transmission, glutamatergic (GO:0035249)",1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GRIA1
glutamate metabolic process (GO:0006536),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GCLC
peptidyl-asparagine modification (GO:0018196),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,VCP;ST6GALNAC3
nucleus organization (GO:0006997),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,BIN1;TPR
peptidyl-tyrosine autophosphorylation (GO:0038083),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,TNK1;ABL2
intracellular protein transport (GO:0006886),16/347,0.6666207293378296,1,0,0,0.9221902017291065,0.3739794964615995,EIF5A;EGR2;TMED9;RAB5B;OR1D2;PDCD6;RAB1B;NPAP1;GGA1;POM121L2;HERC2;GGA3;CTTN;TBC1D4;SNX17;RAB9B
protein sumoylation (GO:0016925),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,ZNF451;EYA1;TPR
regulation of actin filament polymerization (GO:0030833),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,BAIAP2L2;CTTN;RASA1
peptidyl-threonine phosphorylation (GO:0018107),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,TBK1;DCLK2;CAMKK1
negative regulation of protein phosphorylation (GO:0001933),8/178,0.6711220124733558,1,0,0,0.898876404494382,0.3584757948492,LRRC15;PRKDC;LRRTM1;LRTM2;MVP;SPRY2;INSM1;EPHA1
positive regulation of developmental process (GO:0051094),5/113,0.6723926318192525,1,0,0,0.8849557522123893,0.3512502969378424,RPS6KA3;ENPP2;TMEM119;INSM1;ISL1
cellular response to organic cyclic compound (GO:0071407),6/135,0.6731831840991095,1,0,0,0.8888888888888888,0.3517669298080437,FAM210B;AQP8;CASP3;CCL5;IL18;GNAI1
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,NR1H2
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PDCD6
acylglycerol homeostasis (GO:0055090),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,IL18
NAD biosynthetic process (GO:0009435),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,KYNU
cellular response to nerve growth factor stimulus (GO:1990090),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,STMN2
protein homotrimerization (GO:0070207),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,HTRA2
activation of phospholipase C activity (GO:0007202),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,AVPR1B
outflow tract septum morphogenesis (GO:0003148),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ISL1
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,USP25
regulation of DNA biosynthetic process (GO:2000278),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SMG6
regulation of transcription from RNA polymerase III promoter (GO:0006359),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,POLR3F
"DNA catabolic process, endonucleolytic (GO:0000737)",1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CASP3
histone lysine methylation (GO:0034968),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,EHMT2
protein localization to cell surface (GO:0034394),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ANGPT1
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,RAD23B
phosphatidylglycerol metabolic process (GO:0046471),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PLA2G12A
STAT cascade (GO:0097696),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,STAMBP
branched-chain amino acid metabolic process (GO:0009081),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ALDH6A1
regulation of membrane protein ectodomain proteolysis (GO:0051043),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,FURIN
positive regulation of biosynthetic process (GO:0009891),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CCL5
negative regulation of protein import into nucleus (GO:0042308),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,DACT3
regulation of ERBB signaling pathway (GO:1901184),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PTPN18
viral genome replication (GO:0019079),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,VCP
inner ear morphogenesis (GO:0042472),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ZIC1
negative regulation of nervous system development (GO:0051961),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,RFX8
regulation of bone resorption (GO:0045124),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PLEKHM1
negative regulation of lyase activity (GO:0051350),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,GABBR2
regulation of monocyte chemotaxis (GO:0090025),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CCL5
glucose transport (GO:0015758),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SLC2A12
nucleocytoplasmic transport (GO:0006913),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,EIF5A;CITED1
interleukin-12-mediated signaling pathway (GO:0035722),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,GSTO1;PITPNA
positive regulation of protein localization to cell periphery (GO:1904377),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,GNAI1;PLS1
cellular response to interleukin-12 (GO:0071349),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,GSTO1;PITPNA
regulation of cellular component movement (GO:0051270),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,INPP5F;ABL2
icosanoid metabolic process (GO:0006690),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,CYP4A11;FADS1
aminoglycan biosynthetic process (GO:0006023),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,GPC1;XYLT1
regulation of DNA metabolic process (GO:0051052),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,EHMT2;SMG6
regulation of endothelial cell migration (GO:0010594),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,ANGPT1;PDCD6;PROX1
negative regulation of angiogenesis (GO:0016525),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,AGO1;SPRY2;SEMA3E
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,CROCC;CEP120;PLEKHM1
cellular response to DNA damage stimulus (GO:0006974),15/329,0.6803974155349507,1,0,0,0.911854103343465,0.3511351522040958,VCP;PRKDC;RFC2;HTRA2;SMC5;FAAP20;FOXO1;NIPBL;HERC2;RECQL5;APLF;FBXO6;SLX1A;CEP63;ZNF385A
axon guidance (GO:0007411),7/158,0.6813097466135722,1,0,0,0.8860759493670886,0.3400212212397225,DOK4;GPC1;SEMA3F;SPTAN1;NTN1;SCN1B;PDLIM7
positive regulation of endothelial cell migration (GO:0010595),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,ANGPT1;PDCD6;PROX1
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,ABTB1;AREL1;HACE1
Rab protein signal transduction (GO:0032482),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,RAB5B;RAB1B;RAB9B
calcium-mediated signaling (GO:0019722),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,LAT2;VCAM1;SLC9A1
peptidyl-lysine modification (GO:0018205),5/115,0.687326064513291,1,0,0,0.8695652173913043,0.32604041610621337,ZNF451;EYA1;BLOC1S1;TPR;P3H4
epithelium development (GO:0060429),5/115,0.687326064513291,1,0,0,0.8695652173913043,0.32604041610621337,TST;DHRS9;PIH1D1;RARA;PROX1
myofibril assembly (GO:0030239),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,TMOD2;MYH6
positive regulation of tumor necrosis factor production (GO:0032760),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,LBP;ISL1
regulation of organelle assembly (GO:1902115),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,AKAP13;RAB1B
organonitrogen compound biosynthetic process (GO:1901566),8/181,0.6891029839377012,1,0,0,0.8839779005524862,0.32916203353182405,PNMT;SGPL1;GSTO2;GSTO1;CHAT;IL18;FURIN;MFSD2A
regulation of autophagy (GO:0010506),9/203,0.6910425757023396,1,0,0,0.8866995073891626,0.32768321009203705,PLEKHF1;LAMP3;CASP3;PSAP;ATP6V0A2;HTRA2;ABL2;FOXO1;TPCN1
regulation of MAPK cascade (GO:0043408),9/203,0.6910425757023396,1,0,0,0.8866995073891626,0.32768321009203705,GRM4;MYOC;ADRB3;ULK4;INHBB;EPHA1;FAM83D;BMP7;TNFRSF10D
chromosome condensation (GO:0030261),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NIPBL
negative regulation of viral transcription (GO:0032897),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CCL5
"nucleotide-excision repair, DNA gap filling (GO:0006297)",1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,RFC2
positive regulation of cell cycle G1/S phase transition (GO:1902808),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,FAM83D
ammonium transport (GO:0015696),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC5A7
neuronal action potential (GO:0019228),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CACNA1H
cell-cell adhesion mediated by cadherin (GO:0044331),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CDH9
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,RECQL5
cellular amino acid catabolic process (GO:0009063),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,ALDH6A1
zinc II ion transmembrane transport (GO:0071577),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC39A3
glutamine family amino acid metabolic process (GO:0009064),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,GCLC
protein K48-linked deubiquitination (GO:0071108),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,USP25
positive regulation of ATP metabolic process (GO:1903580),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,VCP
phospholipid dephosphorylation (GO:0046839),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,INPP5F
cellular nitrogen compound biosynthetic process (GO:0044271),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,GCHFR
cellular response to ammonium ion (GO:0071242),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CASP3
regulation of smooth muscle contraction (GO:0006940),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CTTN
apoptotic nuclear changes (GO:0030262),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CASP3
cellular response to interleukin-6 (GO:0071354),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,IL6ST
autophagosome maturation (GO:0097352),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,VCP
negative regulation of axonogenesis (GO:0050771),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,FGF13
divalent inorganic cation homeostasis (GO:0072507),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CNNM2
regulation of monooxygenase activity (GO:0032768),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SNCA
positive regulation of monooxygenase activity (GO:0032770),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,DHFR
regulation of microtubule cytoskeleton organization (GO:0070507),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CLASP2
regulation of androgen receptor signaling pathway (GO:0060765),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,DAB2
regulation of vesicle-mediated transport (GO:0060627),6/138,0.6936048973128792,1,0,0,0.8695652173913043,0.31813286332552565,RAB5B;INPP5F;TBC1D4;SNX17;BMP2K;ABL2
transcription initiation from RNA polymerase II promoter (GO:0006367),7/160,0.6938770031397877,1,0,0,0.8749999999999999,0.3197779927015063,CREBBP;TAF13;NR1H2;RARA;POLR2E;GTF2E2;POLR2K
regulation of macroautophagy (GO:0016241),5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,BNIP3L;TBK1;CASP3;RAB1B;ATP6V0A2
sphingolipid metabolic process (GO:0006665),5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,ARSA;FUT5;SGPL1;PSAP;ST6GALNAC3
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,ANGPT1;CCL5;ENPP2;IL18;IL6ST
regulation of ERK1 and ERK2 cascade (GO:0070372),11/247,0.695753252942632,1,0,0,0.8906882591093116,0.3231062538084776,RPS6KA6;CCL3L1;PSCA;ANGPT1;CCL5;FGG;SPRY2;C3ORF33;EPHA1;FAM83D;SLAMF1
actomyosin structure organization (GO:0031032),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,EPB41L1;TMOD2;MYH6
histone acetylation (GO:0016573),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,CREBBP;MSL3;CPA4
nuclear import (GO:0051170),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,NPAP1;POM121L2;TPR
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),9/204,0.6965667786457328,1,0,0,0.8823529411764706,0.3190514231520267,AKAP13;TBK1;CANT1;NLRP7;TRAF5;NLRP3;TRIM59;NLRC3;MAP3K14
vesicle fusion (GO:0006906),4/94,0.6978008887433855,1,0,0,0.8510638297872339,0.3062310439097954,SYT2;SYTL1;SYT13;SYT7
negative regulation of mitotic cell cycle (GO:0045930),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,BTG3;BMP7
regulation of epithelial cell migration (GO:0010632),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,ENPP2;CLASP2
interstrand cross-link repair (GO:0036297),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,SLX1A;FAAP20
amino acid transport (GO:0006865),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,SLC7A9;SLC38A5
neuron differentiation (GO:0030182),6/139,0.7002204199629493,1,0,0,0.8633093525179856,0.30764901396557814,CASP3;DCLK2;FZD8;PCSK9;PROX1;PTF1A
protein modification by small protein conjugation (GO:0032446),18/398,0.703326997898648,1,0,0,0.9045226130653267,0.31833167241504584,ZNF451;VCP;HACE1;AREL1;EYA1;PRKDC;KLHL15;KLHL26;FBXO32;KLHL30;HERC2;KCTD10;GAN;UBE2Q2;TPR;VHLL;FBXO9;UBE2M
regulation of fat cell differentiation (GO:0045598),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,WDFY2;ZNF385A;FOXO1
negative regulation of cell cycle (GO:0045786),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,BTG3;HTRA2;BMP7
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),6/140,0.7067393435253332,1,0,0,0.8571428571428571,0.29750859485229647,NLRP7;NLRP3;NLRC3;PROX1;BMP7;COMMD7
positive regulation of histone methylation (GO:0031062),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,DNMT1
positive regulation of microtubule polymerization (GO:0031116),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CDK5RAP2
membrane protein intracellular domain proteolysis (GO:0031293),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SPPL2A
positive regulation of immune effector process (GO:0002699),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,LBP
regulation of chromosome organization (GO:0033044),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SMG6
positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,VCP
receptor clustering (GO:0043113),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,NRXN2
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PRKDC
negative regulation of developmental growth (GO:0048640),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,FGF13
drug catabolic process (GO:0042737),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CYP3A5
camera-type eye development (GO:0043010),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SHROOM2
receptor catabolic process (GO:0032801),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PCSK9
sensory perception of pain (GO:0019233),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,TRPA1
DNA geometric change (GO:0032392),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RECQL5
axoneme assembly (GO:0035082),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RSPH4A
negative regulation of oxidative stress-induced cell death (GO:1903202),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HTRA2
cellular senescence (GO:0090398),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SMC5
mRNA splice site selection (GO:0006376),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SFSWAP
actin nucleation (GO:0045010),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,JMY
transition metal ion homeostasis (GO:0055076),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HFE
proteoglycan biosynthetic process (GO:0030166),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CANT1
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HFE
negative regulation of T cell proliferation (GO:0042130),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,DLG5
regulation of cell cycle G1/S phase transition (GO:1902806),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,FAM83D
gonad development (GO:0008406),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,KLHL26;LHB
lipid homeostasis (GO:0055088),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,NR1H2;LIPG
regulation of protein kinase B signaling (GO:0051896),7/163,0.7121164303112548,1,0,0,0.8588957055214724,0.29160699221433833,MYOC;ANGPT1;PDCD6;IL18;THEM4;SPRY2;DRD3
protein N-linked glycosylation (GO:0006487),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,VCP;TMEM258;ST6GALNAC3
nucleic acid phosphodiester bond hydrolysis (GO:0090305),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,RFC2;XRN2;RNASE1
regulation of immune response (GO:0050776),11/251,0.7154113263811371,1,0,0,0.8764940239043825,0.2935357625912092,COL17A1;PLSCR1;VCAM1;KIR2DS1;NLRP7;HFE;SPPL2A;HLA-C;NLRP3;SIGLEC7;KIR2DL4
glycerophospholipid biosynthetic process (GO:0046474),7/164,0.7180316688785969,1,0,0,0.8536585365853658,0.282767222784564,PTDSS1;PLA2G12A;PLSCR1;INPP5F;CHAT;AGPAT1;MFSD2A
regulation of cellular protein metabolic process (GO:0032268),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,NR1H2;EIF4E
negative regulation of protein ubiquitination (GO:0031397),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,HFE;PRMT3
neurogenesis (GO:0022008),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,PCSK9;CDK5RAP2
regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,CCL5;GUCA1A;CNGB1
nitrogen compound transport (GO:0071705),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,SLC7A9;SLC17A3;SLC38A5
negative regulation of wound healing (GO:0061045),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CLASP2
regulation of centrosome duplication (GO:0010824),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CEP120
organophosphate ester transport (GO:0015748),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PITPNA
regulation of voltage-gated calcium channel activity (GO:1901385),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DRD4
regulation of spindle assembly (GO:0090169),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TPR
regulation of telomere maintenance (GO:0032204),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SMG6
"protein import into nucleus, translocation (GO:0000060)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,OR1D2
glial cell differentiation (GO:0010001),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GPC1
respiratory chain complex IV assembly (GO:0008535),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,COX16
lamellipodium organization (GO:0097581),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CTTN
"negative regulation of gene expression, epigenetic (GO:0045814)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DNMT1
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HFE
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GSTO1
in utero embryonic development (GO:0001701),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,MYH6
positive regulation of nuclear division (GO:0051785),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DRD3
"RNA splicing, via transesterification reactions (GO:0000375)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PRPF8
female gamete generation (GO:0007292),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CGB3
long-chain fatty acid transport (GO:0015909),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ACSL1
respiratory tube development (GO:0030323),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PROX1
peptide hormone secretion (GO:0030072),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,KLRG1
positive regulation of Rho protein signal transduction (GO:0035025),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,AKAP13
protein depolymerization (GO:0051261),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,STMN2
positive regulation of calcium ion transmembrane transport (GO:1904427),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SNCA
positive regulation of embryonic development (GO:0040019),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CLASP2
regulation of cellular protein localization (GO:1903827),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HFE
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,BMP7
signal transduction in response to DNA damage (GO:0042770),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CEP63
negative regulation of cellular amide metabolic process (GO:0034249),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,DHFR;BIN1;SNCA
purine ribonucleotide biosynthetic process (GO:0009152),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,PPCDC;COASY;NIPSNAP2
peptidyl-tyrosine modification (GO:0018212),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,ABL2;EPHA1
positive regulation of actin filament polymerization (GO:0030838),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,BAIAP2L2;CTTN
cellular protein complex assembly (GO:0043623),6/144,0.7318438803263533,1,0,0,0.8333333333333333,0.26015672167545917,THEG;CENPF;AARS2;BBS10;ANGPT1;FGG
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),6/144,0.7318438803263533,1,0,0,0.8333333333333333,0.26015672167545917,CITED1;HFE;INHBB;FURIN;BMP7;UBE2M
sulfur compound biosynthetic process (GO:0044272),5/122,0.735892322358741,1,0,0,0.8196721311475409,0.25137005909781296,GCLC;GSTO2;ANGPT1;GSTO1;OPLAH
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PROX1
apoptotic cell clearance (GO:0043277),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,RARA
response to growth factor (GO:0070848),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,HTRA2
nucleotide biosynthetic process (GO:0009165),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,RRM2
regulation of p38MAPK cascade (GO:1900744),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,ULK4
positive regulation of wound healing (GO:0090303),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,F12
response to ketone (GO:1901654),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,WBP2
regulation of supramolecular fiber organization (GO:1902903),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,AKAP13
regulation of microtubule-based process (GO:0032886),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CLASP2
regulation of T cell receptor signaling pathway (GO:0050856),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PVRIG
RNA biosynthetic process (GO:0032774),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,TAF13
transforming growth factor beta receptor signaling pathway (GO:0007179),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,CITED1;FURIN;UBE2M
nucleic acid-templated transcription (GO:0097659),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,GTF3C3;POLR2E;POLR2K
hemopoiesis (GO:0030097),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,L3MBTL1;PRDX3;TAL1
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,EYA1;EYA2;FGG
chemokine-mediated signaling pathway (GO:0070098),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,CCL3L1;CCL5
regulation of DNA binding (GO:0051101),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,EDF1;NME1
positive regulation of secretion by cell (GO:1903532),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,FGG;CLASP2
cellular calcium ion homeostasis (GO:0006874),5/123,0.7423591890762312,1,0,0,0.8130081300813008,0.24221306555432562,CASR;CALCB;CCL5;DRD3;DRD4
positive regulation of cytoskeleton organization (GO:0051495),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,BAIAP2L2;CTTN;PROX1
regulation of cytokinesis (GO:0032465),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,KIF20A;KIF20B;DRD3
metal ion transport (GO:0030001),4/101,0.7498448770134236,1,0,0,0.792079207920792,0.22803083128155077,ABCC8;FGF13;SGK1;SLC17A3
mRNA polyadenylation (GO:0006378),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ZC3H3
negative regulation of synaptic transmission (GO:0050805),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PNKD
peptidyl-glutamic acid modification (GO:0018200),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,AGBL4
endocytic recycling (GO:0032456),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ARL4C
cardiac muscle cell development (GO:0055013),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,MYH6
regulation of double-strand break repair via homologous recombination (GO:0010569),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,KLHL15
modulation by host of viral transcription (GO:0043921),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CCL5
negative regulation of osteoblast differentiation (GO:0045668),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CITED1
purine ribonucleoside triphosphate biosynthetic process (GO:0009206),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,NIPSNAP2
regulation of blood vessel diameter (GO:0097746),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ECE1
negative regulation of organelle assembly (GO:1902116),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CDK5RAP2
muscle fiber development (GO:0048747),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,MYH6
regulation of autophagy of mitochondrion (GO:1903146),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,HTRA2
regulation of protein localization to cell surface (GO:2000008),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,HFE
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,ZNF451;WFIKKN1
neutrophil chemotaxis (GO:0030593),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,CCL3L1;CCL5
gene expression (GO:0010467),18/411,0.7518884494540741,1,0,0,0.8759124087591241,0.24978158060799616,RPL4;EIF5A;RPL39L;RPS9;GTF3C3;RPL32;RPL21;MRPS5;SMG6;LSM7;NXF3;TPR;XRN2;RPL36;POLR2E;DROSHA;EIF4E;POLR2K
positive regulation of protein phosphorylation (GO:0001934),18/412,0.7554002364747531,1,0,0,0.8737864077669902,0.24510368940997992,HDAC3;ANGPT1;HFE;KNDC1;INHBB;BMP7;CAMKK1;TNFRSF10D;DAB2;TBK1;GRM4;ADRB3;ENPP2;FLOT1;SPRY2;WDFY2;EPHA1;SNCA
protein targeting to mitochondrion (GO:0006626),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,TIMM29;TIMM10
action potential (GO:0001508),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,CACNA1H;TPCN1
negative regulation of signal transduction (GO:0009968),12/283,0.7608347028834079,1,0,0,0.8480565371024735,0.23180705734297768,PTPN18;CITED1;HEY1;GPC1;PDCD6;CCL5;DACT3;SPRY2;EPHA1;DKK3;SLAMF1;SNCA
cytoskeleton organization (GO:0007010),5/126,0.7610581948279559,1,0,0,0.7936507936507936,0.21670274009732135,ZMYM2;MAST4;BIN1;TLN1;WASF3
positive regulation of hydrolase activity (GO:0051345),7/172,0.762366812650911,1,0,0,0.813953488372093,0.22084793067849354,VCP;DNMBP;CCL3L1;MTCL1;DOCK9;CCL5;ASAP3
regulation of vasculature development (GO:1901342),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,HEY1
negative regulation of endocytosis (GO:0045806),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NR1H2
RNA polyadenylation (GO:0043631),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ZC3H3
neuron projection extension (GO:1990138),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,SEMA3F
regulation of TORC1 signaling (GO:1903432),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PIH1D1
carboxylic acid catabolic process (GO:0046395),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,SLC9A1
negative regulation of response to DNA damage stimulus (GO:2001021),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,TMEM161A
aerobic respiration (GO:0009060),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,BLOC1S1
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,HTRA2
regulation of NIK/NF-kappaB signaling (GO:1901222),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NLRC3
positive regulation of cell communication (GO:0010647),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,RIMS4
negative regulation of JNK cascade (GO:0046329),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,HDAC3
cardiac muscle cell action potential involved in contraction (GO:0086002),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,SCN1B
triglyceride homeostasis (GO:0070328),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,IL18
regulation of fatty acid biosynthetic process (GO:0042304),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NR1H2
regulation of defense response to virus by virus (GO:0050690),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PACS1
positive regulation of lipid biosynthetic process (GO:0046889),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NR1H2
regulation of adenylate cyclase activity (GO:0045761),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GABBR2
regulation of cell morphogenesis (GO:0022604),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ZMYM2
regulation of actin polymerization or depolymerization (GO:0008064),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,RASA1
peptidyl-tyrosine phosphorylation (GO:0018108),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,TNK1;ABL2;EPHA1
positive regulation of angiogenesis (GO:0045766),4/103,0.7633839575456066,1,0,0,0.7766990291262135,0.20970419679401037,PDCD6;ITGB8;EPHA1;ISL1
protein import into nucleus (GO:0006606),4/103,0.7633839575456066,1,0,0,0.7766990291262135,0.20970419679401037,NPAP1;POM121L2;OR1D2;TPR
vesicle organization (GO:0016050),5/127,0.7670589994510474,1,0,0,0.7874015748031495,0.20881225056066524,SYT2;PLEKHF1;SYTL1;SYT13;SYT7
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,ZNF451;WFIKKN1
positive regulation of DNA biosynthetic process (GO:2000573),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,TNKS2;RFC2
Notch signaling pathway (GO:0007219),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,CREBBP;HEY1
monovalent inorganic cation transport (GO:0015672),4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,ABCC8;FGF13;SGK1;SLC17A3
positive regulation of vasculature development (GO:1904018),4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,PDCD6;ITGB8;EPHA1;ISL1
"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,TMED9;RAB1B;COPE
spindle assembly (GO:0051225),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,GOLGA6A;HDAC3;CEP63
regulation of hydrolase activity (GO:0051336),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,PRR5-ARHGAP8;EPHA1;MYH6
regulation of protein serine/threonine kinase activity (GO:0071900),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,PIH1D1;CDK5R2;SNCA
cellular response to hormone stimulus (GO:0032870),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,AVPR1B;CYP11B2;CACNA1H
regulation of protein processing (GO:0070613),5/128,0.7729447333197296,1,0,0,0.78125,0.20120916351791152,C4A;NLRP7;C4BPA;CFB;CPN2
cellular response to cadmium ion (GO:0071276),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,MT1HL1
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,RAD23B
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,TBK1
lung development (GO:0030324),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PROX1
superoxide metabolic process (GO:0006801),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,NOX5
cardiac muscle cell action potential (GO:0086001),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SCN1B
vacuolar transport (GO:0007034),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PCSK9
negative regulation of Notch signaling pathway (GO:0045746),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,HEY1
regulation of neutrophil chemotaxis (GO:0090022),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,KIF20B
negative regulation of lymphocyte proliferation (GO:0050672),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,DLG5
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,EIF4E
regulation of activated T cell proliferation (GO:0046006),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,IL18
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,TLR5
respiratory system development (GO:0060541),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PROX1
regulation of cellular biosynthetic process (GO:0031326),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,CCL5
chromosome organization (GO:0051276),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,COPS6;RAD23B
granulocyte chemotaxis (GO:0071621),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,CCL3L1;CCL5
protein import (GO:0017038),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,NPAP1;POM121L2
cellular iron ion homeostasis (GO:0006879),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,ABCB7;ATP6V0A2
ATP metabolic process (GO:0046034),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,MYH6;NIPSNAP2
glycosaminoglycan catabolic process (GO:0006027),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,GPC1;SLC9A1
epidermis development (GO:0008544),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,COL17A1;KRT14;KRT31
fatty acid metabolic process (GO:0006631),4/106,0.7826130830889017,1,0,0,0.7547169811320754,0.1849938504751301,SGPL1;ACSL1;CYP4A11;THEM4
modulation of chemical synaptic transmission (GO:0050804),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,GRIA1;RIMS4;GRM4
mitotic sister chromatid segregation (GO:0000070),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,NIPBL;BOD1;KNSTRN
positive regulation of cell cycle arrest (GO:0071158),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,INSM1;CRLF3;ZNF385A
IRE1-mediated unfolded protein response (GO:0036498),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,TLN1;PDIA5
positive regulation of cell death (GO:0010942),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,HTRA2;SNCA
regulation of Rho protein signal transduction (GO:0035023),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,AKAP13;MYOC
epidermal growth factor receptor signaling pathway (GO:0007173),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,REPS2;ABL2
protein homotetramerization (GO:0051289),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,TRPA1;MCOLN1
smoothened signaling pathway (GO:0007224),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,B9D1
regulation of defense response to virus by host (GO:0050691),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,RNF216
beta-catenin-TCF complex assembly (GO:1904837),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CREBBP
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,PROX1
cellular response to cAMP (GO:0071320),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,AQP8
bile acid and bile salt transport (GO:0015721),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,SLC51A
activation of protein kinase B activity (GO:0032148),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,IL18
negative regulation of DNA biosynthetic process (GO:2000279),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CTC1
activation of JUN kinase activity (GO:0007257),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,MAP3K9
fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ACSL1
MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,TBK1
positive regulation of cation channel activity (GO:2001259),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,GSTO1
response to estradiol (GO:0032355),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,FAM210B
ATP-dependent chromatin remodeling (GO:0043044),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CHD4
regulation of blood coagulation (GO:0030193),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,F12
positive regulation of B cell proliferation (GO:0030890),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,IL7
regulation of angiogenesis (GO:0045765),7/177,0.7873883393387747,1,0,0,0.7909604519774012,0.18906621102380866,PDCD6;AGO1;ITGB8;SPRY2;SEMA3E;EPHA1;ISL1
transmembrane transport (GO:0055085),16/378,0.7877350565590815,1,0,0,0.8465608465608465,0.2019838885083786,VCP;CHRNB3;ABCB7;ABCC8;AQP8;CLCNKA;ANO9;AQP4;TCIRG1;TPCN1;SLC5A6;SLC5A7;ATP6V0A2;SGK1;SLC22A31;SLC17A3
viral life cycle (GO:0019058),4/107,0.7887401751709202,1,0,0,0.747663551401869,0.1774342589951246,VCP;RAB1B;TPR;FURIN
regulation of response to external stimulus (GO:0032101),4/107,0.7887401751709202,1,0,0,0.747663551401869,0.1774342589951246,NLRP7;GUCA1A;NLRP3;CNGB1
positive regulation of epithelial cell proliferation (GO:0050679),4/107,0.7887401751709202,1,0,0,0.747663551401869,0.1774342589951246,PDCD6;LAMB1;PROX1;NME1
axonogenesis (GO:0007409),9/223,0.7894214255919177,1,0,0,0.8071748878923766,0.1908605175379942,DOK4;GPC1;SLITRK3;SEMA3F;ISL1;SPTAN1;NTN1;SCN1B;PDLIM7
negative regulation of signaling (GO:0023057),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,MVP;PCSK9;EPHA1
establishment of protein localization to membrane (GO:0090150),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,RTP3;CHM;ATG4D
positive regulation of peptidyl-serine phosphorylation (GO:0033138),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,TBK1;SPRY2;SNCA
protein maturation (GO:0051604),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,F12;ECE1;FURIN
phospholipid transport (GO:0015914),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,PITPNA;MFSD2A
ubiquitin-dependent ERAD pathway (GO:0030433),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,VCP;FBXO6
neutrophil migration (GO:1990266),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,CCL3L1;CCL5
regulation of protein activation cascade (GO:2000257),4/108,0.7947283904475327,1,0,0,0.7407407407407407,0.1701887925469081,C4A;C4BPA;CFB;CPN2
regulation of dendritic spine development (GO:0060998),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,DLG5
organelle transport along microtubule (GO:0072384),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,LRPPRC
secondary alcohol metabolic process (GO:1902652),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,CYP11B2
skeletal system morphogenesis (GO:0048705),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,RARA
zinc ion homeostasis (GO:0055069),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MT1HL1
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,FGG
positive regulation of viral genome replication (GO:0045070),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,CCL5
regulation of protein autophosphorylation (GO:0031952),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MVP
cellular zinc ion homeostasis (GO:0006882),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MT1HL1
positive regulation of insulin secretion (GO:0032024),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,ISL1
response to cadmium ion (GO:0046686),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MT1HL1
sarcomere organization (GO:0045214),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MYH6
vesicle-mediated transport to the plasma membrane (GO:0098876),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,SNX17
regulation of cell cycle G2/M phase transition (GO:1902749),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,CENPF;CEP63;CDK5RAP2
regulation of complement activation (GO:0030449),4/109,0.8005792983505415,1,0,0,0.7339449541284404,0.1632438094873767,C4A;C4BPA;CFB;CPN2
protein targeting (GO:0006605),5/133,0.8006749703651704,1,0,0,0.7518796992481203,0.1671430030702634,RTP3;CHM;TIMM10;SRP14;ATG4D
positive regulation of gene expression (GO:0010628),34/771,0.8009120872205036,1,0,0,0.8819714656290532,0.19580127414932463,DNMT1;RHOXF1;CITED1;WBP2;HFE;DDX21;FOXO1;ACTG2;WDR43;C1QTNF1;LAMP3;ZIC1;POLR2E;ITGB8;POLR2K;CDK5RAP2;CREBBP;EGR2;NR1H2;EDF1;PBX4;PROX1;ARID1A;BMP7;MAPK11;PLSCR1;DAB2;TAL1;TBL1XR1;RARA;PKP1;SPRY2;PKP3;CRLF3
cell junction assembly (GO:0034329),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,TLN1;CDH9
sterol metabolic process (GO:0016125),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,CYP11B2;CYP46A1
cell morphogenesis (GO:0000902),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,CDH9;FRYL
adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),5/134,0.8058877075534783,1,0,0,0.7462686567164178,0.16105288569760093,GHRHR;GPR78;ADRB3;PSAP;GNAI1
positive regulation of calcium ion transport into cytosol (GO:0010524),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,SNCA
response to zinc ion (GO:0010043),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,MT1HL1
cellular response to glucagon stimulus (GO:0071377),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,PRKAR2A
sister chromatid segregation (GO:0000819),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,KNSTRN
ceramide biosynthetic process (GO:0046513),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,ST6GALNAC3
protein trimerization (GO:0070206),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,HTRA2
cyclic-nucleotide-mediated signaling (GO:0019935),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,GHRHR
regulation of potassium ion transmembrane transport (GO:1901379),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,KCNE3
activation of adenylate cyclase activity (GO:0007190),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,ADRB3
negative regulation of fat cell differentiation (GO:0045599),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,FOXO1
G2 DNA damage checkpoint (GO:0031572),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,MAP3K14
positive regulation of telomere maintenance via telomerase (GO:0032212),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,TNKS2
positive regulation of T cell differentiation (GO:0045582),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,IL7
positive regulation of transcription factor import into nucleus (GO:0042993),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,HDAC3
mismatch repair (GO:0006298),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,MSH5
aminoglycan catabolic process (GO:0006026),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,GPC1
vasculogenesis (GO:0001570),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RASA1
global genome nucleotide-excision repair (GO:0070911),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RAD23B
"regulation of mRNA splicing, via spliceosome (GO:0048024)",2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,SFSWAP;JMJD6
positive regulation of protein binding (GO:0032092),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,HFE;FLOT1
membrane lipid biosynthetic process (GO:0046467),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,SGPL1;GLT6D1
regulation of peptidyl-serine phosphorylation (GO:0033135),3/86,0.8106028254070419,1,0,0,0.6976744186046511,0.14649563666446674,TBK1;SPRY2;SNCA
mitochondrial transport (GO:0006839),5/135,0.8109917200733027,1,0,0,0.7407407407407407,0.15518328477497187,SLC25A48;SLC25A26;SLC25A18;SLC25A42;TIMM10
regulation of protein binding (GO:0043393),4/111,0.811875792624319,1,0,0,0.7207207207207207,0.1502039028966739,DAB2;PRMT7;HFE;FLOT1
cellular response to oxygen-containing compound (GO:1901701),11/274,0.8122111565206551,1,0,0,0.802919708029197,0.16700322658038597,PRDX3;FAM210B;NLRP7;AQP8;NR1H2;RARA;HTRA2;NLRP3;ABL2;LBP;ZNF16
positive regulation of signal transduction (GO:0009967),8/206,0.8139007806443227,1,0,0,0.7766990291262135,0.15993538758000875,GHRHR;CREBBP;IL7;PIH1D1;DLG5;BMP2K;TLR5;AGPAT1
inflammatory response (GO:0006954),10/252,0.8146376853452667,1,0,0,0.7936507936507936,0.16270779559125684,TBK1;CCL3L1;NLRP7;GPR32;CCL5;IL18;NLRP3;FOLR2;TNFRSF10D;KLRG1
phosphate-containing compound metabolic process (GO:0006796),7/183,0.8147438698485703,1,0,0,0.7650273224043715,0.15673993407787173,ITPKB;GK5;PLA2G4E;INPP1;ENPP2;PLCH2;AGPAT1
actin cytoskeleton reorganization (GO:0031532),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,CTTN;FRYL
glycosaminoglycan metabolic process (GO:0030203),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,GPC1;XYLT1
negative regulation of MAP kinase activity (GO:0043407),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,SPRY2;BMP7
regulation of DNA replication (GO:0006275),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,CTC1;EHMT2
glycogen metabolic process (GO:0005977),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,PYGL
positive regulation of adenylate cyclase activity (GO:0045762),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,ADRB3
activation of MAPKK activity (GO:0000186),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,MAP3K14
"chemical synaptic transmission, postsynaptic (GO:0099565)",1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,DRD4
negative regulation of neurogenesis (GO:0050768),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,BMP7
regulation of T cell differentiation (GO:0045580),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,IL7
negative regulation of mitochondrion organization (GO:0010823),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,ACAA2
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,TPR
response to exogenous dsRNA (GO:0043330),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,FLOT1
tRNA export from nucleus (GO:0006409),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,TPR
intra-Golgi vesicle-mediated transport (GO:0006891),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,COPE
regulation of autophagosome assembly (GO:2000785),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,RAB1B
regulation of postsynaptic membrane potential (GO:0060078),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,DRD4
positive regulation of catalytic activity (GO:0043085),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,ABL2
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,MTCL1
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,LSM7
positive regulation of locomotion (GO:0040017),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,NTN1
regulation of neurotransmitter receptor activity (GO:0099601),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,PSCA
phosphatidylinositol metabolic process (GO:0046488),4/112,0.8173248241169633,1,0,0,0.7142857142857142,0.14408477257015773,PLA2G12A;INPP5F;PLA2G4E;PIGW
apoptotic process (GO:0006915),9/231,0.8216274337473796,1,0,0,0.7792207792207791,0.15309212749731324,EIF5A;BCL2L13;PLSCR1;CDK11A;CASP3;NLRP3;NOX5;CGB3;ZNF385A
regulation of organelle organization (GO:0033043),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,TMED9;ZEB2;TBC1D4;STMN2
positive regulation of kinase activity (GO:0033674),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,EPHA1;DRD4;CAMKK1;ZNF16
regulation of humoral immune response (GO:0002920),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,C4A;C4BPA;CFB;CPN2
divalent metal ion transport (GO:0070838),3/88,0.8227310669841436,1,0,0,0.6818181818181818,0.1330403886090264,MMGT1;CCL5;CACNA1H
diterpenoid metabolic process (GO:0016101),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,GPC1;LRAT
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,TMEM161A;HTRA2
negative regulation of peptidase activity (GO:0010466),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,NLRP7;SERPINA7
establishment of protein localization to organelle (GO:0072594),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,NPAP1;POM121L2
second-messenger-mediated signaling (GO:0019932),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,LAT2;KLRG1
cellular response to cytokine stimulus (GO:0071345),19/456,0.8242479819232588,1,0,0,0.8333333333333333,0.16106987117726593,LRRC15;PTPN18;VCAM1;CCL3L1;LRTM2;IL18;HTRA2;AQP4;FOXO1;MAPK11;TBK1;NLRP7;IL7;CCL5;LRRTM1;CASP3;TPR;LBP;IL6ST
apoptotic mitochondrial changes (GO:0008637),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,THEM4
negative regulation of cellular metabolic process (GO:0031324),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PCSK9
ncRNA metabolic process (GO:0034660),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,DROSHA
positive regulation of muscle cell differentiation (GO:0051149),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,MAPK11
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TNKS2
negative regulation of T cell activation (GO:0050868),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,DLG5
positive regulation of cell development (GO:0010720),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PROX1
positive regulation of chemokine production (GO:0032722),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,IL7
response to glucagon (GO:0033762),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PRKAR2A
"DNA-templated transcription, initiation (GO:0006352)",7/186,0.8273600898825334,1,0,0,0.7526881720430108,0.1426458959005734,CREBBP;TAF13;NR1H2;RARA;POLR2E;GTF2E2;POLR2K
regulation of immune effector process (GO:0002697),4/114,0.8278334479918896,1,0,0,0.7017543859649122,0.13259178568312602,C4A;C4BPA;CFB;CPN2
peptidyl-threonine modification (GO:0018210),3/89,0.8285426848935676,1,0,0,0.6741573033707865,0.1268001726406977,TBK1;DCLK2;CAMKK1
ribosomal large subunit biogenesis (GO:0042273),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,MRPL20;SAMD15
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,PRKDC;ZNF385A
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,LSM7;EIF4E
negative regulation of cell growth (GO:0030308),4/115,0.832896768257819,1,0,0,0.6956521739130435,0.12719691976114322,DACT3;FGF13;CRLF3;ING1
positive regulation of RNA metabolic process (GO:0051254),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,WDR43
lipid phosphorylation (GO:0046834),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,DGKB
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CDK5R2
antibacterial humoral response (GO:0019731),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,BPIFA1
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,LSM7
anatomical structure homeostasis (GO:0060249),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CTC1
positive regulation of DNA replication (GO:0045740),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CTC1
negative regulation of protein complex assembly (GO:0031333),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,NLRC3
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,UTP20
tRNA transport (GO:0051031),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,TPR
regulation of ion transmembrane transport (GO:0034765),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,KCNE3
positive regulation of ATPase activity (GO:0032781),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PLSCR1
membrane protein proteolysis (GO:0033619),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,SPPL2A
regulation of cardiac muscle contraction (GO:0055117),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,SLC9A1
sulfur compound catabolic process (GO:0044273),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,GPC1
regulation of cytokine-mediated signaling pathway (GO:0001959),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,IL7;SPPL2A;AGPAT1
positive regulation of response to external stimulus (GO:0032103),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,CCL3L1;IL18;SNCA
protein tetramerization (GO:0051262),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,TRPA1;CCL5;MCOLN1
regulation of JNK cascade (GO:0046328),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,HDAC3;ULK4;SLAMF1
regulation of GTPase activity (GO:0043087),7/188,0.8353889283325726,1,0,0,0.7446808510638298,0.13393671925321257,DNMBP;CCL3L1;PRR5-ARHGAP8;DOCK9;CCL5;ASAP3;EPHA1
negative regulation of neuron differentiation (GO:0045665),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,STMN2;BMP7
cellular response to acid chemical (GO:0071229),3/91,0.8396768561291149,1,0,0,0.6593406593406593,0.11521197114942941,RARA;HTRA2;ABL2
regulation of potassium ion transport (GO:0043266),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,KCNE3
actin polymerization or depolymerization (GO:0008154),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,WASF3
organic hydroxy compound transport (GO:0015850),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,SLC51A
regulation of muscle cell differentiation (GO:0051147),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,MAPK11
regulation of nitric-oxide synthase activity (GO:0050999),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,DHFR
regulation of filopodium assembly (GO:0051489),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,MYO10
endosome organization (GO:0007032),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,PLEKHF1
centromere complex assembly (GO:0034508),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,CENPF
epithelial cell migration (GO:0010631),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,ZEB2
regulation of cell morphogenesis involved in differentiation (GO:0010769),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,KNDC1
acylglycerol metabolic process (GO:0006639),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,GK5
glutamate receptor signaling pathway (GO:0007215),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,GRM4
spermatid development (GO:0007286),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,KLHL26
activation of MAPK activity (GO:0000187),4/117,0.8426510176169044,1,0,0,0.6837606837606838,0.1170614587500545,MAPK11;GRM4;MAP3K9;DRD4
chromatin assembly (GO:0031497),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,SART3;BAHD1
negative regulation of apoptotic signaling pathway (GO:2001234),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,ACAA2;PIH1D1
protein homooligomerization (GO:0051260),7/190,0.8431186379156546,1,0,0,0.7368421052631577,0.12574033528457515,GSDMD;TRPA1;FLOT1;HTRA2;OLFM4;MCOLN1;VSTM5
positive regulation of apoptotic process (GO:0043065),12/307,0.8460523895990341,1,0,0,0.781758957654723,0.13068976811982114,PXT1;AKAP13;BNIP3L;KLF11;BIN1;PDCD6;JMY;PCSK9;HTRA2;NLRP3;FOXO1;SNCA
regulation of cell cycle (GO:0051726),8/215,0.8480666942392859,1,0,0,0.7441860465116279,0.12263888179781321,L3MBTL1;CENPF;CDK11A;RARA;HTRA2;PROX1;BMP7;MAP3K14
purine ribonucleotide metabolic process (GO:0009150),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,GIMAP7;MYH6
negative regulation of epithelial cell proliferation (GO:0050680),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,MAGED1;NLRC3
sphingolipid biosynthetic process (GO:0030148),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,SGPL1;ST8SIA1
cellular transition metal ion homeostasis (GO:0046916),3/93,0.8501804853980194,1,0,0,0.6451612903225806,0.10471394598415903,ABCB7;ATP6V0A2;MT1HL1
sodium-independent organic anion transport (GO:0043252),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,SLC22A31
protein peptidyl-prolyl isomerization (GO:0000413),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,CWC27
phospholipid biosynthetic process (GO:0008654),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,FADS1
protein K63-linked ubiquitination (GO:0070534),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,UBE2NL
positive regulation of axonogenesis (GO:0050772),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,NTN1
regulation of osteoclast differentiation (GO:0045670),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,TCTA
regulation of carbohydrate catabolic process (GO:0043470),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,TPR
regulation of metal ion transport (GO:0010959),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,CASR
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,RFC2
positive regulation of multi-organism process (GO:0043902),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,INHBB
cilium organization (GO:0044782),7/192,0.8505551215977437,1,0,0,0.7291666666666666,0.11802733427321463,CFAP61;TBC1D32;AVIL;WDR5B;TEKT4;TRIM59;B9D1
positive regulation of GTPase activity (GO:0043547),7/192,0.8505551215977437,1,0,0,0.7291666666666666,0.11802733427321463,DNMBP;CCL3L1;TBC1D4;DOCK9;CCL5;ASAP3;EPHA1
positive regulation of synaptic transmission (GO:0050806),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,RIMS4;FLOT1
positive regulation of endothelial cell proliferation (GO:0001938),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,PDCD6;PROX1
extrinsic apoptotic signaling pathway (GO:0097191),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,SIVA1;CASP3
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,PROX1;CDK5R2
cellular response to UV (GO:0034644),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,CREBBP;TMEM161A
cellular response to fibroblast growth factor stimulus (GO:0044344),3/94,0.855203978006065,1,0,0,0.6382978723404255,0.09983953259459333,CCL5;POLR2E;POLR2K
axon development (GO:0061564),3/94,0.855203978006065,1,0,0,0.6382978723404255,0.09983953259459333,DHFR;SLITRK3;MTR
enzyme linked receptor protein signaling pathway (GO:0007167),4/120,0.8563810483662649,1,0,0,0.6666666666666666,0.10335990128643677,CNKSR1;TNK1;ABL2;IL6ST
potassium ion import (GO:0010107),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,SLC12A5
muscle filament sliding (GO:0030049),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,MYH6
regulation of cellular amide metabolic process (GO:0034248),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,EIF4E
actin-myosin filament sliding (GO:0033275),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,MYH6
regulation of ossification (GO:0030278),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,BMP2K
positive regulation of protein localization to membrane (GO:1905477),3/95,0.86007960317269,1,0,0,0.631578947368421,0.09519810454070905,TCAF1;MTCL1;PLS1
regulation of heart contraction (GO:0008016),3/95,0.86007960317269,1,0,0,0.631578947368421,0.09519810454070905,MYH6;CACNA1H;CORIN
regulation of epithelial to mesenchymal transition (GO:0010717),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,DAB2;CLASP2
monocarboxylic acid biosynthetic process (GO:0072330),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,OSBPL2;CYP46A1
regulation of endopeptidase activity (GO:0052548),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,FURIN;SERPINA7
Golgi organization (GO:0007030),4/121,0.8607254206096335,1,0,0,0.6611570247933884,0.09916015401943896,GOLGA6A;TMED9;HACE1;CLASP2
negative regulation of cell migration (GO:0030336),4/121,0.8607254206096335,1,0,0,0.6611570247933884,0.09916015401943896,TCAF1;DLG5;EPHA1;CLASP2
protein localization to nucleus (GO:0034504),3/96,0.8648106182658194,1,0,0,0.625,0.09077795902611915,NPAP1;POM121L2;BMP7
ciliary basal body-plasma membrane docking (GO:0097711),3/96,0.8648106182658194,1,0,0,0.625,0.09077795902611915,B9D1;CEP63;CDK5RAP2
negative regulation of protein catabolic process (GO:0042177),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,SNCA
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,FGG
purine ribonucleoside monophosphate biosynthetic process (GO:0009168),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,NIPSNAP2
purine ribonucleoside monophosphate metabolic process (GO:0009167),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,MYH6
inositol lipid-mediated signaling (GO:0048017),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,INPP5F
regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,MYO10
regulation of RNA metabolic process (GO:0051252),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,RASA1
DNA biosynthetic process (GO:0071897),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,POLL
regulation of coenzyme metabolic process (GO:0051196),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,TPR
positive regulation of neurogenesis (GO:0050769),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,NIPBL;KIF20B
response to tumor necrosis factor (GO:0034612),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,CCL3L1;CASP3;CCL5
negative regulation of cell motility (GO:2000146),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,TCAF1;DLG5;EPHA1
mitochondrial respiratory chain complex assembly (GO:0033108),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,AARS2;COX16;NDUFAF6
stress-activated protein kinase signaling cascade (GO:0031098),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,MAPK11;MAP3K14
vascular endothelial growth factor receptor signaling pathway (GO:0048010),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,MAPK11;PDCD6
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,VCP;DAB2
negative regulation of TOR signaling (GO:0032007),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PDCD6
"nucleotide-excision repair, DNA incision (GO:0033683)",1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,RFC2
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,SPRY2
positive regulation of epithelial to mesenchymal transition (GO:0010718),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,DAB2
cognition (GO:0050890),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NIPBL
positive regulation of Ras protein signal transduction (GO:0046579),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,AKAP13
peptidyl-proline modification (GO:0018208),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,CWC27
androgen receptor signaling pathway (GO:0030521),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,ARID1A
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,RTP3
negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NR1H2
neuron migration (GO:0001764),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,FGF13
regulation of intracellular transport (GO:0032386),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,INPP5F
regulation of ATPase activity (GO:0043462),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,MYH6
JAK-STAT cascade (GO:0007259),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,STAMBP
phosphatidylinositol biosynthetic process (GO:0006661),3/98,0.8738518002871013,1,0,0,0.6122448979591836,0.08255784648566498,INPP5F;PIGO;PIGW
positive regulation of cell growth (GO:0030307),3/98,0.8738518002871013,1,0,0,0.6122448979591836,0.08255784648566498,RPS6KA3;SYT2;NTN1
Ras protein signal transduction (GO:0007265),8/223,0.8740640723519376,1,0,0,0.7174887892376681,0.09657513663601022,CNKSR1;MAPK11;DNMT1;RAB5B;HACE1;RAB1B;NTN1;RAB9B
Golgi vesicle transport (GO:0048193),10/271,0.8756026805587208,1,0,0,0.7380073800738007,0.09803900512300928,GRIA1;TMED9;TRAPPC6A;SEC24A;MIA;SAR1B;PDCD6;RAB1B;SPTAN1;COPE
regulation of cell communication (GO:0010646),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,GRIA1;NCLN
vesicle-mediated transport (GO:0016192),16/410,0.8766039078231569,1,0,0,0.7804878048780487,0.10279026971738842,RAB5B;SYT2;MIA;SYTL1;ASAP3;SYT13;SYT7;ARL4C;ACAP1;TBC1D4;BIN1;KIF20A;SFT2D1;RAB9B;SCYL2;MFSD2A
protein dephosphorylation (GO:0006470),4/125,0.8769959948339774,1,0,0,0.64,0.08400182624919345,PTPN18;PTPRN2;EYA1;EYA2
glycosaminoglycan biosynthetic process (GO:0006024),3/99,0.8781684208695373,1,0,0,0.6060606060606061,0.07873750329026426,ANGPT1;GPC1;XYLT1
odontogenesis (GO:0042476),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,LAMB1
regulation of calcium-mediated signaling (GO:0050848),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,TMBIM4
peptide transport (GO:0015833),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,CENPF
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,CDH9
telomere organization (GO:0032200),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,CTC1
cellular response to peptide (GO:1901653),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,CYP11B2
spliceosomal complex assembly (GO:0000245),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,SART3
sensory perception of bitter taste (GO:0050913),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,RTP3
negative regulation of proteolysis (GO:0045861),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,NLRP7
gluconeogenesis (GO:0006094),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,PCK2
regulation of cell growth (GO:0001558),7/201,0.8805619416668193,1,0,0,0.6965174129353233,0.08859353598323239,RPS6KA3;CDK11A;FAM107A;DACT3;SGK1;CRLF3;ING1
positive regulation of ERK1 and ERK2 cascade (GO:0070374),7/201,0.8805619416668193,1,0,0,0.6965174129353233,0.08859353598323239,CCL3L1;ANGPT1;CCL5;FGG;SPRY2;EPHA1;SLAMF1
cell-cell junction organization (GO:0045216),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,TLN1;CDH9
lipid biosynthetic process (GO:0008610),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,ACSL1;FADS1
glycoprotein biosynthetic process (GO:0009101),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,FUT5;CANT1
Rho protein signal transduction (GO:0007266),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,CNKSR1;NTN1
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,FBXO6;FBXO9
cellular response to transforming growth factor beta stimulus (GO:0071560),3/100,0.8823533306415342,1,0,0,0.6,0.07509762093621879,CITED1;FURIN;UBE2M
regulation of protein modification process (GO:0031399),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,PPP1R14B
regulation of telomerase activity (GO:0051972),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,SMG6
positive regulation of protein kinase B signaling (GO:0051897),4/127,0.884496020278119,1,0,0,0.6299212598425197,0.07731481246950389,MYOC;ANGPT1;IL18;SPRY2
negative regulation of response to stimulus (GO:0048585),4/127,0.884496020278119,1,0,0,0.6299212598425197,0.07731481246950389,NCOR2;NLRP7;NLRP3;EPHA1
B cell activation (GO:0042113),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,LAT2;VCAM1
canonical Wnt signaling pathway (GO:0060070),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,FZD8;SCYL2
positive regulation of proteasomal protein catabolic process (GO:1901800),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,VCP;DAB2
intrinsic apoptotic signaling pathway (GO:0097193),3/101,0.8864097011888528,1,0,0,0.594059405940594,0.07162931796059352,JMY;HTRA2;ZNF385A
regulation of B cell proliferation (GO:0030888),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,IL7
mitotic metaphase plate congression (GO:0007080),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,BOD1
response to hydrogen peroxide (GO:0042542),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PRDX3
regulation of ATP metabolic process (GO:1903578),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,TPR
positive regulation of protein localization to plasma membrane (GO:1903078),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PLS1
detection of chemical stimulus involved in sensory perception (GO:0050907),3/102,0.8903406760313634,1,0,0,0.588235294117647,0.06832418084741279,OR4C11;OR8S1;OR4F6
mitotic spindle organization (GO:0007052),2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,EML1;CLASP2
glucose homeostasis (GO:0042593),2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,PYGL;FOXO1
mitotic nuclear division (GO:0140014),2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,KNSTRN;CLASP2
MAPK cascade (GO:0000165),10/278,0.8935099822519456,1,0,0,0.7194244604316546,0.08100559163077616,MAPK11;ANGPT1;RASA1;CCL5;TPR;IL18;FGF13;SPTAN1;MARK3;RASGRP3
regulation of actin cytoskeleton organization (GO:0032956),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,ABL2;SEMA3E
regulation of defense response (GO:0031347),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,NLRP7;NLRP3
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,HFE;HLA-C
cAMP-mediated signaling (GO:0019933),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,GHRHR;GPR78
"regulation of transcription, DNA-templated (GO:0006355)",70/1598,0.89501456073011,1,0,0,0.8760951188986232,0.09717234581627163,RHOXF1;CITED1;BHLHE41;CHD4;CGB3;RPS6KA3;NIPBL;ZMYM2;HEY1;NKRF;SCMH1;ZIC1;MLX;HMG20B;FADS1;CDK5RAP2;KLF11;TGIF2;PRMT7;MSX2;PRMT3;KCTD1;ARID5B;EDF1;PROX1;ARID1A;COMMD7;ETV4;ZNF16;DKK3;ETV7;RFX8;TAL1;TBL1XR1;RARA;L3MBTL1;ZNF790;HDAC3;WBP2;MAGED1;FOXO1;IWS1;ZNF429;BAHD1;ZNF267;ZBED4;POLR2K;ZNF420;KLRG1;CREBBP;EGR2;CDK11A;RRM2;ZBTB14;TAF13;NR1H2;PBX4;BMP7;GATAD2A;DHFR;FOXR1;CENPF;FAM200A;GCLC;DAB2;ZNF71;JMY;POLR3F;PTF1A;CRLF3
ribonucleoprotein complex assembly (GO:0022618),5/156,0.8953149759712675,1,0,0,0.641025641025641,0.07088441933337168,MRPL20;SAMD15;SART3;PRMT7;VCX
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),15/396,0.8955197756487819,1,0,0,0.7575757575757576,0.08359922300402568,ANGPT1;MVP;TNK1;TCIRG1;FOXO1;CNKSR1;MAPK11;BAIAP2L2;CASP3;RASA1;POLR2E;ATP6V0A2;ABL2;EPHA1;POLR2K
cholesterol transport (GO:0030301),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,LIPG
adherens junction organization (GO:0034332),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CDH9
detection of chemical stimulus involved in sensory perception of taste (GO:0050912),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,RTP3
amide biosynthetic process (GO:0043604),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,FURIN
positive regulation of viral life cycle (GO:1903902),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CCL5
hexose biosynthetic process (GO:0019319),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,PCK2
regulation of dendrite morphogenesis (GO:0048814),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,KNDC1
carboxylic acid biosynthetic process (GO:0046394),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,FADS1
mitotic nuclear envelope disassembly (GO:0007077),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,TPR
protein deubiquitination (GO:0016579),9/257,0.9005996114817824,1,0,0,0.7003891050583657,0.07332688892035875,USP25;VCP;USP42;TNKS2;NLRP3;OTUD6A;STAMBP;EIF3F;RAD23B
positive regulation of programmed cell death (GO:0043068),9/257,0.9005996114817824,1,0,0,0.7003891050583657,0.07332688892035875,PXT1;AKAP13;BNIP3L;KLF11;BIN1;JMY;HTRA2;FOXO1;SNCA
hexose metabolic process (GO:0019318),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,FPGT
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,ANGPT1
"regulation of synaptic transmission, glutamatergic (GO:0051966)",1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,GRM4
negative regulation of ossification (GO:0030279),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,CITED1
translational elongation (GO:0006414),3/105,0.901412171716172,1,0,0,0.5714285714285714,0.05931009468144877,MRPL20;LTN1;MRPS5
cellular response to hypoxia (GO:0071456),4/132,0.901525280416235,1,0,0,0.6060606060606061,0.06282860249592064,BNIP3L;CREBBP;ACAA2;BMP7
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),2/77,0.9031081450221422,1,0,0,0.5194805194805194,0.05294180301649679,ZNF451;WFIKKN1
ERAD pathway (GO:0036503),2/77,0.9031081450221422,1,0,0,0.5194805194805194,0.05294180301649679,VCP;FBXO6
positive regulation of cellular biosynthetic process (GO:0031328),5/159,0.9042193482148154,1,0,0,0.6289308176100629,0.0633228340831324,CTC1;ZEB2;CCL5;NR1H2;SNCA
positive regulation of cytosolic calcium ion concentration (GO:0007204),4/133,0.9046524128561665,1,0,0,0.6015037593984962,0.060273373383263405,C1QTNF1;AVPR1B;GPR32;ABL2
"DNA-templated transcription, termination (GO:0006353)",3/106,0.9048723287754362,1,0,0,0.5660377358490566,0.05658193494921566,POLR2E;POLR3K;POLR2K
response to endoplasmic reticulum stress (GO:0034976),3/106,0.9048723287754362,1,0,0,0.5660377358490566,0.05658193494921566,VCP;FLOT1;PDIA5
protein complex disassembly (GO:0043241),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,VCP
cellular response to ionizing radiation (GO:0071479),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,NIPBL
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,PRMT3
nuclear envelope disassembly (GO:0051081),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,TPR
cartilage development (GO:0051216),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,ITGB8
tRNA aminoacylation for protein translation (GO:0006418),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,AARS2
pyruvate metabolic process (GO:0006090),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,PCK2
regulation of generation of precursor metabolites and energy (GO:0043467),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,TPR
maturation of SSU-rRNA (GO:0030490),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,UTP20
regulation of fibroblast proliferation (GO:0048145),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,NLRC3
negative regulation of autophagy (GO:0010507),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,SNCA
regulation of cellular response to heat (GO:1900034),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,CREBBP;TPR
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,HFE;HLA-C
fibroblast growth factor receptor signaling pathway (GO:0008543),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,POLR2E;POLR2K
"transcription, DNA-templated (GO:0006351)",13/356,0.9084723125494114,1,0,0,0.7303370786516853,0.07010568983144617,KLF11;EGR2;GTF3C3;TAF13;DDX21;PBX4;GTF2E2;IWS1;ETV7;POLR2E;PKNOX1;POLR3K;POLR2K
protein modification by small protein removal (GO:0070646),9/261,0.9096703260461426,1,0,0,0.689655172413793,0.0652917408140208,USP25;VCP;COPS6;USP42;TNKS2;NLRP3;STAMBP;EIF3F;RAD23B
negative regulation of cellular biosynthetic process (GO:0031327),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,PROX1
fatty acid biosynthetic process (GO:0006633),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,FADS1
histone H4 acetylation (GO:0043967),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,MSL3
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,VCAM1
nucleosome organization (GO:0034728),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,SART3;ARID1A
regulation of endothelial cell proliferation (GO:0001936),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,PDCD6;PROX1
receptor-mediated endocytosis (GO:0006898),6/188,0.9131597476168598,1,0,0,0.6382978723404255,0.0579858151181627,INPP5F;CTTN;DNAJC6;FOLR2;PDLIM7;SNCA
NIK/NF-kappaB signaling (GO:0038061),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,MAP3K14;UBE2M
Wnt signaling pathway (GO:0016055),3/109,0.9146032191683431,1,0,0,0.5504587155963303,0.049136668628761794,TNKS2;FZD8;CSNK1A1L
cytoplasmic microtubule organization (GO:0031122),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,CCDC88B
regulation of mitochondrion organization (GO:0010821),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,HTRA2
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,HTRA2
neuron projection morphogenesis (GO:0048812),5/163,0.9150605393003802,1,0,0,0.6134969325153374,0.05445708756164863,CTTN;SLITRK3;KIF20B;SGK1;BMP7
positive regulation of protein modification process (GO:0031401),5/163,0.9150605393003802,1,0,0,0.6134969325153374,0.05445708756164863,DAB2;HDAC3;FLOT1;KNDC1;WDFY2
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),5/163,0.9150605393003802,1,0,0,0.6134969325153374,0.05445708756164863,AKAP13;TBK1;CANT1;TRAF5;MAP3K14
cilium assembly (GO:0060271),10/288,0.9153493694992352,1,0,0,0.6944444444444444,0.06142323749565701,RSPH4A;BBS10;TBC1D32;AVIL;WDR5B;B9D1;TEKT4;TRIM59;CEP63;CDK5RAP2
positive regulation of transferase activity (GO:0051347),4/137,0.9162983017532836,1,0,0,0.583941605839416,0.05104426883901789,RFC2;EPHA1;DRD4;ZNF16
regulation of cytosolic calcium ion concentration (GO:0051480),4/137,0.9162983017532836,1,0,0,0.583941605839416,0.05104426883901789,C1QTNF1;AVPR1B;GPR32;ABL2
positive regulation of MAPK cascade (GO:0043410),10/289,0.9173089858344156,1,0,0,0.6920415224913495,0.05973073394752387,GRM4;ADRB3;CCL3L1;ANGPT1;CCL5;FGG;SPRY2;EPHA1;SLAMF1;TNFRSF10D
BMP signaling pathway (GO:0030509),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,HFE;BMP7
protein catabolic process (GO:0030163),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,VCP;HTRA2
nervous system development (GO:0007399),17/455,0.9180721822424983,1,0,0,0.7472527472527472,0.06387461303311805,EGR2;EIF2B2;AVIL;SHOX2;TMOD2;PCSK9;NRXN2;MTR;PROX1;CYP46A1;RPS6KA3;ZEB2;RPS6KA6;PCDHA2;FGF13;CDK5RAP2;PCDHAC1
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,BPIFA1
regulation of reactive oxygen species metabolic process (GO:2000377),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,SNCA
establishment of protein localization to mitochondrion (GO:0072655),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,TIMM10
plasma membrane bounded cell projection assembly (GO:0120031),8/241,0.9193661993761398,1,0,0,0.6639004149377593,0.05581461249509647,TBC1D32;AVIL;WDR5B;B9D1;TEKT4;TRIM59;VSTM5;NTN1
phosphorylation (GO:0016310),14/386,0.9199241122724855,1,0,0,0.7253886010362693,0.06054390601152663,CDK11A;PRKDC;DGKB;TNK1;WNK4;NIPSNAP2;GK5;RPS6KA3;RPS6KA6;TBK1;RARA;BMP2K;MAP3K9;SGK1
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),10/291,0.9211129670420751,1,0,0,0.6872852233676976,0.056476009146538685,ABTB1;VCP;HERC2;RNF216;KCTD10;TBL1XR1;KLHL15;LTN1;FBXO6;FBXO9
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,RPS6KA6;ZNF385A
positive regulation of protein secretion (GO:0050714),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,FGG;ISL1
ephrin receptor signaling pathway (GO:0048013),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,RASA1;EPHA1
protein oligomerization (GO:0051259),7/217,0.9215003330125441,1,0,0,0.6451612903225806,0.05274331644604892,GSDMD;CCL5;FLOT1;NLRP3;OLFM4;VSTM5;SLC9A1
cellular response to growth factor stimulus (GO:0071363),4/139,0.9216307962341534,1,0,0,0.5755395683453237,0.04697011427115409,CCL5;STMN2;HTRA2;BMP7
positive regulation of JUN kinase activity (GO:0043507),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,MAP3K9
regulation of blood vessel endothelial cell migration (GO:0043535),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,ANGPT1
wound healing (GO:0042060),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,SYT7
positive regulation of protein ubiquitination (GO:0031398),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,ANGPT1;PDCD6
negative regulation of endopeptidase activity (GO:0010951),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,BIN1;SERPINA7
mitochondrion organization (GO:0007005),5/167,0.9248072028145058,1,0,0,0.5988023952095808,0.046808378792730115,PRDX3;BNIP3L;AARS2;MSTO1;TIMM10
positive regulation of canonical Wnt signaling pathway (GO:0090263),3/113,0.9261680268010687,1,0,0,0.5309734513274336,0.04072545470868394,VCP;TNKS2;TBL1XR1
modification-dependent protein catabolic process (GO:0019941),4/141,0.9266564783264885,1,0,0,0.5673758865248226,0.04321835780862881,AREL1;HACE1;KCTD10;KLHL15
negative regulation of neuron projection development (GO:0010977),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,STMN2
regulation of cellular amine metabolic process (GO:0033238),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,OAZ1
regulation of cellular amino acid metabolic process (GO:0006521),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,OAZ1
arachidonic acid metabolic process (GO:0019369),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,CYP4A11
activation of GTPase activity (GO:0090630),2/84,0.9274839879498789,1,0,0,0.47619047619047616,0.035847499197840214,TBC1D4;EPHA1
cellular macromolecule biosynthetic process (GO:0034645),13/367,0.9275428036098997,1,0,0,0.7084468664850136,0.053286777633238726,RPL4;RPL39L;RPS9;GTF3C3;RPL32;RPL21;RFC2;MRPS5;RECQL5;RPL36;POLR2E;POLL;POLR2K
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),4/142,0.9290588553855328,1,0,0,0.5633802816901409,0.04145531757308912,VCAM1;CLDN19;CLDN18;CDH9
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),2/85,0.9304527474425885,1,0,0,0.47058823529411764,0.03392187580644571,ANGPT1;ENPP2
positive regulation of proteolysis (GO:0045862),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,FURIN
B cell differentiation (GO:0030183),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,VCAM1
positive regulation of nervous system development (GO:0051962),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,DLG5
triglyceride metabolic process (GO:0006641),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,GK5
regulation of cell proliferation (GO:0042127),29/740,0.9322078482910112,1,0,0,0.7837837837837838,0.05502121089737269,BTG3;CCL3L1;PRKDC;TCIRG1;PRDX3;GHRHR;ABL2;UTP20;SLAMF1;EIF5A;KLF11;RPS9;TNK1;HTR1A;PROX1;ZNF16;TNFRSF10D;NME1;AGO3;IL7;DLG5;RARA;STAMBP;INSM1;IL6ST;FOLR2;KIF20B;EPHA1;SGK1
calcium ion transmembrane transport (GO:0070588),2/86,0.9333063042418757,1,0,0,0.46511627906976744,0.032103177510297835,TRPA1;MCOLN1
positive regulation of protein kinase activity (GO:0045860),5/172,0.9355866507969429,1,0,0,0.5813953488372092,0.0387101816514217,PIH1D1;CCL5;MAP3K14;CAMKK1;SNCA
mitochondrial translational elongation (GO:0070125),2/87,0.9360487418513352,1,0,0,0.45977011494252873,0.03038516286569491,MRPL20;MRPS5
cellular response to BMP stimulus (GO:0071773),2/87,0.9360487418513352,1,0,0,0.45977011494252873,0.03038516286569491,HFE;BMP7
regulation of MAP kinase activity (GO:0043405),2/87,0.9360487418513352,1,0,0,0.45977011494252873,0.03038516286569491,SPRY2;BMP7
sensory perception (GO:0007600),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,TRPA1
intracellular transport of virus (GO:0075733),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,TPR
negative regulation of cellular component organization (GO:0051129),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,SPRY2
membrane fusion (GO:0061025),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,HACE1
transport of virus (GO:0046794),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,TPR
cytosolic transport (GO:0016482),3/118,0.9385998386464456,1,0,0,0.5084745762711864,0.03222002416809474,CCDC91;SYT7;RAB9B
positive regulation of protein serine/threonine kinase activity (GO:0071902),3/118,0.9385998386464456,1,0,0,0.5084745762711864,0.03222002416809474,PIH1D1;PROX1;SNCA
negative regulation of translation (GO:0017148),2/88,0.9386840239616273,1,0,0,0.45454545454545453,0.028761981412220677,DHFR;TPR
protein phosphorylation (GO:0006468),17/470,0.9388978553271944,1,0,0,0.7234042553191489,0.04560961537539531,CDK11A;MAST4;PRKDC;TNK1;WNK4;DCLK2;CAMKK1;RPS6KA3;RPS6KA6;TBK1;RARA;BMP2K;ABL2;MAP3K9;EPHA1;SGK1;CSNK1A1L
negative regulation of Wnt signaling pathway (GO:0030178),5/174,0.9394959229953125,1,0,0,0.5747126436781609,0.03586885039386898,DAB2;CITED1;DACT3;SCYL2;DKK3
regulation of axonogenesis (GO:0050770),1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,CTTN
regulation of RNA splicing (GO:0043484),1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,JMJD6
DNA recombination (GO:0006310),1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,RECQL5
regulation of phosphorylation (GO:0042325),3/119,0.9408414997698965,1,0,0,0.5042016806722689,0.030746516803698005,CCL5;TPR;BMP7
mitochondrial translational termination (GO:0070126),2/89,0.9412159961600209,1,0,0,0.449438202247191,0.02722814686661418,MRPL20;MRPS5
DNA replication (GO:0006260),3/120,0.943007142220116,1,0,0,0.5,0.029340711221493156,RECQL5;RFC2;POLL
negative regulation of growth (GO:0045926),3/120,0.943007142220116,1,0,0,0.5,0.029340711221493156,DACT3;CRLF3;ING1
regulation of secretion by cell (GO:1903530),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,HTR1A
DNA-dependent DNA replication (GO:0006261),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,RFC2
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,SPPL2A
phosphatidylinositol-mediated signaling (GO:0048015),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,INPP5F
cellular response to interleukin-1 (GO:0071347),4/150,0.9458578993017942,1,0,0,0.5333333333333333,0.02968689779615251,MAPK11;CCL3L1;NLRP7;CCL5
protein-DNA complex assembly (GO:0065004),2/91,0.9459848142593618,1,0,0,0.43956043956043955,0.024408247313871943,SART3;RAD23B
regulation of glycolytic process (GO:0006110),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,TPR
cellular respiration (GO:0045333),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,BLOC1S1
protein polyubiquitination (GO:0000209),9/283,0.9479450306278001,1,0,0,0.636042402826855,0.034002040056752544,HACE1;RNF216;TNKS2;UBE2Q2;UBE2NL;FBXO6;RNF183;FBXO32;FBXO9
translation (GO:0006412),7/232,0.9482160577150395,1,0,0,0.603448275862069,0.032087091033292194,RPL4;RPL39L;RPS9;RPL32;RPL21;RPL36;MRPS5
cell cycle G1/S phase transition (GO:0044843),2/92,0.9482287784921883,1,0,0,0.43478260869565216,0.02311281666022285,CRLF3;EIF4E
positive regulation of nucleic acid-templated transcription (GO:1903508),18/502,0.9483749173042058,1,0,0,0.7171314741035857,0.038011820931580724,CREBBP;EGR2;CITED1;WBP2;NR1H2;EDF1;PBX4;PROX1;ARID1A;BMP7;FOXO1;DAB2;TAL1;TBL1XR1;ZIC1;RARA;CRLF3;CDK5RAP2
tumor necrosis factor-mediated signaling pathway (GO:0033209),3/123,0.9490704428624263,1,0,0,0.4878048780487805,0.02549866078547662,MAP3K14;COMMD7;TNFRSF10D
positive regulation of intracellular signal transduction (GO:1902533),17/479,0.9490905726198201,1,0,0,0.7098121085594989,0.03708842432884697,CANT1;HDAC3;MYOC;ANGPT1;IL18;TNFRSF10D;AKAP13;HTR6;TBK1;GRM4;ADRB3;CCL5;DLG5;TRAF5;SPRY2;EPHA1;MAP3K14
receptor metabolic process (GO:0043112),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,SNCA
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,SPRY2
regulation of signal transduction (GO:0009966),7/233,0.9496688325218982,1,0,0,0.6008583690987124,0.0310294993604891,CREBBP;PLSCR1;NCLN;ZIC1;DACT3;RFNG;EPHA1
activation of protein kinase activity (GO:0032147),7/233,0.9496688325218982,1,0,0,0.6008583690987124,0.0310294993604891,MAPK11;GRM4;ANGPT1;PRKAR2A;IL18;MAP3K14;DRD4
platelet degranulation (GO:0002576),3/124,0.9509542388487732,1,0,0,0.48387096774193544,0.024333549956038612,PSAP;FGG;TLN1
protein ubiquitination (GO:0016567),18/506,0.9523765891655812,1,0,0,0.7114624505928854,0.03471562924937521,VCP;HACE1;AREL1;PRKDC;KLHL15;KLHL26;FBXO32;KLHL30;ABTB1;HERC2;TNKS2;KCTD10;GAN;UBE2Q2;FBXO6;VHLL;RNF183;FBXO9
cell chemotaxis (GO:0060326),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,GPR32
nucleosome assembly (GO:0006334),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,SART3
response to reactive oxygen species (GO:0000302),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,PRDX3
proteasomal protein catabolic process (GO:0010498),7/237,0.9551223588537756,1,0,0,0.5907172995780591,0.02712327053004207,ABTB1;VCP;HERC2;RNF216;KCTD10;TBL1XR1;LTN1
non-canonical Wnt signaling pathway (GO:0035567),3/127,0.9562226890751985,1,0,0,0.47244094488188976,0.021148561272512884,AGO3;AGO1;FZD8
translational termination (GO:0006415),2/96,0.9563462737985303,1,0,0,0.41666666666666663,0.018598008511252703,MRPL20;MRPS5
potassium ion transport (GO:0006813),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,ABCC8
regulation of vesicle fusion (GO:0031338),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,TBC1D4
positive regulation of leukocyte chemotaxis (GO:0002690),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,CCL5
regulation of cellular ketone metabolic process (GO:0010565),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,OAZ1
positive regulation of NF-kappaB transcription factor activity (GO:0051092),3/128,0.9578577572454201,1,0,0,0.46875,0.02018249573547579,PRDX3;TRAF5;NLRP3
mRNA metabolic process (GO:0016071),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,AGO3;PRPF8
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,SEC24A;SAR1B
antigen processing and presentation of exogenous peptide antigen (GO:0002478),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,SEC24A;SAR1B
protein localization to organelle (GO:0033365),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,CROCC;BMP7
regulation of canonical Wnt signaling pathway (GO:0060828),6/213,0.9584257625041144,1,0,0,0.5633802816901409,0.02392291337420207,VCP;DAB2;TNKS2;TBL1XR1;SCYL2;DKK3
stress-activated MAPK cascade (GO:0051403),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,MAPK11
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,ZNF385A
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),2/98,0.9599334606764933,1,0,0,0.4081632653061224,0.01669033008887676,SEC24A;SAR1B
response to UV (GO:0009411),2/98,0.9599334606764933,1,0,0,0.4081632653061224,0.01669033008887676,CREBBP;TMEM161A
defense response to bacterium (GO:0042742),7/241,0.960039090830733,1,0,0,0.5809128630705394,0.023690367646265958,GSDMD;BPIFA1;DEFB131A;SPACA1;DROSHA;LBP;MPO
synapse assembly (GO:0007416),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,NRXN2
oligosaccharide metabolic process (GO:0009311),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,ST6GALNAC3
carbohydrate homeostasis (GO:0033500),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,PYGL
regulation of proteolysis (GO:0030162),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,ABTB1
protein glycosylation (GO:0006486),3/130,0.9609575692842738,1,0,0,0.46153846153846156,0.018380780149132046,FUT5;TMEM258;TNKS2
cellular protein modification process (GO:0006464),39/1001,0.9610808315145388,1,0,0,0.7792207792207791,0.030932541562035017,PRKDC;RAB1B;WNK4;PCSK9;CHM;ASB17;ASB15;LCE1A;C4A;FUT5;RPS6KA3;RPS6KA6;TBK1;ASB10;ABL2;FBXO6;MAP3K9;FBXO9;ARSA;PTPN18;USP25;CDK11A;PTPRN2;TNK1;FGG;LAMB1;WIPI2;FBXO32;LCE1F;COPS6;LCE2A;GAN;MGAT4A;QPCT;BMP2K;RARA;SGK1;UBE2M;ATG4D
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,CDH9
NADH dehydrogenase complex assembly (GO:0010257),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFAF6
mitochondrial respiratory chain complex I biogenesis (GO:0097031),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFAF6
mitochondrial respiratory chain complex I assembly (GO:0032981),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFAF6
glycerophospholipid metabolic process (GO:0006650),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,PIGW
glucose metabolic process (GO:0006006),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,PCK2
positive regulation of cell adhesion (GO:0045785),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,CCL5
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,ANGPT1
regulation of protein ubiquitination (GO:0031396),2/101,0.9647890418591292,1,0,0,0.396039603960396,0.014196360797659355,ANGPT1;PRMT3
JNK cascade (GO:0007254),1/66,0.9663236546235302,1,0,0,0.30303030303030304,0.010380743845736572,MAP3K9
phagocytosis (GO:0006909),3/135,0.9677952919812572,1,0,0,0.4444444444444444,0.014548750798032252,RARA;SYT7;CSNK1A1L
regulation of cardiac conduction (GO:1903779),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,CORIN
cellular response to tumor necrosis factor (GO:0071356),5/194,0.9683165268397839,1,0,0,0.5154639175257731,0.016596007535230658,CCL3L1;CCL5;COMMD7;MAP3K14;TNFRSF10D
regulation of gene expression (GO:0010468),40/1037,0.9684215238559458,1,0,0,0.7714561234329798,0.02475435136836264,DDX3Y;RBM27;DNMT1;RHOXF1;ZNF790;CITED1;MAGED1;ZC3H3;HFE;ACTG2;IWS1;C1QTNF1;SART3;NLRP7;ZNF429;LAMP3;MLX;HMG20B;ITGB8;NLRP3;ZNF267;FADS1;ZNF420;KLRG1;CREBBP;CDK11A;TGIF2;PRMT7;PRMT3;EDF1;PROX1;ZNF16;MAPK11;PLSCR1;ZNF71;PKP1;SPRY2;PKP3;INSM1;PTF1A
regulation of cellular response to stress (GO:0080135),2/104,0.9690762134019278,1,0,0,0.38461538461538464,0.0120815456087189,CREBBP;TPR
neuropeptide signaling pathway (GO:0007218),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,NPBWR2
negative regulation of developmental process (GO:0051093),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,RPS6KA6
mitochondrial translation (GO:0032543),2/107,0.9728581476955978,1,0,0,0.3738317757009345,0.01028672748442257,MRPL20;MRPS5
regulation of small GTPase mediated signal transduction (GO:0051056),3/140,0.9734908104308518,1,0,0,0.42857142857142855,0.011514383115519571,ARHGAP33;AKAP13;ARHGAP20
positive regulation of Wnt signaling pathway (GO:0030177),3/140,0.9734908104308518,1,0,0,0.42857142857142855,0.011514383115519571,VCP;TNKS2;TBL1XR1
negative regulation of cellular process (GO:0048523),18/534,0.973585513281085,1,0,0,0.6741573033707865,0.01804693278084859,BTG3;BNIP3L;KLF11;ADAMDEC1;ANGPT1;CCL3L1;HTRA2;PROX1;ING1;BMP7;NME1;DLG5;RASA1;TXNIP;DACT3;UTP20;INSM1;CRLF3
positive regulation of growth (GO:0045927),1/71,0.9739647545480367,1,0,0,0.28169014084507044,0.00743103163098366,RPS6KA3
regulation of cation channel activity (GO:2001257),1/71,0.9739647545480367,1,0,0,0.28169014084507044,0.00743103163098366,SLMAP
endosomal transport (GO:0016197),6/229,0.9747981501300949,1,0,0,0.5240174672489082,0.013375469829496991,ARL4C;BIN1;BLOC1S1;SNX17;RAB9B;SCYL2
regulation of Wnt signaling pathway (GO:0030111),2/109,0.9751270159817813,1,0,0,0.3669724770642202,0.009243135290725672,CITED1;DACT3
lymphocyte differentiation (GO:0030098),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,VCAM1
positive regulation of cytokine secretion (GO:0050715),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,MAPK11
DNA metabolic process (GO:0006259),9/314,0.9775565154292575,1,0,0,0.5732484076433121,0.013012264489298363,CTC1;DNMT1;VCP;RECQL5;PRKDC;RFC2;FBXO6;SLX1A;POLL
protein autophosphorylation (GO:0046777),4/175,0.9776183591008238,1,0,0,0.45714285714285713,0.010347845016468711,TNK1;ABL2;MAP3K9;EPHA1
mRNA 3'-end processing (GO:0031124),1/74,0.9776904281936729,1,0,0,0.2702702702702703,0.00609789044447976,ZC3H3
ubiquitin-dependent protein catabolic process (GO:0006511),10/341,0.9780078129906765,1,0,0,0.5865102639296188,0.013042592513904125,ABTB1;VCP;HERC2;HACE1;AREL1;RNF216;KCTD10;TBL1XR1;KLHL15;LTN1
"mRNA splicing, via spliceosome (GO:0000398)",7/261,0.9780539499357546,1,0,0,0.5363984674329502,0.011902921727736455,LSM7;PRMT7;SART3;POLR2E;CWC27;PRPF8;POLR2K
positive regulation of MAP kinase activity (GO:0043406),4/177,0.9791925960289664,1,0,0,0.4519774011299435,0.009503696496085842,MAPK11;GRM4;MAP3K14;DRD4
endocytosis (GO:0006897),7/263,0.9793648420387298,1,0,0,0.5323193916349809,0.011099411760360334,CTTN;BIN1;DNAJC6;FOLR2;SYT7;PDLIM7;CSNK1A1L
regulation of hematopoietic stem cell differentiation (GO:1902036),1/76,0.9798733026216075,1,0,0,0.2631578947368421,0.005350525977491548,TAL1
positive regulation of JNK cascade (GO:0046330),1/76,0.9798733026216075,1,0,0,0.2631578947368421,0.005350525977491548,SLAMF1
positive regulation of apoptotic signaling pathway (GO:2001235),1/76,0.9798733026216075,1,0,0,0.2631578947368421,0.005350525977491548,HTRA2
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",6/236,0.979883008259396,1,0,0,0.5084745762711864,0.010333268019124788,LSM7;SART3;POLR2E;CWC27;PRPF8;POLR2K
negative regulation of canonical Wnt signaling pathway (GO:0090090),3/148,0.9806622539772427,1,0,0,0.40540540540540543,0.007916418722549444,DAB2;SCYL2;DKK3
regulated exocytosis (GO:0045055),3/148,0.9806622539772427,1,0,0,0.40540540540540543,0.007916418722549444,PSAP;FGG;TLN1
response to ionizing radiation (GO:0010212),1/77,0.9808833558575986,1,0,0,0.2597402597402597,0.00501343630948899,EYA1
regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/77,0.9808833558575986,1,0,0,0.2597402597402597,0.00501343630948899,TAL1
protein O-linked glycosylation (GO:0006493),2/115,0.9808862990126357,1,0,0,0.34782608695652173,0.0067126014891210894,SLC35C1;RFNG
regulation of G2/M transition of mitotic cell cycle (GO:0010389),3/149,0.981416039698096,1,0,0,0.40268456375838924,0.007553883933884644,CENPF;CEP63;CDK5RAP2
negative regulation of cell communication (GO:0010648),1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,EPHA1
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,CREBBP
negative regulation of cell differentiation (GO:0045596),3/150,0.9821417073273939,1,0,0,0.39999999999999997,0.00720787048982501,CITED1;NR1H2;FOXO1
protein stabilization (GO:0050821),3/152,0.9835125918696039,1,0,0,0.3947368421052631,0.006562436097584378,CRTAP;FLOT1;CPN2
positive regulation of stress-activated MAPK cascade (GO:0032874),1/80,0.9836196507462239,1,0,0,0.25,0.004128997611953673,SLAMF1
regulation of mitotic cell cycle phase transition (GO:1901990),4/184,0.9839182957428624,1,0,0,0.43478260869565216,0.007048877460408607,CENPF;MAD2L1BP;CEP63;CDK5RAP2
regulation of cellular macromolecule biosynthetic process (GO:2000112),21/631,0.9843278975678201,1,0,0,0.6656101426307448,0.010514116394907127,CREBBP;CDK11A;ZNF790;PRMT7;RHOXF1;TGIF2;MAGED1;EHMT2;PRMT3;EDF1;ZNF16;ZNF71;ZNF429;MLX;HMG20B;PTF1A;EIF4E;ZNF267;FADS1;ZNF420;KLRG1
positive regulation of protein targeting to mitochondrion (GO:1903955),1/81,0.9844418345091214,1,0,0,0.24691358024691357,0.003871719481130927,HTRA2
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),5/215,0.9845068780813672,1,0,0,0.46511627906976744,0.007262509096398892,PRDX3;JMY;TRAF5;ARID5B;NLRP3
cytokine-mediated signaling pathway (GO:0019221),21/633,0.984996061989487,1,0,0,0.6635071090047393,0.010030658823487651,LRRC15;VCAM1;CCL3L1;GSTO1;LRTM2;HFE;PITPNA;IL18;HLA-C;COMMD7;FOXO1;TNFRSF10D;IL27RA;IL7;CCL5;LRRTM1;CASP3;LBP;IL6ST;GBP2;MAP3K14
"retrograde transport, endosome to Golgi (GO:0042147)",1/82,0.9852227825319085,1,0,0,0.24390243902439024,0.003631094688901337,RAB9B
negative regulation of binding (GO:0051100),1/82,0.9852227825319085,1,0,0,0.24390243902439024,0.003631094688901337,DAB2
stimulatory C-type lectin receptor signaling pathway (GO:0002223),2/121,0.9853427079965097,1,0,0,0.3305785123966942,0.004881246751261704,CLEC4A;CREBBP
regulation of transcription from RNA polymerase II promoter (GO:0006357),57/1478,0.9869076649809899,1,0,0,0.7713125845737482,0.010164970517281817,CITED1;EHMT2;ANKRD33;HFE;BHLHE41;CHD4;CGB3;RPS6KA3;NIPBL;TBK1;ZMYM2;HEY1;NKRF;MLX;VENTX;KLF11;NKX6-3;TGIF2;MSX2;IL18;KCTD1;ARID5B;PROX1;ARID1A;ISL1;ETV4;ETV7;NCOR2;RFX8;PLSCR1;ZEB2;TAL1;TBL1XR1;RARA;NCOA7;HDAC3;PRKDC;WBP2;ZBTB5;FOXO1;SLC9A1;TPR;NLRP3;ZBED4;SNCA;CREBBP;EGR2;TAF13;NR1H2;BMP7;GATAD2A;FOXR1;FAM200A;AGO1;JMY;INSM1;CRLF3
innate immune response activating cell surface receptor signaling pathway (GO:0002220),2/124,0.987173993434516,1,0,0,0.3225806451612903,0.004164183852806964,CLEC4A;CREBBP
dephosphorylation (GO:0016311),2/124,0.987173993434516,1,0,0,0.3225806451612903,0.004164183852806964,PTPN18;PTPRN2
negative regulation of macromolecule metabolic process (GO:0010605),2/124,0.987173993434516,1,0,0,0.3225806451612903,0.004164183852806964,PCSK9;ITGB8
mitotic cell cycle phase transition (GO:0044772),5/221,0.9874462808047124,1,0,0,0.4524886877828054,0.005716372340113483,CEP63;CRLF3;EIF4E;CDK5RAP2;CLASP2
negative regulation of cell proliferation (GO:0008285),10/363,0.9881251459239097,1,0,0,0.5509641873278237,0.006581775945361194,BTG3;KLF11;CCL3L1;MAGED1;DLG5;UTP20;NLRC3;PROX1;INSM1;NME1
G2/M transition of mitotic cell cycle (GO:0000086),2/126,0.9882689055470334,1,0,0,0.31746031746031744,0.0037461735428357327,CEP63;CDK5RAP2
RNA processing (GO:0006396),4/193,0.9885116590964149,1,0,0,0.41450777202072536,0.004789571691251934,LSM7;XRN2;DROSHA;PRPF8
cell cycle G2/M phase transition (GO:0044839),2/127,0.9887816352200313,1,0,0,0.31496062992125984,0.0035533118886497796,CEP63;CDK5RAP2
T cell activation (GO:0042110),1/88,0.9891512672040396,1,0,0,0.22727272727272727,0.002479093046554197,NLRC3
regulation of stem cell differentiation (GO:2000736),1/88,0.9891512672040396,1,0,0,0.22727272727272727,0.002479093046554197,TAL1
regulation of protein targeting to mitochondrion (GO:1903214),1/88,0.9891512672040396,1,0,0,0.22727272727272727,0.002479093046554197,HTRA2
negative regulation of cellular protein metabolic process (GO:0032269),1/89,0.9896959732105118,1,0,0,0.2247191011235955,0.002327523771873428,DHFR
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),29/848,0.9904553657833242,1,0,0,0.6839622641509433,0.006559523793792118,HDAC3;PRKDC;WBP2;FOXO1;SLC9A1;RPS6KA3;NIPBL;TBK1;HEY1;NKRF;MLX;NLRP3;VENTX;CREBBP;EGR2;NKX6-3;NR1H2;IL18;PROX1;ISL1;ETV4;PLSCR1;ZEB2;TAL1;TBL1XR1;AGO1;RARA;NCOA7;CRLF3
positive regulation of cellular protein metabolic process (GO:0032270),1/91,0.9907047643496917,1,0,0,0.21978021978021978,0.002052462844095697,NR1H2
phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),1/91,0.9907047643496917,1,0,0,0.21978021978021978,0.002052462844095697,GPR32
regulation of nucleic acid-templated transcription (GO:1903506),19/607,0.991205704381249,1,0,0,0.6260296540362438,0.005529841169935242,CREBBP;CDK11A;ZNF790;PRMT7;RHOXF1;TGIF2;MAGED1;PRMT3;EDF1;ZNF16;ZNF71;ZNF429;MLX;HMG20B;PTF1A;ZNF267;FADS1;ZNF420;KLRG1
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/93,0.9916148544307698,1,0,0,0.21505376344086022,0.0018108599286685806,CREBBP
proteolysis involved in cellular protein catabolic process (GO:0051603),1/93,0.9916148544307698,1,0,0,0.21505376344086022,0.0018108599286685806,VCP
transcription from RNA polymerase II promoter (GO:0006366),14/485,0.9923986050672259,1,0,0,0.5773195876288659,0.0044051983065166,KLF11;CREBBP;EGR2;TAF13;NR1H2;DDX21;PBX4;GTF2E2;IWS1;ETV7;RARA;POLR2E;PKNOX1;POLR2K
regulation of cytoskeleton organization (GO:0051493),1/95,0.9924358915832194,1,0,0,0.21052631578947367,0.0015984971305800805,STMN2
cell morphogenesis involved in neuron differentiation (GO:0048667),1/97,0.993176581718741,1,0,0,0.20618556701030927,0.001411712214835502,SLITRK3
cellular response to organonitrogen compound (GO:0071417),1/97,0.993176581718741,1,0,0,0.20618556701030927,0.001411712214835502,AQP8
B cell receptor signaling pathway (GO:0050853),1/104,0.9952429552680097,1,0,0,0.19230769230769232,9.169991309490005e-4,LAT2
positive regulation of lymphocyte activation (GO:0051251),1/104,0.9952429552680097,1,0,0,0.19230769230769232,9.169991309490005e-4,CCDC88B
RNA splicing (GO:0008380),1/106,0.9957088736018097,1,0,0,0.18867924528301885,8.113886235340445e-4,PRPF8
mRNA processing (GO:0006397),6/283,0.9959327577369046,1,0,0,0.42402826855123676,0.0017281424688094721,LSM7;SART3;POLR2E;CWC27;PRPF8;POLR2K
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/110,0.9965083121081099,1,0,0,0.1818181818181818,6.359632838921655e-4,HTRA2
positive regulation of B cell activation (GO:0050871),1/119,0.9978042883455355,1,0,0,0.1680672268907563,3.694329014686676e-4,IL7
"positive regulation of transcription, DNA-templated (GO:0045893)",37/1120,0.9981290252596934,1,0,0,0.6607142857142857,0.001237337614126337,HDAC3;CITED1;PRKDC;WBP2;FOXO1;WDR43;SLC9A1;RPS6KA3;TBK1;HEY1;NKRF;ZIC1;MLX;NLRP3;CDK5RAP2;VENTX;CREBBP;EGR2;NKX6-3;NR1H2;IL18;EDF1;PBX4;PROX1;ARID1A;ISL1;BMP7;ETV4;PLSCR1;ZEB2;DAB2;TAL1;TBL1XR1;AGO1;RARA;NCOA7;CRLF3
negative regulation of multicellular organismal process (GO:0051241),1/125,0.9983882960769273,1,0,0,0.16,2.580806584071521e-4,RPS6KA6
regulation of mRNA stability (GO:0043488),1/128,0.9986191297313574,1,0,0,0.15625,2.1591008571631521e-4,SERBP1
positive regulation of mitochondrion organization (GO:0010822),1/128,0.9986191297313574,1,0,0,0.15625,2.1591008571631521e-4,HTRA2
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/133,0.99893267616922,1,0,0,0.15037593984962405,1.6058553781593565e-4,MYO10
Fc-gamma receptor signaling pathway (GO:0038094),1/134,0.99898625000142,1,0,0,0.14925373134328357,1.5138271502198073e-4,MYO10
Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/135,0.9990371293746406,1,0,0,0.14814814814814814,1.427162197126682e-4,MYO10
positive regulation of macromolecule biosynthetic process (GO:0010557),1/142,0.9993283968538873,1,0,0,0.14084507042253522,9.462377077918737e-5,CTC1
T cell receptor signaling pathway (GO:0050852),1/163,0.9997711364778918,1,0,0,0.12269938650306748,2.8084627651602883e-5,EIF2B2
Fc-epsilon receptor signaling pathway (GO:0038095),1/182,0.9999123468660401,1,0,0,0.10989010989010989,9.632634694539242e-6,LAT2
Fc receptor signaling pathway (GO:0038093),1/183,0.9999166029420871,1,0,0,0.1092896174863388,9.114812638352758e-6,LAT2
antigen receptor-mediated signaling pathway (GO:0050851),2/257,0.9999710068675668,1,0,0,0.1556420233463035,4.51261521279322e-6,LAT2;EIF2B2
